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Abstract 
This thesis examines the synthesis and proteolytic properties of 
a new class of latent reactive amino acid analogue, eg: 1-(N-Phthaloyl-L-
phenylalanyl)-2-hydroxymethylpyrrole 2.52, designed to inhibit serine 
proteases and the HN protease. 
Chapter One discusses the possible mode of protease inhibition 
by these derivatives. The substrate specificity of chymotrypsin, and 
HN -1 protease suggests that the pyrrole occupies the PI' subsite, and 
the N-acyl group the PI subsite. Acceptance into the active site, and 
subsequent cleavage of the amide bond releases the highly reactive 
l-azafulvene 1.3 that can alkyl ate an active site nucleophilic residue. 
Chapter Two presents procedures for the N-acylation of pyrrole 
derivatives. Pyrrole-2-carboxaldehyde was successfully N-acylated with 
non-amino acid acylating agents using either, NaH, MeLi, or BuLL A 
new mild procedure was developed for the N-acylation of pyrroles 
using a DMAP / organiC base combination. The DMAP / organic base (TEA 
or Hiinigs base) methodology was extended to the N-acylaUon of 
pyrrole-2-carboxaldehyde with N-Pth protected amino acid acid 
chlorides. The subsequent reduction of the N-acylated formyl pyrrole, 
1-(N-Phthaloyl-L-phenylalanyl)-2-formylpyrrole 2.37, with Zn(BH4l2 
produced high yields of the N-acylated hydroxymethyl pyrrole 2.52. A 
IH NMR analysis of the camphanate prepared from 2.37 demonstrated 
that racemisation had not occurred. A detailed I Hand 13C NMR 
spectral analysis of the formyl and hydroxymethyl pyrroles is discussed 
in this chapter. 
Chapter Three extends the synthesis to incorporate potential 
hydrogen bonding sites in the Px' sub site direction. The imine N-(2-
Pyrrolylmethylene)-L-alanine Ethyl Ester 3.12 was prepared from 
pyrrole-2-carboxaldehyde, by reaction with H2N-Ala-OEt and pyrrole-2-
carboxaldehyde with removal of water. The analogous imine formation 
using the N-acylated formyl pyrrole 1-(3-Phenylpropionyl)-2-
formylpyrrole 2.31 produced high yields of the non-acylated imine 
3.12. The N-acylation of 3.12 under the DMAP/Hiinigs base conditions 
using hydroclnnamoyl chloride did not proceed. 
Esterification of the hydroxymethyl pyrrole 2.52 under 
Mitsunobu conditions with the dipeptide N-Cbz-Val-Val-OH produced 
the tetrapeptide, N-benzyloxycarbonyl-L-valinyl-L-valine-l-(N-
phthaloyl-L-phenylalanyl)pyrrol-2-ylmethyl Ester 3.39. 
Chapter Four presents a hydrolysis and mechanistic study on the 
deacylatIon of 1-(3-Phenylpropionyl)-2-hydroxymethylpyrrole 2.32 with 
HO-. The deacylatIon of 2.32 in CD3CN, containing one equivalent of 
KOH, produced 2-(3-Phenylpropionyl)-2-methylpyrrole Ester 4.5. This 
species was shown to form via an intramolecular mechanism. Chiral, 
deuterium labelling of the methylene position showed that 
racemisation at this position had not occurred in the formation of 4.5. 
An azafulvene intermediate is therefore precluded. A kinetic analysis of 
the subsequent conversion of 4.5 to 2-Butylaminomethylpyrrole 4.6, in 
the presence of n-butylamine, showed the reaction to be first order 
with respect to HO-. 
The hydrolysis of deuterium labelled [6-d11-(6S)-I-(N-Phthaloyl-
L-leucyl)-2-hydroxymethylpyrrole 4.14 with HO- in CD3CN, gave the 
corresponding O-acetylated pyrrole 4.9 without racemisation. The 
addition of (S)-(+)-sec-butylamine to the reaction, trapped the 
azafulvene as [6-dd-(8S)-( + )-2-( I-methylpropionylamino)methylpyrrole 
4.36.N-acylation was also shown to suppress azafulvene chemistry and 
therefore increase the stability of the hydroxymethyl pyrrole system. 
The camphanate from [6-dl]-(6S)-I-(3-Phenylpropionyl)-2-hydroxy 
methylpyrrole 4.10 formed under the Mitsunobu conditions proceeded 
with 62% inversion of configuration of the methylene position, 
Chapter Five deals with the a-chymotrypsin and HN-l protease 
inhibitor properties of the pyrrole derivatives 2.32, 2.52, 1-(N-
Phthaloyl-D-phenylalanyl)-2-hydroxymethylpyrrole 2.55, 3.39, 1-
(Undecyl)-2-hydroxymethylpyrrole 3.53 and 1-((5-Methoxycarbonyl) 
hexanyl)-2-hydroxymethylpyrrole 3.55. These compounds were found 
to be modest inhibitors of a-chymotrypsin, but poor inhibitors of HN-1 
protease. The stability of the hydroxymethyl pyrrole 2.52 was shown to 
be low under the HN protease assay conditions. A discussion on 
molecular modelling and docking the proposed inhibitors into the 
active site of HN -1 protease is presented. 
CHAPTER ONE 
NTRODUCTION 
Introduction 2 
HN protease and chymotrypsin are two examples of proteases that 
cleave peptide substrates on the carboxyl side of aromatic amino acids. The 
work described in this thesis outlines the design, synthesis and protease 
inhibitor properties of a new class of potential mechanism based enzyme 
inhibitors. The inhibitors target those enzymes that cleave on the carboxyl 
side of aromatic amino acids. 
Additionally, there are several enzymes that have the unusual 
characteristic of cleaving a peptide on the N-terminal side of proline (Pro). 
Among these enzymes are the HN-l and HN-2 proteases 1 and Kidney 
Prolidases2 . Cleavage next to Pro is unusual in mammalian systems, and as 
such to develop an inhibitor that acts specifically on this system must be of 
pharmaceutical importance. 
The inhibitors discussed in this thesis have been designed so that 
phenylalanine (Phe), or indeed any amino acid. is joined to a group X that 
possess latent reactivity, see 1.1 in Figure 1.1. A hydroxymethyl pyrrole. 1.2, 
has been chosen for the latent reactive group X. 
1.1 
X= ~OH N 
I 
1.2 
Figure 1.1 
~ N 
1.3 
Enzyme catalysed hydrolysis of the Phe-X amide bond releases a highly 
reactive azafulvene 1.3, that is postulated to react with a nucleophilic residue 
in the protease active site, to give covalent inhibition. Since the latent 
reactivity is released on enzyme hydrolysis, and since the reactive group is 
not directly bound to the enzyme, the process is classed as metabolically 
activated inhibition. This is an important subset of true mechanism based 
inhibition. A general discussion of latent reactive inhibitors is discussed in 
Section 1.1.1. 
If the hydroxymethyl pyrrole is thought of as a proline analogue, then 
the po~ential inhibitor 1.1 represents a dipeptide analogue, containing latent 
reactivity. The system then represents an analogue of the dipeptide Phe-Pro. 
suitable to target the HN protease and Kidney Prolidase. 
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1.1 Mechanism Based Inhibition 
Mechanism based inhibitors were first conceptualised in the early 
1940s. but were not given a name until 1970 when Bloch and co-workers 
described the inhibition of p-hydroxydecanoylthioester dehydrase by 3-
decyanoylthioesters 3 • A mechanism based enzyme inhibitor is formally 
described as "a relatively unreactive compound. having a structural similarity 
to the substrate or product for a particular enzyme that. via its normal 
catalytic mechanism of action. converts the inhibitor molecule into a species 
which. without prior release from the active site. binds. most often covalently. 
to that enzyme."4 
Mechanism based inhibitors are designed as non-reactive. latent 
reactive compounds. which are delivered to the targeted enzyme in such a 
way as not to disturb other enzymic processes in the body. The latent 
inhibitor must be suffiCiently similar to the natural substrate to be accepted 
into the active site of the enzyme where hydrolysis of the scissile bond 
occurs. to produce a highly reactive species. This reactive species alkylates or 
acylates a nucleophilic residue on the enzyme. 
Le Chatelier principle dictates that the position of the equilibrium to 
form the enzyme-inhibitor complex. Eel. over the enzyme-substrate complex. 
EeS. is governed by the concentration of the enzyme. the inhibitor and· the 
substrate. 
E + I .. -----;)0_ E- I 
E+S -----;)11.... E-P ::;; .. r===::: E+P 
Figure 1.2 
The concentration of a drug must be maintained at a saturation level at 
the site of action for a drug to have maximum pharmacological effect. 
Mechanism based inhibitors are designed so that nonspecific alkylatlons and 
acylations do not occur at other proteins. Therefore. undesired side effects do 
not occur. and hence the toxicity of the specific inhibitor Is low. Table 1.1 
shows a selection of enzymes that have been targeted for mechanism based 
inhibition. 
Introduction 
Enzymes Targeted by Mechanism Based Inhibitors 
and Their Therapeutic Goal 
Enzyme 
Monoamine oxidase 
Thymidylate synthetase 
~-Lactamase 
Serine Proteases 
DNA Polymerase I 
Dihydrofolate reductase 
Therapeutic goal 
Antidepressant agent 
Antiparkinsonian agent 
Anticancer agent 
Synergistic with antibiotics 
Anticoagulant agent 
Antiviral agent 
Treatment of emphysema 
Arthritis 
Pancreatitis 
Inflammation 
Antiviral agent 
Anticancer agent 
Antibacterial agent 
Antiprotozoal agent 
Table 1.1 
1.1.1 The Design of the Latent Reactive Enzyme Inhibitor 
4 
The N-acylated pyrrole 1.4, Figure 1.3, is designed to mimic the 
enzyme's natural substrate, hence the "pseudo" amino acid Pyr is placed at 
PI' subsite and Phe at PI, where PI and PI' define the cleavage site. Shecter 
and Berger5 developed a notation to describe the amino acid sequence of the 
substrate residues flanking the scissile bond. Figure 1.4. TIle letter 'S' is used 
for subsites on the enzyme and 'P' for the inhibitor or substrate. The scissile 
bond is placed between PI and PI' with subsequent amino acids being 
numbered sequentially from the SCissile bond and denoted with a prime (') if 
on the C-terminal side of the scissile bond. and without the prime if on the N-
terminal side. 
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\ Z <tI" 
, \..<tI" 
......... - .... Enzyme 
.; 
.; 
~ 
\ 
, 
, 
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\ : \ .; 
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Figure 1.3 
5 
Catalytic hydrolysis of the amino acid-Pyr 1.4 scissile bond. with 
subsequent loss of the leaving group L, would produce an electrophilic 
azafulvene 1.5 in Figure 1.3. 
sclssUe bond 
:. w SAY~ H 50 W S'\(~ HS" w Si
AY
",. :. 
I"w"NY'N NY'N N~N Ny' 
II - H - H - H -o , Rt, 0 I ~ 0 Rl' • 0 R3' 
• I I , , . . 
I • • 
, I • 
I • • 
• I • 
• I I 
• I I I I I 
I I I 
I I I ! P4 : P3 ! P2 
N terminal 
P' 1 
Figure 1.4 
P' 2 P' 3 
c terminal 
Enzyme 
Interactions 
Substrate 
Substrate 
Interactions 
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The azafulvene. produced at the active site. would then alkylate a . 
nucleophilic or charged residue, to give the bound pyrrole derivative 1.6. 
Serine proteases. eg: chymotrypsIn, would be expected to be 
particularly susceptible to this type of inhibition, as they have several suitable 
nucleophilic residues in the active site. 
Aspartic acid proteases, eg: the HIV protease. lack obvious 
nucleophilic residues although some covalent inhibitors of HIV protease are 
known6 • The catalytic aspartic acids may themselves act as the nucleophilic 
residue. Other possible nucleophilic species included Thr26 or an active site 
water molecule that has been identified by X-ray crystallography7. There is a 
possibility that this tightly bound water molecule could act as the nucleophilic· 
residue. see the discussion on HIV proteases. 
1.1.2 Azafulvene Chemistry - The Mode of Inhibitlon 
A pyrrole substituted with a leaving group at the 2-position as in 1.7 
Figure 1.5. is known to undergo loss of this leaving group to form an 
azafulvene 1.38 ,9,10.11. This process occurs readily when the pyrrole nitrogen 
is not acylated. 
~L \.112 
H 
1.7 
A 2-substttuted pyrrole 
Figure 1.5 
~ N 6 
1.3 
Azafulvene 
The reaction of 1.8 with LiAlH4 does not give 1.9 as in Figure 1.6. this 
suggests that N-acylation of a pyrrole. as in 1.10. suppresses azafulvene 1.3 
formation ll , see Section 2.1.2 and Section 4.7.1 for further details. When 
pyrrole-2-carboxaldehyde is subjected to the same LWH4 conditions the 
product is 2-methyl pyrrole. 
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An N~ substituted, 
2 substituted pyrrole Azafulvene 
I(J 
N 
R)lO-
1.12 
Figure 1.6 
Pyrrole N~acylation, as in 1.11 removes 
electron density from the nitrogen, see Figure 
1.7, and thus suppresses azafulvene formation. 
The more electron withdrawing the substituent. 
the more suppressed the pyrrole is to azafulvene 
formation. 
Figure 1.7 
Spectroscopic data suggest that 
azafulve~es, eg: 1.13, are best represented by the 
resonance forms as depicted in Figure 1.812• 
4 3 
5 t:;haH .. ~C:H 01 Jo ~,H .. N C 
1 X I II X X 
X=NMe2' O· X=NM~, O· X=NM~+.O 
1.13 1.14 1.15 
Figure 1.8 
The resonance contributing structure, 1.14 shown in Figure 1.8. has a 
positive charge at the 6~position and as such, an azafulvene is extremely 
susceptible to nucleophilic attack at this position. 
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1.2 Target Prot eases 
CHYMOTRYPSIN 
Serine proteases are ideal for mechanism based inhibition. The 
nucleophilic residues Ser and His are both contained Within the active site. 
Serine proteases comprise the largest and most thoroughly understood group 
of proteolytic enzymes l3 . Many serine proteases are known with a diversity of 
function. They include chymotrypsin (digestion). trypsin (digestion), 
thrombin (blood coagulation). plasmin (lysis of blood clots), acrosin (sperm 
penetration) and subtilisin (digestion) as well as elastase (emphysema). 
Chymotrypsin is biosynthesised in the pancreas as non-active pre-
chymotrypsin. The proteolitic enzyme trypsin cleaves the pre-chymotrypsin 
in the intestine to produce ~-chymotrypsln. Several further modifications to 
~-chymotrypsin. by ~-chymotrypsin itself, produce the fully active form, a-
chymotrypsinl4. This contains a total of 245 amino acid residues that make up 
three polypeptide chains linked by disulfide bridges. Chymotrypsin is 
therefore not strictly a monomeric enzyme. X-Ray crystallography confirmed 
that chymotrypsin possesses two active sites and is a roughly symmetrical 
globular enzymel7. 
The X-ray crystal structure also reveals the pOSition of the polypeptide 
backbone with three amino acid reSidues of the active site clearly set up to act 
in a charge relay system, Section 1.2.1, the aspartyl residue at position 102, 
the imidazole ring of histidine at pOSition 57 and the serine residue at 
position 195. The catalytic triad described here is characteristic of all serine 
proteases. 
The ingested proteins and polyproteins found in the intestine are the 
natural substrates for chymotrypsinl5. On contact with the substrate, the 
enzyme acts as an endopeptidase cleaving the polypeptides in a broad but 
clearly defined region. Chymotrypsin cleaves at aromatic residues, and less 
readily at hydrophobic aliphatic residues. Cleavage at Phe. Tyr and Trp 
residues positioned at PI occur readily, while He, Leu and Val represent less 
favoured cleavage sites. The enzyme-substrate recognition of serine proteases 
relies on the recognition of the primary binding substituent S 1. The amino 
acid side chain of the cleaved peptide, pOSitioned at PI', has been found to be 
important in the stability of the new peptide before it leaves the active sitel6. 
Hydrogen bonding interactions between active site amino acids and the 
peptide substrate up to three peptides removed from the primary binding 
amino acid are also important. The subsites S4, S2, S2' and S3' have been 
found to be particularly sensitive to replacement with amino acid residues 
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with different properties, ie: acidic groups for basic groups. 
1.2.1 Mechanism of Serine Protease Hydrolysis of a Peptide Bond 
The driving force for the hydrolysis of the peptide bond in serine 
proteases is the catalytic triad, comprising Aspl02. His57 and Ser195 in 
chymotrypsin 1.16, Figure 1.9. The Asp and His residues act as an electron 
sink and source in a charge relay system that enhances the nuc1eophil1city of 
the Ser-OH residue 1 7 • 
/ 
Gly-N. 
H 
\ 
.N-Gly 
H 
O-H ( 
Ser 
1.21 
/ \ 
Gly-N. .N-Gly 
H H 
o 
RAOH 
His 
O-H r=( ( 
Ser 
N~ NH ~ 
Asp-C02-
1.20 
Figure 1.9 
j 
/ \ 
Gly-N. .N-Gly 
H H , , 
, . O-f-R OH ol His ( r=< 
Ser H~~; 
O-H 
Asp-C" \J 
II 
o 
1.19 
The Ser-OH is acylated by the substrate to give the acyl enzyme 
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, 
intermediate with the release of a new N-terminal peptide 1.18. The reaction 
proceeds via a tetrahedral intermediate that is stabilised by an oxyanion hole 
of the enzyme backbone 1.17. The acyl enzyme is finally hydrolysed to yield 
the C-terminal peptide with the regeneration of the catalyUctriad 1.19-1.21. 
1.2.2 Inhibition of Chymotrypsin 
Inhibitors of serine proteases provide anticoagulant agents, antiviral 
agents, and potential treatments of emphysema. inflamation. arthritis. adult 
respiratory distress syndrome. pancreatitis. some degenerative skin disorders 
and digestive disorders. Chymotrypsin is responsible for a variety of digestive 
disorders. The inhibition of these enzymes must lead to a potential 
pharmocalogical agent. 
A brief description of several classes of chymotrypsin and serine 
protease inhibitors is described below. There are several books and reviews 
on the inhibition of serine proteases4,15,17,18. 
1.2.2.1 Mechanism Based Inhibition oj Serine Protease 
Chymotrypsin has been shown to be inhibited by the succinimide 1.22. Figure 
1.1018. 
\ C'o~.ser" Ph~-OSo.CH3 ; . 
o I 
1.22 Nil I ~ JJ I N , 
Ii.. ..... .; 
Figure 1.10 
j 
-, 
O. /\ ~oser , Ph I W I ~J I 
c Yt"J I 
C{"'"N I 
1.23 ~] I 
{~ , 
H ......... .; 
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Enzyme hydrolysis of the succinimide amide bond, generates an 
electrophilic isocyanate 1.23 via a KLossen Rearrangement". Figure 1.10 
summarises the mechanism of a typical mechanism based inhibitor in the 
active site of chymotrypsin. 
The isocyanate 1.23 rapidly reacts with the active site His residue, to 
inactivate the enzyme. This reaction gives credence to the postulate that 
serine proteases may well be inactivated by the amino aCid-Pyr type inhibitors 
that have been designed in the present work. 
The synthesis of a-amino halo enol lactones has been developed in 
order to achieve more selective protease inhibitors 1 9. This allows for the 
inclusion of the halo enol lactone into an oligopeptide. 
Halo enollactones, as in 1.24 in Figure 1.11, contain a latent reactive 
halogen within the inhibitor20• On enzyme action, Figure 1.11, the reactivity is 
released as an electrophilic a-halo ketone 1.25. This species is attacked by a 
nucleophilic residue. again most likely His, to give the bound compound 1.26. 
R W 
fth fx ~~O~ 
Enz-Ser-OH 0 R 
1.24 
O~H 
o C. R/"\ 
Figure 1.11 
"'Ser X V -I Y-Enzyme 
Enzyme (His) 
1.25 
j 
O~H 
O ... S R Y-Enzyme Ir (His) 
Enzyme 
1.26 
The 4-chloroisocoumarin system 1.27 forms the basis of a number of 
mechanism based inhibitors of serine proteases21 • The nature of the 
substituents Rand R' determine the inactivator specificity. The 
dichloroisocoumarin. R=CI, R'=H, is a general inhibitor of all chymotrypsin 
like enzymes. A proposed mechanism based inhibition mechanism is 
summarised in Figure 1.12. 
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Ser195 catalyses lactone ring opening to give 1.28. Tautomerisation 
releases the latent reactivity in the form of an acid chloride 1.29. R=Cl. 
Irreversible covalent inhibition occurs when a nucleophilic residue, either 
Ser195 or His57, reacts with the acid chloride to give 1.30 . 
o 
Cl 
1.27 1.28 
11 
o o 
X-Enzyme 
Cl 
1.30 1.29 
Figure 1.12 
1.2.2.2 Affinity LabeUed Inhibitors 
This class of inhibitors is comprised exclusively of covalent inhibitors. 
They contain a reactive functional group that generally inhibits via SN2 
alkylation or acylation. Often. more than one enzyme or protein undergoes the 
alkylation or acylation and therefore. this is not a selective inhibition 
approach. 
An affinity labelling reagent gains specificity if it binds initially to the 
enzymes active site. rather than simply undergoing degradation in solution22• 
On attack at the reactive centre and covalent bond formation, the enzyme 
becomes irreversibly alkylated. Figure 1.13 shows an affinity labelling reagent 
based on the <x-chloro ketone system, and a reactive azapeptide. 
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This method has been useful in the identification of nucleophilic 
residues active site residues23. 
1.2.2.3 Transition State Analogues 
This approach to protease inhibition is discussed in detail in Section 
1.2.4.1. The carbonyl of the scissile bond is replaced with a non-hydrolysable 
group to block the active site. These inhibitors often employ aldehydes or 
boronic acids24. The trigonal arrangement of the boron in boronic acids 
appears similar to a transition state in the normal hydrolysis pathway. 
discussed earlier in Section 1.2.2.1. 
1.2.2.4 Peptides 
Simple peptides have frequently been found to possess some 
inhibitory action. Cyclic peptides have been designed to mimic the reactive 
site structures of naturally occurring protease inhibitors. These simple cyclic 
peptides inhibit chymotrypsin more effiCiently than linear peptides24. 
Serine proteases. such as chymotrypsin. are ideally suited to 
mechanism based inhibition by virtue of the nucleophilic residues in the 
active site. Several mechanism based inhibitors have been developed to target 
this important class of enzyme. but none as yet. have reached the human drug 
market. Many other classes of inhibitor are known. but only a selection is 
described in the text above. 
HIV -1 PROTEASE 
Barre-Sinoussi's group25 in 1983 described a virus which was to 
become one of the most feared diseases of the latter portion of the 20th 
century. Almost without precedence it promoted a huge scientific and clinical 
effort to understand and to find a cure for the deadly virus. The Human 
Immuonodefieciency Virus (HIV) is the causative agent of the Acquired 
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ImmunodeficIency Syndrome - AIDSl. 
The virus targets the Immune system. over time leadIng to a severe 
depletion of the CD4+ T-Iymphocytes. CD4+ T-lymphocytes are responsIble for 
the detection and destruction of foreIgn material enterIng the body. A 
depletion of the lymphocytes results in opportunistic infections, and also In 
many neurologIc disorders. Ultimately. death is caused by these 
complications. 
Much of the Initial research on HIV lead to an understandIng of the 
virus action at a molecular level. ThIs. In turn. produced several potential 
molecular targets for AIDS therapy. Figure 1.1426. 
.. ~~ .~ 
... 
Figure 1.14 
One of these targets was 
identified as a viral protease. HIV-1 
protease. ThIs proteolytic enzyme is 
responsIble for viral component 
maturation by cleavage of the large 
polyproteins. The amino acid 
sequence of the protease shows that a . 
highly conserved triad. Asp-Thr(Ser)-
Gly. was homologous to other 
proteases in the aspartic acid family. 
Classical aspartic acid proteases such 
as pepsin and renin have 
approximately 200 amino acid 
residues and two catalytic triads . 
An initial X-ray crystal structure of 
the HIV protease27 finnly established the homodimeric nature of the enzyme 
and showed that each monomer of 100 residues was related to the other by a 
crystallographic C2 axis of symmetry. The catalytic triad of Asp25-Thr26-
Gly27 occurs in a l<?op which is hydrogen bonded to the corresponding loop 
in the other monomer. This characteristic is called the "fireman's grip" and 
is typical of aspartic acid proteases such as Rocus Sarcoma Virus (RSV)28. and 
Simian Immunodeficiency Virus (SIV)29 proteases. A distinct ~-hairpin loop 
extends from each monomer over the active site to enclose a cleft in which 
the substrate is bound. This "flap" allows the protease to bind six to seven 
residues in a hydrophobic environment. 
Site directed mutagenesis of the HIV protease established that 
without the functioning protease enzyme, a non-infectious virus was formed30• 
These experiments also showed that the mammalian host cell is unable to 
process the HIV genome. Hence with the HIV-1 protease inactivated, only 
immature and non-infectious virons would be produced. 
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The HIV protease is required to make several highly specific cleavages 
on large polyproteln substrates. The cleavage sites span amino acid sequences 
wWch are not homogeneous. The conformation of the amino acid sequence is 
also important for substrate recognition. 
The commonly observed cleavage at an aromatic amino acid-Pro site, 
is of particular interest. N-Terminal hydrolysis next' to Pro is most 
uncommon in mammalian systems and leads to the possability of a target for 
inhibition. Remarkable diversity of amino acids is observed about the scissile 
bond (PI-PI'): Leu-Ala. Phe-Leu, Met-Met. Leu-Phe are found at the cleavage 
site. 
Crystallographic data was in agreement with the postulate that 
multiple hydrogen bonding occurs between the enzyme and inhibitor 1 ,7. 
These were found to span the P4-P3' subsites of the enzyme. Close van der 
Waals contact for P3-P3' side chains are also evident. 
1.2.3 Mechanism of Aspartic Acid Protease Hydrolysis of Peptide Bonds 
Aspartic acid proteases are fewer in number than the serine proteases 
and are less well understood. Examples include pepsin and renin (both 
digestive enzymes) and HIV protease (viral maturation). Unlike the serine 
proteases, the aspartic acid proteases do not appear to utilise covalent 
interactions in their catalytic mechanism. Water is instead directly added to 
the substrate bond. Aspartic proteases appear to utilise the ~-carboxyl groups 
located on two active site aspartic acids to catalyse the hydrolysis. The 
mechanism is thought to proceed as shown in Figure 1.15. 
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Figure 1.15 
1.2.4 Inhibition of HIV Protease 
The close similarity of the inhibited protease crystal structures is 
remarkable. Figure 1.16 shows a number of HIV protease inhibitors. 
A slight reorganisation of the enzyme's core with respect to the native 
enzyme is observed in each of the enzyme-inhibitor complexes. The enzyme-
inhibitor structure for acetyl-pepstatin31.32.33. 1.35 Figure 1.16. revealed that 
the 44 Ca core atoms of each monomer in the enzyme move with a root mean 
square deviation of 0.4 relative to the native enzyme. In 1.36 and 1.37 the 
corresponding movement is only 0.65.A. despite the very different structures. 
The flap region of the enzyme has the largest conformational change 
for the unbound relative to the inhibitor bound protease. The tips of each loop 
move up to 7A on binding with the inhibitor. "Closing" the flaps forms a 
hydrophobic tube which shields apprOximately 80% of a bound inhibitor from 
solvent. 
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All of the enzyme-inhibitor complexes studied by X-ray crystallography 
have a tightly bound water molecule that bridges the two enzyme flaps 
positioned by hydrogen bonds to Ile50 and Ile250 and amide hydrogens of the 
P2 and PI' carbonyl oxygens of the inhibitor. Each of the four inhibitors is 
bound in an extended conformation spanning the P 4 -P3' sites of the enzyme. 
A complex network of hydrogen bonds exists between the enzyme and polar 
atoms in the inhibitor. 
1.2.4.1 Transition State Mimic Inhibitors 
A classical approach for designing an enzyme inhibitor is to replace 
the scissile amide bond, as in 1.39 with a transition state mimic. This 
technique has had good results in the production of potent renin inhibitors34• 
Dreyer and co-workers35 attempted a similar ploy with the HIV protease by 
replacing the scissile amide bond with non-hydrolysable dipeptide isosteres, 
1.40, 1.41, 1.42. 1.43. 1.44. 1.45. Figure 1.17. They found that 
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hydroxyethylene isostere 1.41 containing peptides, had the greatest affinity 
for the HIV protease. The statine based inhibitors 1.40 had moderate to low 
potency, while the phosphinate isostere inhibitors 1.44 had modest affinity. 
The reduced-peptide 1.45 analogues were also weak inhibitors. 
Many other hydroxyethylene isostere based inhibitors have been 
synthesised and tested36• 
H OH 0 
~N~I' 
R 
1.40 
Statlne: R = i-butyl 
AHPPA: R = CH2Ph 
H OH R' 0 
~N~N01 
R R" 
1.43 
Hydroxyethylamlne 
Isostere 
H 0 R' XN~NJy 
R H 
1.99 
Natural Substrate 
H OH R' 
~N~' 
R 0 
1.41 
Hydroxyethylene 
Isostere 
H 0- R' 
~NY~h' R OH 0 
1.44 
Phosphlnate 
Isostere 
Figure 1.17 
H OH R' 
~N~' 
R OH 0 
1.42 
Dlliydroxyethylene 
Isostere 
H R' 
~N~NAy' 
RHO 
1.45 
Reduced AmIde 
Isostere 
The observation that the HIV protease cleaves at the unusual pOSition 
of the N-terminal side of proline, caused Roberts37 and co-workers to develop 
a series of modified hydroxyethylamine dipeptide isosteres to mimic Phe-Pro, 
Figure 1.18. 
He, ~ '?' '?' H OH H OH ~ Asn-N~N "H ACSer-LeU-Asn-N~N ~N ~ : : I..... .J. Ile-Val-OMe 
o Ph"'; O~NA.... Ph 0 
H 
Figure 1.18 
These compounds were shown to be are respectable inhibitors of HIV-
1 protease. 
Other selective inhibitors of HIV-1 protease have been developed by 
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replacing Pro with the six membered analogue, pipecolic acid38• 
1.46 
Ph R-~~ r £. Y '( 'N-R 
:: OH H 
Ph"""-
1.47 
Figure 1.20 
A novel series of transition 
state mimics have been developed by 
Sham ~nd co-workers39• In these 
inhibitors the hydrolysable Phe-Pro 
bond was replaced with a non-
hydrolysable difluoroketone 
transition state mimic, Figure 1.19. 
Figure 1.19 
1.2.4.2 Symmetry Based HW Protease Inhibitors 
The crystallographic observation that the HIV protease is a 
homodimer with each monomer related by a C2 axis of symmetry prompted 
Kempf40 to synthesise C2 symmetry based inhibitors, eg: 1.46 and 1.47. 
Figure 1.20. These inhibitors have several advantages over the classical 
transition state mimic inhibitor. The first is that the less peptide like 
structure may overcome stability problems in vivo, where genuine peptides 
tend to degrade. The second is that the symmetry imparts a high degree of 
enzyme specificity for the targeted enzyme. 
The amino acid sequence was extended in the N-direction. 
Compounds with only PI and PI' residues produced little inhibitory action. eg: 
R=Ac. Introduction of the P2 and P2' residues, eg: R=Val-Cbz, resulted in 
nanomolar inhibitors. Replacement of the hydroxyl group of 1.46 with a 
carbonyl group, caused a one thousand fold decrease in potency, thus 
indicating that tetrahedral geometry is important. 
1.2.4.3 Non-Peptide Based Inhibitors of HW Protease 
Peptide based transition state inhibitors are plagued with a lack of oral 
activity, short duration of action, a lack of specific target ability and the 
inability to cross the blood-brain barrier. The following are non-peptide based 
inhibitors which are expected to be more robust in the body. 
The epoxide containing antifungal antibiotic cerulenin, Figure 1. 21, 
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was identified by both Blumenstein7 and Pear141 as a potent HIV protease 
inhibitor. 
o 
o 0 
cerulenin. le50 2 500 
The epoxides are thought to 
inhibit the protease by electrophilic ring 
opening and subsequent alkylation. The 
carbon chain appears to position the 
epoxide at the active site. 
Figure 1.21 
The electrophilic inhibition 
postulated for the epoxides. is similar to 
the mode of action that is postulated for 
the azafulvenes. eg: 1.3 produced in our inhibitors. 
A series of long chain dicarboxylates. eg: HOOC(CH2120COOH, were 
tested against the HIV protease42. Crystal structures of other HIV protease 
inhibitor complexes reveal a hydrophobic substrate binding groove. This 
groove. approximately 24 long. has several charged hydrophilic residues 
(Asp29 & 30 and Arg8) at either end of the hydrophobic tube. The long chain 
dicarboxylates are thought to interact with these charged residues. 
R 
N 
Halopelidol R :::: CI 
Bromopelidol R = Br 
Figure l.22 
F 
DesJarlais 43 identified 
Haloperidol, Figure 1.22 (R=CI), as 
an HIV protease inhibitor by a 
comparison of the active site of the 
enzyme and the crystal structures of 
small molecules contained in the 
Cambridge Database. 
This represents the first 
attempt to solely use receptor structure to search for an innovative new 
inhibitor lead. The search produced a small set of molecules which fitted the 
profile; bromoperidol was one such compound (Figure 1.22, R=Br). 
Haloperidol was used for the inhibitory studies, but was found to be 
highly toxic at the levels required to inhibit HIV-1 and HIV-2 protease and as 
such is not useful as an anti-AIDS pharmaceutical. The drug Haloperidol 
points the way to a new generation of protease inhibitors. 
A recent report by Karlstrom and Levine44 has indicated that Cu2+ also 
inhibits the HIV protease. On recovery, denaturation and refolding of the 
enzyme. full activity was restored. This evidence strongly suggests that 
cysteine is binding the copper. 
A remarkable amount of progress has been made towards establishing 
potent inhibitors of the HIV protease. A casual observation of the previously 
described inhibitors indicates that there is not a great deal of structural 
consistency. Hydrophobic interactions dominate the crystal structures of the 
enzyme-inhibitor complexes and this trend appears to follow through into the 
other non-crystalline enzyme-inhibitor complexes. Optimum residues for an 
inhibitor need not resemble substrate sequences as these appear less crucial 
to recognition than in other enzyme systems. 
KIDNEY PROLIDASE 
The manganese dependent dipeptidase. Prolidase (or 
Prolinedipeptidase) is another of the few enzymes known to catalyse the 
hydrolysis of peptide bonds on the N-terminal side of Proline2 • The enzyme is 
cytosolic and therefore an inhibitor would be required to pass through the 
cell membrane. Humans lacking this enzyme suffer from skin lesions and limb 
abnormalities. Prolidases are found in most mammalian tissues and 
microorganisms where they degrade exogenous and endogenous 
polypeptides, allowing for recycling or renal excretion of proline and 
hydroxyproline45• 
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1.2.5 Inhibitors of Prolldase 
A model of the active site of the kidney prolidase has been proposed. 
There are three distinct subsites in the active site region, acidic, basic and 
hydrophobic. Using this information Wolfenden2 proposed that the 
cyclopentane-1,2-dicarboxylic acid 1.49, Figure 1.23, would be an inhibitor of 
the enzyme. since it resembles the product of hydrolysis (Pro). 
H2N/jr):( H2o --Y0H HN':( 10 H2N 
o COOH Prol1dase 0 COOH 
1.48 
Glycyl-L-Proline Glycine Proline 
Km=1.2J..lM K l>10-
2M K L=O.51pM 
HOoey 
COOH 
1.49 
Cyclopentane-l.2-dicarboxylate 
acid 
K l=O.51pM 
Figure 1.23 
COOH 
~ A HO-P-O CH2 
". HO 
1.50 
Phosphenolpyruvate 
K i=8.5nM 
The dicarboxylate 1.49 also has the same spatial arrangement as the 
natural substrate Gly-Pro 1.48. 
It was found that although the "substrate shaped" inhibitor provided 
adequate inhibition of the prolidase. the transition state analogues of phosphyl 
and phosphonyl based inhibitors. were superior. The discovery that the 
phosphonic compounds and phosphoenol pyruvate 1.50, a well known 
glycolytic intermediate, were respectable inhibitors46 lead to much work 
optimising the type of phosphonic compounds that inhibit the enzyme. 
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1.3 The Aim of the Research 
The synthesis of amino acid-pyrrole compounds, eg: 1.4 requires a 
new methodology to be developed for the N-acylation of: pyrrole. The few 
existing methods for the acylation reaction tend to be harsh and low yielding. 
A mild general reaction suitable for use with an amino acid sequence was the 
aim of the synthesis. 
The initial aim was to produce simple N-acylated pyrrole derivatives, 
with the aim of extension to amino acids on the pyrrole nitrogen to utilise the 
important P region recognition. This is described in Chapter Two. 
The next step was to extend the P' recognition aspects of simple 
derivatives to larger analogues, this work is described in Chapter Three. 
An understanding of the postulated mode of inhibitor action, 
azafulvene chemistry, was also proposed via hydrolysis studies, Chapter Four 
and enzyme assays, Chapter Five. 
The results are presented in this thesis, and although not complete, 
pave the way for future developments. 
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CHAPTER Two 
N-ACYLATION OF PYRROLE 
DERIVATIVES 
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2.0 Pyrrole Nomenclature 
A descriptive naming system is used throughout this thesis for the 
ease of reading and understanding. This system is based on the standard 
procedure of describing peptides in the N- to C-direction. 2-Substituted 
pyrrole derivatives are described as p-2-X. where the descriptor X describes 
the functionality on the 2 position of pyrrole. The main descriptor is 'c' for a 
carboxaldehyde derivative. (-CHO). eg: p-2-c represents pyrrole-2-
carboxaldehyde. 2.A. Figure 2.0. 
Q-yH QyH ~OH N 
H 0 
H3CAo 0 Ph~O 
2.A 2.B 2.C 
p-2-c N-Acetyl-p-2-c N-Cinnamoyl-p-2-0H 
2.D 
N-(N-Pth-PheJ-p-2-0-Val-Val-Cbz 
* 
o N 
o 
camphanate pyr acyl 
Figure 2.0 
The hydroxymethyl pyrrole derivatives are described as p-2-0H. while 
further extension in the C-direction (Figure 2.9) is described in that 
direction. The description Implies a CH2 substituent between the pyrrole and 
the -OR group. This is not, however, the case where the formyl pyrrole (-CHp. 
c) is described. 
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The designator N- precedes p-2-X for compounds acylated on the 
pyrrole nitrogen, for examples see Figure 2.0. Hence N-acetyl-p-2-c 2.B 
describes N-acetyl-pyrrole-2-carboxaldehyde, and N-cinnamoyl-p-2-0H 2.C 
describes the N-cinnamoyl hydroxymethyl pyrrole. and N-(N-Pth-Phe)-p-2-0-
Val-Val-Cbz is the pseudo peptide 2.D drawn. in Figure 2.0. A selection of 
other partial descriptors used throughout this work are shown in Figure 2.0. 
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2.1 Introduction 
The retrosynthetic analysis presented in Scheme 2.1 indicates the 
steps required to synthesise the potential hydroxymethyl pyrrole mechanism 
based inactivators 2.1. 
~OH 
N 
PHN~ 
: 0 
R 
2.1 
potential mechanism 
based inhibitor 
QyH 
PHN~ 0 
. 0 
R 
2.2 
Q\yH 
H 0 
X 
PHN0 
. 0 
R 
2.3 
P = amino acid protectlng group 
X = activating group 
Scheme 2.1 
The synthesis necessitates the acylation of pyrrole-2-carboxaldehyde 
(p-2-c) on nitrogen with an amino acid, eg: 2.3. A general methodology was 
required to enable different acyl groups to be used. The reduction of the N-
acylated formyl pyrrole 2.2 to the N-acylated hydroxymethyl pyrrole 2.1, 
would then complete the syntheSiS. This species contains an amino acid for 
recognition and a leaving group for azafulvene formation, on enzyme 
hydrolysis of the amino acid-pyrrole amide bond, see Section 1.1.2 for a 
detailed discussion. 
N-Acylated-p-2-c derivatives are commonly prepared via the initial N-
acylation of pyrrole followed by a Vilsmeier-Haack formylation. Other 
preparations have been carried out using Thallium(I) ethoxide and acetyl 
chloride l , while the reaction of pyrrole derivatives in triethylamine (TEA) and 
acetic anhydride (AC20) at reflux have also been reported2 • These 
preparations suffer from either low yields and/or cumbersome reaction 
conditions. Only a few isolated reports of mild acylation conditions have been 
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reported and in these few examples the pyrrole ring is heavily 
substituted3 ,4,5. The designed hydroxymethyl pyrrole inhibitor requires the 
acylation of the pyrrole nitrogen with an amino acid. Non-acidic conditions 
are required in the synthesis to eliminate pyrrole polymer formation, and 
mildly basic conditions must also be used to ensure that racemisation of the 
amino acid does not occur. Extensive investigations were carried out to arrive 
at the final DMAP methodology described in Section 2.4. 
2.1.1 The Chemistry of Pyrrole-2-Carboxaldehyde 
The pyrrole derivative chosen for the N-acylation reaction was 2-
formyl pyrrole, p-2-c. The pyrrole nucleus of p-2-c causes the formyl 
substituent to behave in an atypical manner, with respect to other aldehydes. 
P-2-c can be represented by three resonance forms6 , Figure 2.2, and as such 
the aldehyde is deactivated and hence less electrophil1c than other aldehydes. 
The deactivated aldehyde of the p-2-c formyl group is manifested by a low 
carbonyl IR stretching frequency (1667 cm -I, with respect to 1740-1 720cm- 1 
of aliphatic aldehydes) and the relative upfield 1 H NMR formyl sIgnal at 
9.54ppm (a usual aldehyde signals at apprOximately 10ppm). 
H4 H3 ~H ~H ~H '" '" '" N~ Hs N H 0- H 0-
H 0 
2.4 2.5 2.6 
Figure 2.2 
The extended conjugation in p-2-c has the overall effect of increasing 
the acidity of the p-2-c NH and allows electrophilic attack at either N- or 0-. 
The resonance forms 2.5 and 2.6 account for reaction through 0; for example, 
formation of the pyrrylol pyrazine 2.19 in the NaH reaction of p-2-c and N-Ts-
Leu-CI, Section 2.2.1.2. 
Structure 2.4 also indicates the pyrrole ring numbering system used 
throughout this theSis when describing the pyrrole derivatives. 
'Toube7 performed IH NMR spectral studies on p-2-c and concluded 
that the preferred conformation of the aldehyde group is syn rather than anti 
based on the five bond coupling (JS-CHO) between the formyl proton and H-5, 
Figure 2.3. This is in keeping with the well documented "zig-zag" ruleS. 
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-- "zig-zag" coupling 
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The syn conformer is also 
likely to be stabilised by 
in tramolecular hydrogen bonding 
between the carbonyl group and 
the pyrrole NH. 
Figure 2.3 2.1.1.1 C- versus 0- Acylation and 
Alkylation of Formyl Pyrroles 
Pyrrole derivatives can be acylated (or alkylated) on carbon-I, Scheme 
2.4. with the correct choice of base. 
MeLi or 
NaH 
MeMgI Q-yR 
H 0 
Scheme 2.4 
The reaction to form the deSired C-methylated derivative 2.10 (a 
precursor to hydroxy methyl bilane) via the pyrrole aldehyde 2.7 using methyl 
magnesium iodide, Scheme 2.5, yields the magnesium salt 2.8, which on 
reaction with methyl iodide returned starting material, rather than the 
desired alkylated pyrrole 2.10. The researchers postulated9 that the 
azafulvene like species 2.9, formed by alkylation on the formyl oxygen rather 
than carbon, gave starting material on work up. 
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H2O 
THF 
AMe pMe 
~H 
Mg+ 0 
Mel [ OyOMe] AMe pMe ~H 
H 0 
MeMgI. 
2.7 2.8 2.9 
AMe = CH2C02Me 
pMe = C:t-l2C:t-l2C02Me Mel 
AMe pMe 
n H 
MeA!,!'lr 
H 0 
2.10 
Scheme 2.5 
The corresponding acetal protected aldehyde 2.11 gave the desired 
product on a similar treatment with NaH and methyl iodide. Scheme 2.6. 
AMe pMe 
2.7- ~O ~ oJ 
2.11 
AMe = C:t-l2C02Me 
pMe = CH2C:t-l2C02Me 
1) MeMgI 
2) Mel 
Scheme 2.6 
AMe pMe 
no MeA~~J 
2.12 
~H'.1l20 
2.10 
A competition between 0- and C- alkylation therefore exists, work 
described later supports a similar identified competition as occurring in the 
reaction of a pyrryl anion and the amino acid acid chloride, N-Ts-Leu-CI, 
Section 2.2.1. 
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2.1.2 The ChemistIY of N-Acylated Pyrrole-2-Carboxaldehyde 
N-Acylation of pyrroles results in the deshielding of the pyrrole ring 
components. The amide bond increases the TC electron delocalisation and 
deactivates the pyrrole ring, Figure 2.7. 
(J 
N 
R)lO-
Figure 2.7 
IH NMR spectral studies have shown that the change in the NMR 
spectra peak positions between different N-acyl groups is caused by inductive 
interactions between the substituent and pyrrole ringlO. 
N-Acylated-p-2-c also gives similar delocal1sation interactions, in 
addition to the previously described aldehyde delocalisation,' Figure 2.2. The 
overall result is to give the set of resonance contributors shown in Figure 2.8. 
QyH ~H ~H .. 
'" 
N~ Oi .. 
RAoo A 0- RAO- 0 R 0 . 
2.13 2.14 2.15 
Figure 2.8 
The >N+=C< IR stretching vibrations, in 2.15, confirmed the 
existence of such canonical forms. A combination of these canonical forms 
also explains the unusual downfield position of the pyrrole proton resonances. 
The effect of altering the electron density in the ring is further discussed in 
Section 2.7. Acylation of formyl pyrroles has been shown to give a more 
aldehyde like character to the formyl group, see Section 2.7.1 for IR, UV and 
NMR evidence. This is evidence that the pyrrole nitrogen lone pair of 
electrons is delocalised into the acyl group rather than into the formyl group. 
Thus, resonance contributor 2.14 Figure 2.8, becomes less important. 
A consequence of this is that azafulvene formation II, in hydroxymethyl 
pyrrole derivatives, eg: 2.1, is suppressed due to the unavailability of the 
nitrogen lone pair, see Section 4.7.1. This is a crucial factor in the designed 
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mechanism based inactivators. 
P-2-c proved to be a suitable starting material for the synthesis of N-
acylated p-2-c's. A simple reduction of the aldehyde to give an alcohol, allows 
for the extension of an amino acid chain in the C-direction (see Figure 2.9 for 
a definition of this term). 
~RI > 
N 
R extension in C-direction 
ij 
extensIon In N-direction 
Figure 2.9 
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2.2 The Sodium Hydride, NaH. reaction 
A report by Moon5 indicated that reaction of C-substituted pyrroles 
with NaH and subsequent reaction with an acid chloride gave the N-acylated 
pyrrole in yields ranging from 75-80% depending on the pyrrole derivative 
and the acylating agent. 
2.2.1 Reaction of Pyrrole-2-Carboxaldebyde Salt with N-Ts-Leu-Cl 
Moon's methodology was adapted to an acid chloride of an amino acid. 
NaH (lequiv.) was added to p-2-c dissolved in freshly dried and disUled THF. 
Mter fifteen minutes N-Ts-Leu-CI acid chloride 2.17 prepared from N-Ts-Leu-
OH, using DMF and oxalyl chloride, was added dropwise to the stirred 
solution of the precipitate of the sodium salt ofp-2-c 2.16, (Scheme 2.10). 
--_.... p-2-c 2.18 2.19 
2.16 2.17 
Scheme 2.10 
The addition of the acid chloride to the pyrrole salt caused an 
immediate discolouration of the solution to produce a deep brown/black 
solution and a new accompanying precipitate. Work up gave a black oil, that by 
TLC contained four UV active compounds, three of which were pyrrolic (these 
gave a positive Ehrlich test, see Section 2.7.3.3 for a full discussion of this 
test). 
The 1 H NMR spectrum of the crude products gave further evidence of 
three different pyrrolic compounds with appropriate signals in the 6.1-
O~ H N '",1-..0 
H kJ>=o 
Ts'" ~ y 
2.18 
7.0ppm range. The crude sample was purified by radial 
chromatography on silica to give four fractions. The first 
fraction was identified as the oxazolidinone 2.18 (8.0%), 
discussed in the following section. 
The second compound was tentatively assigned as 
the cyclic N-substituted pyrrole, a dihydropyrrl piperazine 
2.19 (to be discussed in Section 2.2.1.2) as a brown oil 
(5%), The remaining pyrrolic material was found to be 
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starting material p-2-c (55%). The low recovery of pyrrol1c species was 
assumed to be due to polymer formation. The final fraction was free N-Ts-Leu-
OH amino acid. The mode of formation of these compounds is discussed in 
the mechanism section. Section 2.2.2. 
2.2.1.1 Oxazolidinone from NaH Reaction - Structure Assignment 
The oxazolidinone 2.18 was of particular interest as it existed as a 
single stereoisomer. NOE difference irradiation of the a-amino acid proton 
resonance (H-8) at 4.10ppm. Figure 2.11, gave a strong positive enhancement 
of the resonance at 6.68ppm which was therefore assigned as the pyr-CH (H-
6) resonance. An NOE enhancement was observed in the reverse direction on 
irradiation of H-6 (6.68ppm). enhancements to the amino acid a-proton at 
4.10ppm and to pyrrole H-3, 6.24ppm were also observed. The ORD of 
[a]D26=-17° (el. MeOH) indicated an optically active species. 
- NOE Enhancement 
IH NMR (ppm) 
Figure 2.11 
The NOE data allowed the assignment of 
the absolute configuration of both stereogenic 
centres since the stereochemistry of the a-
carbon of the amino acid would remain intact. 
The NOE data and the non-racemisation of the 
amino acid is consistent with a 6R. 8S s y n 
stereochemistry. 
One and two dimensional NMR spectral 
techniques along with comparison with other 2-
substituted pyrroles confirmed the structure of 
the oxazolidinone 2.18. NOE irradiation of the IH 
NMR spectrum signal due to H-5 at 6.85ppm. 
depicted in Figure 2.11, enhanced the signal at 
6.18ppm (H-4). Irradiation of the H-4 signal 
(6.18ppm) also enhanced the resonances at 6.85ppm (H-5) and 6.24ppm (B-
3). thereby assigning the pyrrole ring protons. NOE irradiation at 6.24ppm 
(H-3) enhanced both the resonances at 6.18ppm (H-4) and 6.68ppm which 
was assigned as H-6. pyr-CH. Irradiation at 6.68ppm (B-6) enhanced the 
signal at 4.10ppm (B-8. as described previously) and 6.24ppm (H-3). The 
amino acid a-proton at 4.10ppm (B-8) on irradiation enhances 6.68ppm (H-
6) anq also to a lesser extent the protons of the amino acid side chain, 
CH2CH(CHs12. 
The NOE data described above were important in the aSSignment of 
the 13C NMR spectra. The 13C NMR spectrum signals for C-3 and C-4 were 
found to be inverted with respect to other pyrrole C-3 and C-4 Signals, as 
described in Section 2.6.1.3. Generally C-3 is downfield with respect to C-4. 
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In the oxazolidlnone case C-4 is downfield with respect to C-3, as determined 
by a HETCOR experiment (Figure 2.12). 
HETCOR of Oxazolidinone 2.18 
LL ,U 
Figure 2.12 
A molecular ion at 362mu in the mass spectra of 2.18 is consistent 
with the structural formulae C17H22N203S. The observed fragmentation 
pattern is typical of an oxazolidinone with loss of C012. 
2.2.1.2 Pyrrylol Pyrazine Formation from the NaH Reaction - Structure 
Assignment 
The second species isolated from the NaH reaction was assigned as 
the pyrrylol pyrazine 2.19. 
The IH NMR spectral data [3 (CDCI3) 0.85 (3H. d. J=6.9Hz. Leu-CHs): 
0.93 (3H. d. J=6.7Hz, Leu-CHs); 1.70 (2H. m, Leu-CH2); 1.89 (1H, sept, 
J=7.0Hz, CH(CH3h): 2.31 (3H, s, Ts-CHS); 5.55 (1H. bm, pyr-CH(OH)-N); 
6.05 (1H, m, H-4); 6.73 (1H, m. H-3); 6.99 (1H, m, H-5): 7.00 (2H, d, 
OJ-! 
"I'('f-°H 
HO 
N ..... Ts 
2.19 
J=8.2Hz, Ts-CH); 7.35 (2H, J=8.3Hz, Ts-CH); 9.09 (1H, s. 
N-pyr-C(OH)=)] was consistent with N-substitution. Ie: each 
pyrrole proton signal was shifted downfield, this is 
discussed in Section 2.1.2 and Section 2.7. 
The 1 H NMR spectrum was inconsistent with the 
desired N-(N-Ts-Leu)-p-2-c 2.21, Scheme 2.14, since 
signals were not observed for the formyl. -CHO, group 
(expected at approximately 10.2ppm) and the a-hydrogen ?f 
the amino acid (at approximately 4.5ppm). NOE 
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experiments, Figure 2.13, showed clearly that the pyrrole H·3, H-4 and H-5 
ring system was intact. Irradiation at H·3 (6. 73ppm) indicated a very small 
enhancement at 5.55ppm (pyr-CH(OH)-N, H-6). A better correlation was 
obtained using the HMBC NMR technique to indicate the carbons to which 
distant protons were attached. The result was positive but not conclusive. The 
HMBC correlation was found between H-3 (6.73ppm) and the signal at 
56.2ppm (pyr-CH(OH)-N). These data suggested that a second ring was 
present in the structure and that the 1 H NMR signal at 5.55ppm and 13C 
NMR spectrum 56.2ppm signal belonged to the moiety at the pyrrole 2-
position as in structure 2.19. The signal at 5.55ppm sharpened on D20 
exchange indicating coupling to the -OH, a signal that was not observed. 
A high resolution mass spectrum was also consistent with formulae 
ClSH22N204S and the cyclic structure. The IH and l3C NMR signals as well as 
the NOE and HMBC correlations are summarised in Figure 2.13. 
6.05 
109.4 
6.73 
120.7 HwH 5.55 ~ ~ H56.2 
6.99 H OH 
126.5 N 
N 137.5 < r-8 
9.09 HO :::::-.... "s ~ J. CH3 
166.2 85.8 O2 \\ // 2.31 
1 70 7.35 7.00 24.4 44.1 129.1 126.3 
1.89 --'CH3 
30.9 0.85 
21.4 
2.19 
IH NMR and l3C NMR (ppm) 
Figure 2.13 
CH3 
- NOE enhancement 
- - - - HMBC correlation 
A possible mechanism for the formation of this cyclic species is 
summarised in Section 2.2.2.2. 
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2.2.2 Proposed Mechanisms for the Reaction of Pyrrole-2-Carboxaldehyde 
withNaH 
A possible mechanism for the reaction of N-Ts-Leu-CI and p-2-c anion 
to give 2.18 and 2.19 is presented in Scheme 2.14 and Scheme 2.17. 
2.2.2.1 Mechanism of OxazoZidmone Formation 
The oxazolldinone is thought to form via the key azafulvene like 
structure 2.20, (Scheme 2.14). 
CA fH ___ CA~ pathway a O~ H C" ~ .. '~N"~OXO .. N ""f-0 ~ C H) 'I H ..-N.j>=O 2.16 .Leu rHN 'Leu Ts:. ~ B I uu Ts TsHN 0 Co 2.20 2.18 
2.17 
jpathwaY c 
QyH 
TSHN~ 0 
_ 0 
Leu 
2.21 
(WO~OUP) jpathway b 
o 
p-2-c TSHNJ 
_ OH 
Leu 
Scheme 2.14 
Once the azafulvene has formed, it can either cyclise through nitrogen 
to give the oxazolidinone 2.18 (pathway a). or it can form the starting material 
(p-2-c) with the release of free amino acid (pathway b). The low yields from 
the NaH reaction appear to be an artefact from the hydrolysis of the 
azafulyene. Hydrolysis of azafulvenel3 2.20 to starting materials produces an 
unreactive amino acid and fully protonated p-2-c. There is therefore no 
further reaction. 
Amino acid nitrogen attack at the electrophilic azafulvene 2.20 centre, 
before decomposition. produces the oxazolidinone 2.18. This reactIon ~s 
analogous to that designed to occur on hydrolysis of the amino acid-pyrrole 
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bond in an enzyme active site. 
The described mechanism explains how polymer formation can occur 
from the NaH reaction. Details in Section 4.3.3 describe how production of 
polymer occurs when few nucleophlles are available. The azafulvene reacts 
indiscriminately with any nucleophile, often other pyrroles. The alkylation of 
azafulvene by further pyrroles, produces the polymer described in this 
reaction. Experimental observation of polymer formation via azafulvenes is 
described in Section 3.2.2 and in Section 4.3.3. 
A competition exists between cyclisation of the key intermediate 
azafulvene 2.20, Scheme 2.14, to yield the oxazolidinone 2.18, or a dead end 
pathway of hydrolysis (pathway b) during work up to yield p-2-c and N-Ts-
Leu-OH. The desired N-acylated pyrrole 2.21 (pathway c) was not observed. 
The desired N-acylated derivatives were observed for simple non-amino acid 
examples. using the NaH method, Section 2.2.3. 
Precedence for the reaction through 0 of the -CHO group was found in 
the reaction to synthesize a hydroxymethyl bilane, as described in Section 
2.1.1.1. 
2.2.2.1.1 Oxazolidinone 2.18 as a Possible ChiralAuxiliary Agent 
The oxazolidinone 2.18 is a single syn isomer about pyr-CH (H-6) and 
CH-Leu (H-B) on the basis of the observed NOE. An optical rotation of [a]D26 -
17° also shows that it is optically active. 
B-2 C-2\B-2 
H-f° Base H~O 
"NJO -to-.. N ;j P -:. p" 
.-
~ ~ 
2.22 2.23 
oxazolidinone enolate 
Scheme 2.15 
Ra+ 
10 
2.24 
hydrolysis I 
HO ° 
PHNXRo 
~ 
2.25 
The high degree of stereoselectivtty observed for this reaction 
suggests that the oxazolidinone may be useful as a chiral auxiliary agent in 
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amino acid synthesis. The use of oxazolidinones in the asymmetric synthesis 
of chiral species is well documented 14. Scheme 2.15 outlines the use of chiral 
oxazolidinones. eg: 2.22 in the enantloselective alkylation of amino acids. eg: 
2.25. 
Bulky R substituents at the C-2 position. 2.23 Scheme 2.15, direct 
approach of the electrophile to the less hindered face of the planar enolate. 
The general protocol for oxazolidinone formation involves reaction of 
the sodium salt of the free amino acid 2.26 with pivaldehyde to furnish the 
corresponding imine, The imine is then cyclised in the presence of the 
acylating reagent benzoyl chloride, PhCOCI, Scheme 2.16, to give a mixture of 
the syn and anti oxazolidinones 2.2714, 
2,26 
1) pivaldehyde 
pentane. reflux 
2) PhCOCI. CH2C~ 
2.Z7 
syn and anti oxazolidinone 
Scheme 2.16 
This is in contrast to the present study where oxazolidinone formation 
occurs directly via an amino acid acid chloride. The synthesis of the 
oxazolidinone 2.18 described in this work produces the syn isomer optically 
pure and in a one pot synthesis. Using the oxazolidinone 2. 18 for 
enantloselective alkylations of amino acids, the enolate 2.28 was modelled on 
2.28 
proposed enolates derived for existing chiral alkylation 
reactions15. The Re face, as drawn. is less hindered to 
electrophilic attack, and as such a high degree of 
diastereomeric excess would be expected. 
The pyrrole of the oxazolidinone 2.18 chiral 
template, could also act as a "diene" for a Diels-Alder 
reaction. Pyrroles do not usually undergo Diels-Alder 
reactions6 but rather tend to react with the dienophile by 
conjugate addition. Cases where pyrrole acts as a 
dienophile . have been reported 16. Approach of the 
dieneophile to the diene may be influenced by the 
configuration of the oxazolidinone. if a Diels-Alder reaction was to proceed. 
No attempt has been made to optimise the yield of 2.18. 
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2.2.2.2 MechanismJor the Formation oJ the Pyrrylol Pyrazine 2.19 
The pyrryl anion 2.16 can also attack the amino acid acid chloride 
through nitrogen to form the desired N-acylated-p-2-c, Scheme 2.17. This 
subsequently undergoes base promoted cyclisation to give the pyrrylol 
pyrazine 2.19. 
2.16 ~H Qxo 
0 iii JfH LeU) o N,
-!del Ts TsHN 0 Leu Co 
2.21 
2.17 j 
Q{o. Q{OH 
OJ-yN'TS .. A('Ts HO 
Leu Leu 
2.22 2.19 
Scheme 2.17 
2.2.3 NaH Reaction - Acylation of Pyrrole-2-Carboxaldehyde by Simple 
Activated Acyl Species 
P-2-c was acylated with acetyl chloride in an attempt to improve an 
understanding of the NaH reaction described above, and to help clarify the 
assignment of IH NMR spectra. The pyrrole anion was formed using NaH, in 
an analogous reaction as above, Section 2.2.1. Acetyl chloride 2.23 (1.2equiv.) 
was added. and stirring continued for one hour. Scheme 2.18. 
2.16 2.23 
Scheme 2.18 
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During this time a large amount of black precipitate formed. again 
attributed to formation of a pyrrole polymer. Chromatography gave two 
pyrrolic compounds, the starting material p-2-c (21%), and the required N-
acetyl-p-2-c (20%) 2.24. The spectral data of the N-acetyl-p-2-c 2.24 were 
consistent with the same compound reported by Bohlmann 17. 
2.2.4 NaH Reaction - Conclusion 
The two competing pathways of pyrrylol pyrazine and oxazolidinone 
formation occur with an amino acid derived acid chloride. The desired N-
acylated species. were only observed with the simple model acid chloride. A 
new methodology was therefore required for the acylation of p-2-c on 
nitrogen. 
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2.3 Alkali Metal Mediated Acy1ation of Pyrrole Derivatives 
2.3.1 Methyl Lithium Mediated Acylation 
Metallic potassium has been used extensively for the preparation of 
pyrryl-anion potassium salts. We reasoned that MeLi would be a more 
convenient method for the productIon of lithium pyrryl-anion salts. Pyrrole 
2.25 was dissolved in dry ether at -78°C under nitrogen. and treated with one 
equivalent of MeLt 2.26. After five minutes hydrocinnamoyl chloride 2.27 was 
added to yield. after twenty four hours. the N-cinnamoyl-pyrrole 2.28. 
Scheme 2.19. essentially pure by 1 H NMR spectroscopy (95% after 
chroma tography). 
A similar reaction using N-Cbz-L-Phe-p-nitrophenyl ester 2.29 
(lequiv.) gave the desired N-acyl-pyrrole 2.30 and starting material. After 
chromatography. 2.30 was isolated in 48% yield. The IH NMR spectrum of 
2.30 was consistent with N-acylation. the pyrrole signals of H-2 and H-3 that 
were observed. had shifted downfield and the characteristic triplets at 
6.30ppm and 7.10ppm were found to be consistent with N-acylation [8 
(CDCI3) 6.30 (2H. t. J=2.4Hz. H-2); 7.10 (2H. t. J=2.3Hz. H-3)]. A similar IH 
NMR spectrum was observed for the N-acyl-pyrrole 2.28. 
Attempts to formylate the N-acyl-pyrroles 2.28 and 2.30 to yield the 
N-acyl-p-2-c 2.31 and 2.33 precursors to the desired hydroxymethyl pyrroles 
2.32 and 2.34. Scheme 2.20. are discussed in Section 2.6. 
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o FormylaUon 
.. 
Q-yH Reduction ~OH 
N 
R 
2.28 R=COCH2CH2Ph 
2.30 R=CO-Phe-Cbz-N 
R 0 
2.31 R=COCH2CH2Ph 
2.33 R=CO-Phe-Cbz-N 
Scheme 2.20 
.. N 
R 
2.32 R=COC~CH2Ph 
2.34 R=CO-Phe-Cbz-N 
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The MeL! reaction was then attempted on p-2-c. Addition of MeL! 
(lequiv. in ether) to p-2-c in dry ether at -78°C, produced a pale blue solution 
after five minutes. 
?yOH 
H CH3 
2.35 
1) MeL! and 
p-2-c .. 
2) 2.27 
2.31 
~ N CHO 
or 2) 2.29 
X 
CbZHN~ 
_ 0 
Ph/ 
2.33 
~ N CHO 
or 2) 2.36 N-pth-Phe-CI 
loo 
FthN~ 
: 0 
Ph/ 
2.37 
Scheme 2.21 
The addition of hydrocinnamoyl chloride 2.27 to the pyrryl anion and 
subsequent work up afforded the N-cinnamoyl-p-2-c 2.31 in 89% yield after 
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chromatography. The result was surprising as it was expected that the MeLi 
may undergo nucleophilic addition at the formyl group to give the secondary 
alcohol 2.35, Scheme 2.21. 
The lack of this substitution suggests that the N-acylation occurs via 
the pyrrole/lithium enolate 2.38 with either a reversible attack at oxygen and 
acyl transfer to nitrogen, or direct acylation on nitrogen. This is further 
evidence of the non-aldehydic nature of p-2-c as described in Section 2.1.1. 
The extension of this reaction to the amino acid 
derivative required for enzyme recognition purposes was then 
attempted. Preparation of the lithium salt of p-2-c, as above, 
followed by addition of N-Cbz-Phe-p-nitrophenyl ester 2.29, 
produced a yellow colour within five minutes. 1 H NMR spectral 
2.38 
analysis of an aliquot at fifteen minutes, one hour and one day 
showed no sign of the desired N-acylated product 2.33. The less reactive 
oxazolone 2.39 was thought to be forming on addition of the amino acid 
derivative to the MeL!. This is discussed in detail in Section 2.4.7.1. 
The addition of N-pth-Phe-Cl 2.36 to the p-2-c salt produced, within 
ten minutes, 90% by NMR spectrum of the N-acylated-
p-2-c 2.37 (remaining 10% as p-2-c). A discussion of 
N~Ph 
Ph/"..O-'Z. _)\-OH 
o 
2.39 
the characteristics of this product is found in the 
DMAP methodology section, Section 2.4.2. 
The MeLi reactions were quenched at -78°C as 
it was thought that the decomposition product of MeLl, 
LiOH, may cause deacylation of the product N-acyl 
species. 
The high yield of the deSired N-acylated amino acid pyrrole 
derivatives 2.31 and 2.37 using MeLi to form the anion of p-2-c therefore 
provides a viable synthesis of the desired N-acylated pyrrole derivatives that 
have been designed as enzyme Inactivators, see Section 1.1. 
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2.3.2 n-Butyl Uthlum Mediated Acylation 
The reaction of p-2-c with n-BuLi followed by the addition of 
hydrocinnamoyl chloride at -78°C was also attempted. IH NMR spectral 
analysis indicated' the N-acyl species 2.31 had formed in 80% yield, in 
addition to 20% p-2-c. 
Reaction of BuLi and N-Cbz-Phe-p-nitrophenyl ester with p-2-c 
produced no acylated product after twenty four hours. The failure of this 
reaction again pointed to oxazolone 2.39 formation, discussed in Section 
2.4.7.3. 
The MeLi reaction had been found to proceed more efficiently and was 
therefore used in preference to n-BuLi. 
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2.4 The DMAP Methodology of Acylation Promotion 
A 1969 paper by Stegl1ch and Hofle18 identified N.N-Dimethyl-4-
pyridinamine (DMAP 2.40. Scheme 2.22) as an effective. high yielding, 
acylating catalyst (O.lequiv. with respect to the species being acylated); a two 
fold excess of triethyamine (TEA) is also added to the reaction. 
DMAP is believed to act in a similar manner to pyridine in promoting 
acylation reactions. The enhanced reactivity of DMAP over pyridine is not a 
result of increasing basicity (DMAP pKb=9.70. pyridine pKb=5.29). but is due 
to the high concentration of N-acyl pyridinium salts 2.41 formed. which are 
very effective acylating agents, Scheme 2.2219. 
o 
2.40 (DMAP) 
AD- PH3 R N I. N 
+ ~ /I \ 
CH3 
2.41 
Scheme 2.22 
2.4.1 DMAP Mediated N-Acylatlon of Pyrrole-2·Carboxaldebyde 
Acetyl chloride (l.lequiv.) was added to p-2-c, TEA (1.5equiv.,) and 
DMAP (O.lequiv.) in dry CH2CI2: a general reaction is described in Table 2.1 
below. The resultant deep yellow solution was then stirred for twenty four 
hours. Washing with citric acid (10% solution in water). effectively removed 
the TEA and the DMAP. The N-acetyl-p-2-c 2.24 was isolated as a crystalline 
solid (63%). 
A further reaction using acetic anhydride was attempted to test the 
generality of the methodology. The addition of AC20 (1.1equiv.) to p-2-c, TEA 
and DMAP in CH2Cl2 gave a quantitative yield of the N-acetyl-p-2-c 2.24. The 
enhanced yield over the acetyl chloride reaction (63%). was surprising and 
warranted further investigation. 
2.4.1.1 Effect oj Base on Yield oj DMAP Catalysed Reaction oj Pyrrole-2-
Carboxaldehyde 
A series of acylating agents were investigated using the p-2-c/DMAP 
system. The non-nucleophilic hindered base N.N-dUsopropylethyl amine 
(Hunigs base) was also investigated. Each reaction used the methodology 
discussed in the previous section. The results for these reaction are recorded 
N -A cul atl on 0 f Purrol e Deri vatl ves 
as isolated yields in Table 2.1. 
Effect of Binding Base on Yields in the DMAP Reaction 
with Pyrrole-2-Carboxaldehyde 
Isolated Yield (%) 
QyH 1) DMAP, TEAjHunigs base 9rrH ... 
H 0 
2) (RCO)20jRCOX R~OO 
Activated Acyl R TEA Hiinigs Base 
Species 
(CH3CO)20 
-
CH3 2.24 Quant 58 
(CH3CH2C0120 -CH2CH3 2.42 Quant c53 
CHsCOCI 
-
CH3 2.24 50 Quant 
CHsCH2COCI 
-
CH2CH3 2.42 45 90 
PhCOCI -Ph 2.43 45 Quant 
PhCH2CH2COCI -CH2CH2Ph 2.31 50 95 
Quant. = Quantitative Yield 
50 
The pyrrole 2.44 in the presence of DMAP and TEA was acylated by 
acetyl chloride. producing the N-acetylated pyrrole 2.45 in 95% isolated 
yield. Table 2.2. The reaction indicated that a wide variety of pyrrole 
derivatives have the possibility of being N-acylated by the DMAP reaction. 
W CN 7 ~ 1) DMAP. Hunigs base ~ .. N C02 Et 2) CH COCI H 3 H 
2.44 2.45 
Scheme 2.23 
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Effect of Binding Base on Yields in the 
DMAP Reaction with Pyrrole 2.44 
Activated Acyl 
Species 
2.45 
TEA 
95 
55 
Quant. = Quantitative Yield 
Table 2.2 
Hiinigs Base 
58 
Quant 
51 
A clear trend emerges from these data: acid chlorides generally gave a 
lower yield of the N-acylated pyrrole product using DMAP and TEA. rather 
than DMAP and Hiinigs base. However. high yields of N-acylated pyrrole 
product were obtained using the corresponding acid anhydrides with DMAP 
and TEA. while lower yields were obtained in the reactions using Hiinigs base. 
Where decreased conversion to the N-acylated pyrrole product was observed. 
the yields were not increased with longer reaction times. This protocol was 
used throughout the subsequent work. 
The hindered Hiinigs base may help to stabilise the more reactive acid 
chloride and hence a higher yield is observed than in the corresponding 
reaction using TEA. 
2.4.2 N-Acylation of Pyrrole-2-Carboxaldehyde with Amino Acids 
The use of MeLi to promote N-acylation of pyrrole. but not p-2-c. with 
amino acids has been discussed. Section 2.3. The DMAP reaction was 
developed for the acylation of p-2-c with simple acylating agents. The 
methodology was now in place to extend the N-acylating species to an amino 
acid. Phenylalanine (Phe) was chosen since both serine proteases and the HIV 
protease cleave on the carboxyl side of an aromatic amino acid. 
2.4.2.1 Phthalyl Protected Phenylalanine Amino Acid 
. The phthalyl (Pth) group was used in the initial extension studies. The 
N-Pth-Phe-CI acid chloride 2.36 was prepared from N-pth-Phe-OH using DMF 
and oxalyl chloride. N-pth-Phe-CI was added slowly to a stirred solution of p-
2-c, Hiinigs base and DMAP in CH2Cl2 under nitrogen, Scheme 2.24. 
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1) DMAP. Hunigs Base 
p-2-c 
2) 2.36 N-pth-Phe-Cl 
Scheme 2.24 
~H 
PthN~ 0 
_ 0 
Ph/ 
2.37 
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An immediate colour change was observed. Colourless, to yellow, to 
green and finally to black over five minutes. The reaction mixture was stirred 
for twenty four hours and worked up as before. The 1 H NMR spectrum did 
not show a 9.54ppm signal due to the p-2-c. A new signal at 10. 17ppm and a 
triplet (J=3.4Hz) at 6. 19ppm were evident and indicated that N-acylation of 
p-2-c had occurred to give 2.37; see Section 2.7.1 for more detailed NMR 
spectral analysis. The yield of the reaction was low «15%), due to polymer 
formation. 
The order of reagent addition was changed in an attempt to minimise 
polymer formation. A similar reaction was attempted where p-2-c. DMAP. and 
Hunigs base in CH2CI2. were added dropwise to the stirred solution of ice 
cold acid chloride. Again a deep yellow/brown solution resulted over ten 
minutes. After fifteen minutes an aliquot was removed from the mixture that 
showed by 1H NMR spectroscopy essentially 100% conversion to an N-
acylated pyrrole. A signal at 9.54ppm (p-2-c) was not observed whereas a 
downfield signal at 10.17ppm and a triplet (J=3.4Hz) at 6.19ppm were 
observed. The product N-acyl-pyrrole 2.37 was isolated in a preparative 
experiment, but proved to be unstable to chromatography. 
The product was unstable and deacylation occurred after three days in 
a freezer. Therefore. it was decided to reduce the N-acyl-pyrrole 2.37 without 
further purification. as discussed in Section 2.4.4. The hydroxymethyl pyrrole 
was expected to be more resistant to deacylation, as explained in Section 
2.1.2. 
2.4.3 DMAP N-Acylation of Pyrrole 
The most widely used method for preparation of N-acylated pyrrole is 
the acylation of the potassium salt of pyrrole20. The reaction is tedious and 
the yields are low21 . The use of acyl imidazole as an acylating agent of pyrrole 
at reflux has also been reported21. This method is not useful for products that 
are heat sensitive or for species that will not form the acylated imidazole. 
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Another acylation reaction involves MeL! as previously found in this work, 
Section 2.3.1. 
The DMAP methodology was shown to be very effective when applied 
to pyrrole. AC20 was added to pyrrole, TEA and DMAP in CH2Cl2 to 
o 
N 
give the N-acetyl-pyrrole 2.46 in 64% yield. The NMR spectral data 
were consistent with that reported elsewhere22 • 
H3C~O 
2.46 
2.4.4 Reduction of N-Acylated Formyl Pyrrole Derivatives 
Standard methods for the reduction of formyl pyrroles use 
NaBH4in aqueous soluUon23• 
However, it was decided not to use aqueous conditions to limit 
problems with decomposition of the sensitive amino acid-pyrrole system. 
2.4.4.1 Sodium Borohydnde Reduction of N-Acyl-Pyrrole-2-Carboxaldehyde's 
The reduction of related formyl pyrroles with NaBH4 in CH2CI2/MeOH 
has been reported24• 
The N-acetyl-p-2-c 2.24 was reduced under the same conditions, 
Scheme 2.25. 
2.24 
~OH 
N 
H3C~O 
2.47 
Scheme 2.25 
The 1 H NMR spectrum of the crude reaction mixture gave no 
evidence of the starting material -CRO signal at 10.30ppm. Chromatography of 
the crude sample gave two fractions. 
The NMR spectrum of the first fraction showed a new broad doublet 
(J=:6.0Hz) at 4.63ppm. This fraction was isolated in 84% yield and identified 
as the desired N-acetyl hydroxymethyl pyrrole 2.47. A detailed NMR spectral 
study of this and other hydroxyrnethyl pyrroles is found in Section 2.7.2. 
, The second fraction was identified as the formyl pyrrole. p-2-c (13%) 
the result of deacylaUon rather than reduction. This compound is clearly 
produced under the reduction conditions. as the starting material contained 
no p-2-c. 
The deacylation of N-acetyl-p-2-c 2.24 was studied by IH NMR 
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spectroscopy. The aldehyde in d4-MeOH slowly hydrolysed to p-2-c (30% 
after one hour). Acetate was also observed on standing. N-acetyl-p-2-c does 
not undergo deacylation in CDC13; however the addition of one equivalent of 
NaOH caused total deacylation to p-2-c and acetate in ten minutes, see 
Sections 4.2 and 4.3 for similar experiments. 
The formyl group of the N-acylated formyl pyrrole increases ring 
delocalisation. Figure 2.8, and hence makes the amide bond more susceptible 
to nucleophilic attack and subsequent deacylation. 
The reduction of amino acid derived pyrrole derivative 2.37 was then 
attempted. 
2.4.4.2 NaBH4 Reduction of Amino Acid PYrTole Derivatives 2.37 
The reduction of the amino acid aldehyde 2.37 using NaBH4 in 
MeOH/ CH2Cl2, as above, produced a polymeric species, p-2-c and the 
unstable acetal 2.49, Scheme 2.26, [0 (CDCl3) 3.29 (3H, s, OMe); 3.45 (3H, s, 
OMe); 3.56 (2H, m, CH2-Ph); 5.66 (lH. m, Phe-CH); 6.14 (lH, t. J=3.4Hz, H-
4); 6.47 (lH, m, H-3); 7.07 (lH, dd, J=3.4 &1.6Hz, H-5); 7.11-7.21 (5H, m, 
Phe-Ph); 7.69 (2H, dd, J=5.4 & 2.5Hz, Pth-CH); 7.77 (2H, dd, J=5.3 & 2.6, 
Pth-CH)]. There was no evidence of the desired reduced amino acid pyrrole 
2.51. The formation of the acetal 2.49 is consistent with N-acylation 
increasing the carbonyl character of the formyl group. The acyl group 
decreases the contribution of resonance structure 2.48, Scheme 2.26, due to 
the delocalisation of the nitrogen lone pair as in structure 2.50; see Section 
2.7.3.2 for supporting UV data. 
The complex electronic structure of the 1t pyrrole system, is again 
demonstrated by the stability of the pyrrole derivatives and their subsequent 
reaction. 
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PthN~ 0 
_ 0 
Ph/ 
2.37 
2.49 
.. .. 
Scheme 2.26 
2.4.4.3 Reduction 012.37 with LiAlH4 
WH "'~'~ pthN~ 0-
:: 0 
Ph/ 
2.48 
1 
Q-yH 
pthNV(O- 0 
Ph/ 
2.50 
~OH 
N 
pthN~ 
_ 0 
Ph/ 
2.51 
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The attempted reduction of the amino acid pyrrole aldehyde 2.37 
using LWH4 in dry ether gave only starting material. A literature report 
suggests that N-acyl-pyrroles are hydrolysed by LWH4 to give deacylated 
pyrrole and an aldehyde or primary alcoho125 this was not observed for this 
system. 
2.4.5 Zinc Borohydrlde Reduction of the N-Amino Acid Formyl Pyrroles 2.31 
and 2.37 
A trial reductIon of the formyl pyrrole 2.31 in dry ether with zinc 
borohydrIde26 2.51 (1.2equiv. in dry ether), Scheme 2.27, under dry nitrogen 
for thIrty minutes afforded. after radIal chromatography. the desired 
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hydroxymethyl pyrrole 2.32 in 90% yield. 
The- hydrocinnamoyl moiety (COCH2CH2Ph) has successfully been used 
as a Phe analogue in the inhibition of tRNA synthetase27• This species 2.32. 
therefore. was expected to be a potential inhibitor of the proteolytic enzymes. 
chymotrypsin and HlV protease. The results of the assays on these enzymes 
are found in Chapter Five. 
Reduction of the amino acid aldehyde 2.37 in dry ether with zinc 
borohydride 2.51 (1.2equiv. in dry ether). Scheme 2.27. under nitrogen for 
thirty minutes afforded. after radial chromatography. the desired 
hydroxymethyl pyrrole 2.52 in 62% yield. 
2.51 (Zn{BH4h). 
~OH 
N 
2.31 )II ~o Et20 
Ph 2.32 
9rrH 2.51 (Zn{BH~v. ~OH PthN~O 0 .. PthN~O Et20 
Ph Ph 
2.37 'L' amino acid 2.52 'V amino acid 
2.54 'D' amino acid 2.55 'D' amino acid 
Scheme 2.27 
The 1 H NMR spectrum was consistent with an N-acylated pyrrole and 
reduction to a hydroxymethyl pyrrole. NMR spectral analysis is described in 
Section 2.7.4. This mauve amorphous solid resisted all attempts at 
crystallisation but was nevertheless remarkably stable. Little decomposition 
was observed over six months when stored under nitrogen in a freezer. 
The hydroxy methyl pyrrole 2.52 exhibited the characteristics 
necessary to give mechanism based inactivation of a protease. The pyrrole 
ring deactivated by the N-acylated amino acid. and a leaving group at the 2-
pOSition. allows azafulvene formation on enzymic deacylation. This compound 
was tested against the HlV protease and a-chymotrypsin. see Sections 5.1 and 
5.2. 
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2.4.6 Determination of Enantiomeric Excess of the Amino Acid-Pyrrole 
Derivative 
For the designed hydroxymethyl pyrrole derivatives. it is required that 
no racemisation of the amino acid should occur. We therefore designed the 
following experiment to determine the enantiomeric excess. 
The enantiomeric excess of the L-amino acid hydroxymethyl pyrrole 
deriva tive 2.52 was determined by conversion to the corresponding 
camphanate 2.53 using (-)-camphanic acid under Mitsunobu conditions28• 
Scheme 2.28. A detailed IH NMR spectral analysis of the camphanate made 
from the L-derivative 2.53 determined the enantiomeric excess to be 90%. 
The analogous reaction sequence starting with D-Phe. followed by N-
protection with N-carbethoxyphthalimide29, acid chloride formation and 
reaction with p-2-c, Hiinigs base and DMAP gave 2.54. The Zn(BH4}2 
reduction with the final Mitsunobu reaction formed the camphanate to give 
the D-amino acid derivative 2.56 as a reference for the calculation. Figure 2.29 
shows the 1 H NMR spectra of the camphanate methyl signal region and the 
Pyr-CH2 region for the two camphanates 2.53 and 2.56. 
2.52 
2.55 
DEAD, PhaP. 
(-}-campharuc acid 
2.53 'L' amino acid 
2.56 'D' amino acid 
Scheme 2.28 
IH NMR Spectra of Camphanate Methyl Region 
of Camphanates 2.53 and 2.56 
I ' i ' I ' j " j 0 1 I I I i I I 
.,.. 1.~4 • t,~ • I.~ , •• ;. "t, t , I i I 1.14 1.&.1 I." • t,,. ,.N '.IH .... .... t.u '.N .... .... ,.N 
2.53 2.56 
i • , 
.. " ,.,.. 
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IH NMR Spectra of Camphanate pyr-CH2 Region 
of Campbanates 2.53 and 2.56 
2.53 2.56 
Figure 2.29 
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Table 2.3 shows a comparison of the 1 H NMR spectra of the two 
isomers. 
Selected IH NMR Spectral Data for the N-Acylated Camphanates 
2.53 and 2.56 
Orlgin of Signal 
camphana te-CH3 
camphanate-CH3 
camphanate-CH3 
pyrrole-CH2-CO 
pyrrole-CH2-CO 
pyrrole H-4* 
L isomer 2.53 
o (ppm) 
0.89 
0.99 
1.03 
5.35 
5.49 
6.09 
D isomer 2.56 
o (ppm) 
0.92 
0.96 
1.03 
5.34 
5.50 
6.09 
*In table to show that the spectra referenCing was correct 
Table 2.3 
The data in Table 2.3 summarises the major differences in IH NMR 
spectra of the two isomers. The 1 H NMR spectrum of the 'L' amino acid based 
compound 2.53 indicated a 95:5 (L:D) ratio. A ratio of 65:35 (D:L) was 
.. 
determined for the 'D' derived hydroxymethyl pyrrole 2.56. The optical rotary 
N-Aculation of Purr ole Derivatives 59 
dispersion (ORD) spectra of all of the amino acid derivatives used in the 
formation of the camphanates 2.53 and 2.56 was measured to pin-point the 
source of racemisation in the 'D' series; these data are expressed in Table 2.4. 
Pyrrole derivative 
Phe-OH 
N-Pth-Phe-OH 
N-(N-pth-Phe)-
p-2-c 
N-(N-pth-Phe)-
p-2-0H 
N-(N-Pth-Phe)-
p-2-0-camph 
ORD data from Phenylalanine Derivatives 
[(e!. MeOH) , [a]D25] 
D lit. value L 
+31- 2.57 +33(c2. H20). -34-
+98 2.59 +212(cl. EtOH)t -217-
+ 196 2.54 -210 2.37 
+ 180 2.55 -195 2.52 
+114 2.55 -90 2.53 
lit; value 
-33(c2. H20)· 
-212(c1.9, EtOH)t 
-Obtained from SIgma Chemical Co.: ·Slgma Chemical Co.; tFrom 30 
Table 2.4 
Racemisation has clearly occurred in the preparation of the protected 
amino acid N-Phthalyl D-amino acid 2.59 via N-carbethoxy phthalimide 2.58, 
Scheme 2.30. 
2.57 
D-Phe 
o 
~N-co,Et 
o 
2.58. 
Na2COa·lOH20 
Scheme 2.30 
()--10 0 
rNrOH 
Ph 
2.59 
N-Pth-D-Phe 
The 'V version of the protected amino acid, N-Pth-L-Phe-OH, was 
obtained from the Sigma Chemical Company. Repeating the sequence with 
optically pure31 N-Pth protec~ed D-Phe amino acid was not felt necessary as 
the 'L' and 'D' series camphanates. 2.53 and 2.56 respectively, had clearly 
distinguishable IH NMR spectral signals, Figure 2.29. 
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The high enantiomeric excess found in the "L' derivative 2.53 clearly 
shows that the steps involved in the synthesis of N-acylated hydroxymethyl 
pyrroles did not cause racemisation of the amino acid a-carbon during the 
synthesis. This finding will therefore allow the production of this class of 
inhibitor in high optical purity. 
N-Pth protected dipeptide acid chlorides, and other N-Pth protected 
amino acids were also tried using the DMAP methodology to N-acylate p-2-c. 
This is discussed in Section 3.3. 
2.4.7 Deprotection of N-Phthala1yl Protected Amino Acid Pyrrole Derivative 
2.52 
The phthalyl protecting group of 2.52 proved to be difficult to remove. 
Conditions tried included those described as mild32 , NaBH4/2-propanol 
followed by hot acetic acid. The traditional methods of hydrazinolysis33 , and 
acid catalysed hydrolysis34 were considered to be detrimental to the pyrrole. 
These results were expected, but are unfortunate as extension in the 
N-direction from the pyrrole would be most advantageous for recognition of 
the inhibitor by the targeted enzyme. The HIV protease, for example, requires 
up to four amino acids in the N-direction from the scissile bond, the PI-P4 
subsites, to make an adequate inhibitor; see Section 1.2 for a discussion. At 
present there is only one amino acid and a large N-protecting group, both of 
which are consistent with known inhibitors of the HIV-1 protease, Section 
1.2.4 and Section 3.2.5. 
We therefore tried to extend the reaction to the benzyloxycarbonyl 
(Cbz) protecting group. 
2.4.7.1 N-Cbz Protection of the Acylated Amino Acid Phenylalanine 
We expected that an analogous reaction using an activated ester of an 
N-protected amino acid, eg: the conveniently crystalline p-nitrophenyl ester, 
would yield the desired N-acyl product, Scheme 2.31. 
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o 
PHN~ 
_ X 
Ph"""'" 
DMAP, 
TEA 
2.29 P=Cbz, X=pnitrophenyl ester 
2.60 P=Fmoc, X=CI 
Scheme 2.31 
QrrH 
PHN~ 0 
_ 0 
Ph"""'" 
2.33 P=Cbz 
2.61 P=Fmoc 
The DMAP methodology was used in an attempt to N-acylate p-2-c. 
Addition of N-Cbz-Phe-p-nitrophenyl ester 2.29 to the pyrrole solution 
produced a yellow colour that intensified over twenty four hours. This colour 
was attributed to the release of p-nitrophenol. During the standard DMAP 
work up the organic layer was washed with water until the yellow colour had 
been removed from the washings. The IH NMR spectrum of this, was 
consIstent with the desired N-acylated pyrrole 2.33, ie: a downfield shift of 
the of -CHO signal to 10.38ppm and shifts downfield, as well as characteristic 
multiplicity changes to the pyrrole H-3, H-4, H-5 signals [0 (CDCI3) 6.34 (IH, 
t. J==3.6Hz, H-4); 7.04 (lH, m, H-3); 7.21 (IH, dd, J==3.1 & 1. 7Hz, H-5)]. 
This reaction was repeated many Urnes after this initial success. 
However problems were encountered with the reproducibility. The yield (by 
IH NMR spectrum) was at best 13% N-(N-Cbz-Phe)-p-2-c 2.33, with 87% p-
2-c. The following modifications were attempted in order to improve the 
reprod ucibili ty: 
1) amino acid and DMAP were scrupulously dried by 
recrystallisation followed by drying under high vacuum for twenty four hours, 
2) p-2-c and TEA were freshly distiled, 
3) the reaction was performed in a "dry box", 
4) freshly activated 4A molecular sieves were added to the 
reaction, 
5) the reaction carried out at reflux, 
6) varying the amounts of each reagent and solvent, 
7) glassware both washed in strong acid and strong base 
respectively, 
8) the addition of water to the reaction mixture, 
9) altering the order of addition of reagents, all to no avail. There 
was no doubt that the first reaction, and several of the later reactions, gave 
the desired N-acylated pyrrole derivative 2.33. The assumption was that the 
problem was in the source of the starting materials. The p-2-c in the first 
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successful reaction was obtained from Aldrich Chemical Company. whereas in 
subsequent reactions it was prepared from Vilsmeier-Haack formylation of 
pyrrole35. The amino acid. obtained from Sigma, was also of different batches. 
This reaction was not pursued further due to the problems of 
reproducibility. 
2.4.7.2 N-(9-Fluorenylmethyl)oxycarbonyl (Fmoc) Protection oj the Acylated 
Amino Acid Phenylalanine 
N-Fmoc protected amino acids have received much attention in 
peptide synthesis due to ease of deprotection. Addition of a solution of N-
Fmoc-Phe-CI36 2.60, Scheme 2.31. to p-2-c under the DMAP conditions 
produced no sign of N-acylated product 2.61, there was full recovery of p-2-c. 
2.4.7.3 Loss oj Activity oj Cbz and Fmoc Amino Acid Acylating Agents and 
Possible Methods to Overcome this Problem 
The use of an Na.-urethane, eg: Cbz. protected amino acid acid 
chlorides had been limited since the necessary basic co-reagent. DMAP. 
causes immediate conversion of the amino acid to the corresponding 
oxazolone37 2.39, Scheme 2.32. 
Base 
p= Fmoc, Cbz, Boc 2.39 
Scheme 2.32 
Oxazolones are more sluggish than the parent acid chloride to further 
acylation and result in racemisation. Extension of amino acid chain in the N-
d~rection (Figure 2.9) required the removal of the protecting group. 
The oxazolone 2.39 was assumed to have formed on the addition of 
DMAP to the activated amino acid derivatives. Carpin036 also indicated that 
the formation of the oxazolone is overcome by the slow addition of the amino 
acid acid chloride to the compound that is to be acylated. Here, direct 
reaction of the pyrrole with the acid chloride competes favourably with 
oxazolone formation. This order of addition is opposite to that used in the N-
Pth protected case where high yields of the N-acyl product were observed. 
Section 2.4.2.1. The DMAP reaction produced no N-acylated product on the 
reversal of addition as described above. 
Carpino also suggested that (X-amino acid fluorides do not undergo 
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oxazolone formation. The acid fluoride is expected to acylate the pyrrole 
derivative readily, this the reaction was not attempted38• 
Activation of amino acids by DCC 2.62 and HOBt39 2.64, Scheme 2.33, 
was also attempted. The formation of the HOBt/amino acid complex 2.65. 
Scheme 2.33, has been shown to depress oxazolone formation, Scheme 2.32. 
o-N=C=N-Q 
2.62 (DCC) 
.. 
Q 
HO-N, .... N 
N 
2.66 (DCU) 
Scheme 2.33 
2.63 
2.64 (HOEt) 
oQ 
II N .. N 
R/'....O ..... 'N' 
2.65 
One equivalent each of HOBt 2.64 and DCC 2.62 were added to the 
free N-Cbz-Phe-OH and a white solid, attributed to the DCU 2.66, formed. 
indicating formation of the activated amino acid, eg: 2.65. This was followed 
by the addition of the necessary reagents for the DMAP promoted acylation of 
pyrrole. The 1 H NMR spectrum of aliquots of this mixture did not show 
evidence of N-acylated product after fifteen minutes, three hours and twenty 
four hours. We were forced to conclude that the HOBt activated amino acid 
species was not reactive enough to acylate p-2-c. 
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2.5 Protection of the Pyrrole-2-Carboxaldehyde Formyl Group 
- Acetal Studies 
The NaH and MeLi studies indicated that the pyrrole aldehyde played 
a part to the detriment of the N-acylation reaction via reaction through 
oxygen. Electron and/or resonance donating substituents at the 2-position of 
the pyrrole have been found to activate the nitrogen towards nucleophilic 
attack. 
Protection of the formyl group by acetal formation was not expected to 
alter the electron density on the pyrrole nitrogen. The p-2-acetal 2.67, 
Scheme 2.34, described by Loader40 was prepared by the method described 
as indirect. The acetal was shown to be stable and survived the DMAP 
conditions. 
DMAP, 
2.27 
2.67 
Scheme 2.34 
The addition of one equivalent of hydrocinnamoyl chloride to p-2-
acetal 2.67 using the DMAP methodology produced no evidence by IH NMR 
spectrum of the desired N-acylated species 2.68. This reaction was attempted 
several times without any success. Nor was success obtained with the MeLi 
promoted acylation of 2.67. The IH NMR spectrum signal for the pyr-CH-
acetal was expected at 5.8-5.9ppm with similar shifts and multiplicity of H-3, 
H-4 and H-5, as observed in the N-acylated-p-2-c derivatives, Section 2.7.1. 
The continual lack of products from the reaction with the acetal 
forced the conclusion that acetal formation removes suffiCient electron 
density from the pyrrole nitrogen so as to deactivate it towards the acylation 
reactions. The use of acetal protected p-2-c was therefore discontinued. 
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2.6 Formylation of N-Acyl-Pyrrole Derivatives 
The N-acylation of pyrrole itself was moderately successful via both the 
DMAP and MeLi methods, Section 2.3.1. and Section 2.4.3. The Vilsmeier-
Haack formylation of the product 2.28 and 2.30. Scheme 2.35. only resulted 
in the formation of p-2-c and polymer. No evidence for the desired formyl 
pyrroles 2.31 or 2.33 was observed. 
o POCls • DMF 
N 
R 
2.28 R=COCH2CH2Ph 
2.30 R=CO-Phe-Cbz-N 
X .. Q-yH 
R 0 
2.31 R=COCH2CH2Ph 
2.33 R=CO-Phe-Cbz-N 
Scheme 2.35 
A recent report indicated that formylation of aromatic compounds 
using the trifluoromethanesulfonic anhydride/DMF complex41 proceeds in 
higher yields than the standard Vilsmeler-Haack reaction. This reaction was 
considered. but not attempted. 
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2.7 Spectroscopic Data of Pyrrole Derivatives 
The formyl pyrroles 3.44, 3.52, 3.54 and 3.56 and the hydroxymethyl 
pyrroles 3.45. 3.53, 3.55 and 3.57 are described in Chapter Three. they are 
included in the NMR spectral discussion, below. for completeness. 
2.7.1 Nl\m.Ana1ysis of the N-AcyIated Pyrrole-2-carboxaldehyde's 
2.7.1.1 N-Acyl-Pyrrole-2-Carboxaldehyde lH NMR Spectral Signal Positions 
IH NMR spectral analysis of the N-acylated-p-2-c species 2.24, 2.31. 
2.37. 2.42. 2.43. 3.44. 3.52. 3.54 and 3.56 showed that the H-3 and H-5 
pyrrole ring protons of the N-acylated pyrroles were downfield. They ranged 
from 7.12-7.26ppm for H-3 and 7.25-7.43ppm for H-5. An upfleld signal for 
H-4 was observed at 6.25-6.39ppm, and the formyl signal was found in the 
range IO.04-10.34ppm. This data Is tabulated in Table 2.5. and a 
representative 1 H NMR spectra Is shown in the Figure 2.36 of the N-acetyl-p-
2-c 2.24. 
IH NMR Spectra of N-Acetyl-Pyrrole-2-carboxaldehyde 2.24 
r 
k' il"" 
,--
-
--..., 
--' 
V \..-. 
, 
.:, .:, , , t t , ,t" ... t.. ... . .. . .. 
2.24 
Figure 2.36 
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IH NMR Spectral Data for N-Acylated-Pyrrole-2-Carboxaldehyde's 
[0 ppm (300MHz). CDCI3. TMS internal standard] 
4 3 
5~H N 2 
R 0 
Rgroup H-3 H-4 H-5 -cm 
H 7.03 6.38 7.17 9.55 
-COCH312 2.24 7.21 6.35 7.35 10.29 
-COCH2CH3 2.42 7.26 6.39 7.43 10.34 
-COPh 2.43 7.22 6.38 7.31 10.04 
-COCH2CH2Ph 2.31 7.21 6.33 7.32 10.29 
-CO-(Phe-pth-N) 2.37 7.07 6.19 7.18 10.10 
-COCH2CH(CH3l2 3.56 7.12 6.25 7.25 10.32 
-CO-(Leu-Pth-N) 3.44 7.16 6.31 7.29 10.14 
-CO (CH2) lOCH3 3.52 7.22 6.35 7.35 10.32 
-CO(CH2)4C02Me 3.54 7.23 6.36 7.36 10.30 
Average Position: 7.19 6.32 7.32 10.24 
/). with respect to p-2-c: +0.16 +0.06 +0.15 +0.69 
Table 2.5 
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The signals for the formyl pyrroles, Table 2.5, are shifted with respect 
to the free p-2-c on average +0. 16ppm for H-3, +0.06ppm for H-4, +0.15ppm 
for H-5 and +0.69ppm for -CHO. These downfield shifts indicate that the 
protons are deshielded by N-acylation, since the nitrogen lone pair is 
delocalised into the amide bond to give ring deactivation, see Section 2.1.2. 
This pattern of pyrrole NMR spectral signals was consistent with N-acylation. 
Studies by Jones42 on N-acylated pyrrole derivatives concluded that 
the variation in IH NMR chemical shifts may be dIrectly correlated with the 1t 
electron density at the ring protons and with the varying electronegatlvlty of 
the pyrrole nitrogen, as described in Section 2.1.2. Toube7 • SectIon 2.l.1, 
found that the relatively large formyl proton deshieldlng by the anisotropic N-
acyl carbonyl group caused a downfield shift of all the pyrrole protons and in 
particular the aldehyde proton. The N-acylation work described here was 
found to be consistent with both these conclusions. 
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2.7.1.2 Pyrrole Protons Resonance Multiplicity 
The multiplicity of the pyrrole proton signals were characteristically 
altered on N-acylation. The IH NMR spectrum of p-2-c. Figure 2.37, showed 
that the pyrrole proton H-3, H-4 and H-5 were coupled to each other and to 
the NH of the'pyrrole. 
IH NMR Spectra of Pyrrole-2-Carboxaldebyde 
-
Pyrrole-2-Carboxaldebyde (p-2-c) 
Figure 2.37 
The H-5 signal is further coupled to the formyl group via the "zig-
zag"S arrangement. Irradiation of the broad pyrrole-NH signal at 
apprOximately lOppm simplifies the multiplet due to H-3. H-4 to a doublet of 
doublets (J=3.5 & l.OHz) and H-5 to a very broad singlet. N-Acylated pyrroles 
produce a similar result on irradiation of the NH resonances, the multiples of 
H-3 and H-4 simplifY. while H-5 appears as doublet of doublets', In addition, 
the pyrrole IH NMR spectrum signals shift downfleld. The coupling constants 
for the ,N-acylated pyrroles synthesised are summarised in Table 2.6. 
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NMR Spectral J Coupling Constants (Hz) for 
N-Acylated-Pyrrole-2-Carboxaldebyde's 
[0 ppm (300MHz). CDCI3. TMS internal standard] 
4 3 
.gyH 
N 2 
R 0 
Rgroup H-3 H-4 H-S 
H m m m 
-COCH312 2.24 dd dd dd 
3.5&2.0 3.5&3.5 3.5&2.0 
-COCH2CH3 2.42 dd dd dd 
3.7 & 1.6 3.7&3.2 3.2 & 1.7 
-COPh 2.43 dd dd dd 
3.1 & 1.5 3.5&3.1 3.7 & 1.6 
-COCH2CH2Ph 2.31 dd t dd 
3.1 & 1.6 3.1 3.1 & 1.7 
-CO-(Pbe-Ptb-N) 2.37 dd t dd 
3.4&2.2 3.4 3.4&2.3 
-COCH2CH(CH312 3.S6 dd t dd 
3.5& 1.5 3.5 3.5& 1.5 
-CO-(Leu-Pth-N) 3.44 dd t dd 
3.5 & 1.5 3.5 5.8&3.1 
-CO(CH2) 1OCH3 3.52 dd t dd 
3.8 & 1.8 3.7 3.7 & 1.9 
-CO(CH2)4C02Me 3.54 dd t dd 
3.5 & 1.5 3.5 3.5 & 1.5 
Table 2.6 
2.7.1.3 Carbon Spectra of N-Acylated Formyl Pyrrole Derivatives 
. The 13C NMR spectra showed the same effects of N-acylation as the 
1 H NMR spectra did. there are downfield signal shifts corresponding to N-
acylation. These observations are summarised in Table 2.7. This again 
demonstrates that the amide bond deactivates the pyrrole ring by an increase 
in the electron delocalisation. 
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13C NMR Spectral data for N-Acylated-Pyrrole-2-Carboxaldehyde's 
[0 ppm (75MHz), CDCl3, CDCl3 internal reference] 
4 3 
5~H N 2 
R 0 
R C-2 C-3 C4 C-5 -ClIO 
0 0 0 0 0 
H 132.6 121.4 111.4 126.4 179.3 
-
COCH3 2.24 135.5 122.8 112.8 126.6 182.4 
-COCH2CH3 2.42 135.7 122.5 112.8 125.9 182.6 
-COPh 2.43 135.3 122.8 112.0 129.3 181.0 
-COCH2CH2Ph 2.31 139.7 122.9 112.8 125.9 182.4 
-CO-(Phe-Pth-N) 2.37 135.6 122.9 113.3 125.7 181.6 
-CO-(Leu-Pth-N) 3.44 135.3 122.6 113.2 125.5 181.6 
-COCH2CH(CH312 3.56 135.4 122.0 112.4 126.0 182.4 
-CO(CH2) lOCH3 3.52 135.7 122.4 112.7 125.9 182.6 
-CO(CH2)4C02Me 3.54 135.6 122.8 112.8 126.0 182.4 
Average Position: 135.5 122.6 112.8 126.3 182.1 
11 with respect 
to p-2-c: +3.1 +1.2 +1.4 -0.1 +2.8 
Table 2.7 
2.7.2 NMR Spectral Analysis oftbe N-Acyl Hydroxymetbyl Pyrroles 
2.7.2.1 N-Acyl Hydroxymethyl Pyrrole Proton Signal Positions 
The pyrrole proton resonances for H-3, H-4 and H-5 of the 
hydroxymethyl pyrroles 2.32, 2.47, 2.51, 3.43, 3.53 and 3.57 occur at similar 
chemical shifts to p-2-c. The doublet of doublets observed for the pyrrole H-5 
shifted upfield by 0.25ppm to 7.07ppm, H-4 moved on average upfield by 
0.15ppm to 6.17ppm. A most remarkable shift was observed for that of H-3, 
the signal moved upfield by 0.98ppm, with respect to the N-acylated formyl 
derivative, with a multiplicity increase from a doublet of doublets to a 
multiplet. Figure 2.38. This H-3 shift. is in contrast to that of p-2-c where 
there are two downfield (H-3. H-5) and one upfield signal (H-4). The 
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hydroxymethyl pyrrole compounds have one downfield (H-5) and two upfield 
signals (H-3, H-4). A representative IH NMR spectra of 2.47 is shown in 
Figure 2.38, p-2-c is in Figure 2.37 above for comparison. 
lH NMR Spectra of N-Acetyl-Hydroxymethyl Pyrrole 2.47 
. .'. ,:. 'i .:. 
2.47 
Figure 2.38 
, •.. .:. , . .. 
A representative example of all hydroxymethyl pyrroles, the N-(N-Pth-
Phe)-p-2-0H 2.51 system is described here: irradiation of the broad singlet 
due to CH20H at 4.59ppm collapsed the H-3 Signal (6.14ppm) to a doublet of 
doublets (J=3.4 & 1. 4Hz) , suggesting that the CH20H signal is coupled to H-3. 
two bonds distant. A very broad singlet at 3.66ppm was assigned to the OH on 
the basis that irradiation of this signal at 3.66ppm collapsed the broad singlet 
at 4.59ppm (CH20H) to a sharp singlet. 
The overall upHeld shifts are indicative of the loss of the aldehyde 
carbo~yl. This causes the ring system to have an increase in electron 
density42 due to the loss of the inductive formyl substituent. The reduction of 
the formyl group causes a decrease in the number of resonance contributors. 
and therefore an increase in the ling electron density, see Section 2.1.1. 
The shifted upfield 1 H NMR spectral signals of the N-acyla ted 
hydroxymethyl pyrroles are represented in Table 2.8. 
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IH NMR Spectral data for N-Acylated Hydroxymethyl Pyrroles 
[0 ppm (300MHz), CDCI3, TMS internal standard, multiplicity, 
(J Coupling in Hz)] 
4 3 
5~OH 
N 2 
R 
Rgroup H-3 H-4 H-5 CH20H 
H 6.14, m 6.12, m 6.78, m 4.62. bs 
-COCHs 2.47 6.24, m 6.21, t 7.08, dd 4.63, d 
3.3 3.4& 1.6 6.0 
-COCH2CH2Ph 2.32 6.21, m 6.17, t 7.06, dd 4.62, bs 
3.3 3.3& 1.6 
-CO-(Phe-Pth-lV) 2.51 6.14, dd 6.05, t 6.93, dd 4.59, bs 
3.4& 1.4 3.4 3.4& 1.5 
-CO-(Leu-Pth-N) 3.43 6.22, m 6.17, t 7.06, dd 4.63, bs 
3.5 3.4& 1.5 
-COCH2CH(CH3)2 3.57 6.22, m 6.19, t 7.11, dd 4.63, bs 
3.5 3.5&2.0 
-CO(CH2) 10CH3 3.53 6.22. m 6.19, t 7.12, dd 4.62, bs 
3.0 3.0& 1.0 
-CO(CH2)4C02Me 3.55 6.23, m 6.21, t 7.11. dd 4.63, bs 
3.5 3.5&2.0 
Average Position: 6.21 6.17 7.07 4.62 
A with respect to 
average N-Acyl-p-2-c: -0.98 -0.15 -0.25 n.a. 
Table 2.8 
The coupling values of the pyrrole protons are also represented in 
Table 2.8. 
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The 13 C NMR spectral signals for the hydroxymethyl pyrroles 
produced by formyl reduction are given in Table 2.9. 
l3C NMR Spectral data for N-Acylated Hydroxymethyl Pyrroles 
[0 ppm (75MHz). CDCI3. CDCl3 internal reference] 
4 3 
5~OH 
N 2 
R 
R C-2 C-3 C-4 C-5 aI20H 
0 0 0 0 0 
-COCH3 2.47 135.6 114.8 112.3 121.7 57.9 
-COCH2CH2Ph 2.32 135.5 114.5 112.2 120.7 57.9 
-CO-(Phe -pth-lV) 2.51 135.9 114.9 113.1 120.2 57.6 
-CO-(Leu-Pth-N) 3.45 136.1 114.9 113.0 120.1 57.6 
-COCH2CH(CH312 3.57 135.4 114.5 111.9 121.0 57.9 
-CO(CH2hoCH3 3.53 135.5 114.4 111.9 120.9 57.9 
-CO(CH2)4C02Me 3.55 135.5 114.6 112.2 120.8 57.9 
Average Position: 135.6 114.7 112.4 120.8 57.8 
A with respect to 
average N-Acyl-p-2-c: +0.1 -7.9 -0.4 -5.5 na 
Table 2.9 
2.7.3.1 IR Spectroscopy of the N-Acylated pyrrole Derivatives 
The formyl group of p-2-c is less aldehyde like in nature than other 
aliphatic aldehydes due to the deactivation by the 1t electron system. Figure 
2.2, Section 2.1.1. This is manifested in the UV. IR and the NMR spectra 
(Section 2.7.1) of the N-acyl-pyrrole derivatives. 
The p-2-c carbonyl stretching frequency is lowered to 1667cm-1 on 
N-acylation. as discussed in Section 2.1.1. This is due to the pyrrole nitrogen 
lone pair being delocalised into the 1t system and to the N-acyl group. The 
effect is to increase the stretching frequency of the formyl carbonyl to a more 
aldehyde like position. The figures in Table 2.10 show the increase in the 
aldehyde IR stretching frequency and the amide stretching frequency on N-
acylation of p-2-c. 
N-Aculation ofP!1rrole Derivatives 
m Stretching Frequencies for the Carbonyl Groups of 
N-Acylated-Pyrrole-2-Carboxaldebyde's 
(FTIR, neat. em-I) 
4 3 
5~H N 2 
R 0 
R -CHO R-CO 
-
COCH3 2.47 1730 167011 
-COCH2CH3 2.42 1725 1655 
-COPh 2.43 1770 1677 
-COCH2CH2Ph 2.31 1729 1654 
-CO-Phe-N-Pth 2.51 1732 1660 
-CO-Leu-N-Pth 3.44 1738 1668 
-COCH2CH(CH312 3.56 1727 1665 
-CO(CH2)4C02Me 3.54 1731 1651 
-CO(CH2) lOCH3 3.52 1738 1660 
Table 2.10 
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There is a uniform increase in wave number as the formyl becomes 
more aldehyde like in nature. as would be expected by the increased 
delocalised system that approximates a true aldehyde, more closely. 
2.7.3.2 UV Spectroscopy oj N-Acylated Pyrrole Derivatives 
A decrease in Amax of the UV spectra of 2.32. 2.42. 2.43. 2.51. 3.44 
and 3.56 relative to p-2-c, was consistent with a decrease in conJugation 
between the pyrrole ring and the formyl substituent. This is due to an 
increased electron withdrawing capability of the N-acyl species. as 
exemplified by the N-Pth protecting group. The largest Amax decrease. Table 
2.11. is observed when the R group is -COPh. A similar large shift was 
observed where R was -N(MeJ2, that was explained via steric interactions that 
lead to a 640 out of planar twist43 . The same argument can be applied to the 
case where R is -COPh 2.43. 
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Table 2.11 shows that as the electron withdrawing ability of the N-acyl 
group increases. a decrease in A.max is observed. 
UV Spectra of N~Acylated Pyrrole Derivatives (run) 
4 3 
5/1\ H "~""2f( 
R 0 
R 
-COCH2CH3* 
-COCH2CH2Ph* 
-COCH2CH(CH312* 
-CO-(Leu-N-Pth)t 
-CO-(Phe-N-Pth)t 
4 3 
5 n OH 'N~ 
R 
A.max -eHO 
n.r. 
285 
283 
283 
279 
-COPh* 301:F-
-N(CH312* 268:F- not available 
(c=l, '" CHCIs: t MeOH: n.r. Corresponding Aldehyde Not Reduced; :F- From 91 
Table 2.11 
Reduction of the N-acyl formyl pyrroles to N-acyl hydroxymethyl 
pyrroles. 2.32, 2.42, 2.43. 2.51. 3.45 and 3.57, causes an increase in the 
A.max. This is consistent with loss of the formyl group and hence in 
conjugation. 
2.7.3.3 Thin Layer Chromatography - TLC 
Throughout the pyrrole acylation work, extensive use of TLC 
monitoring and the Ehrlich reaction44, Section 2.7.3.4 was employed. 
A standard solvent system of ethyl acetate: petroleum ether= 1:2 was 
found to resolve the pyrrolic species under investigation, satisfactorily. Table 
2.12 indicates the Rf values of the series of N-cinnamoyl pyrrole derivatives. 
The series is representative of the N-acyl-pyrrole derivatives that were 
studied. 
Generally. N-acylation of p-2-c lowered the Rr. reduction of the formyl 
group lowered the Rf further. 
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Effect of Various N-Cinnamoyl Pyrrole Derivatives 2.31 and 2.32 
on Rf and the Rate of Colour Formation in the Ehrlich Reaction 
pyrrole derivative 
p-2-c 
N-cinnamoyl-p-2-c 
N-cinnamoyl-p-2-0H 
2.31 
2.32 
Rf 
0.48 
0.46 
0.40 
Ehrlich Reaction 
++ 
+ 
++ 
+++, Instantaneous development of colour: 
++, full colour developed within 30 seconds: +, full colour in five minutes 
Table 2.12 
2.7.3.4 The Ehrlich Reaction 
Further valuable information was gained from the staining of the TLC 
plate. Once the UV active species were identified, the TLC plate was dipped 
in an ethanolic solution of 4-dimethylamino benzaldehyde containing a 
catalytic amount of HCI (the Ehrlich reaction44). This produced a red-purple 
spot that has been attributed to formation of an azafulvene like structure45 
2.69, Scheme 2.38. 
~ N R 
H 
PhCHO, 
The rate of formation of the 
spot depends to a large extent on the ~ 
PhHC N R electronic character and orientation of 
H 
2.69 
the substituents on the pyrrole ring46. 
The greater the amount of electron 
Scheme 2.38 donating ability of the substituent on 
the pyrrole, the greater the rate of 
colour formation. Derivatives with electron withdrawing substituents do not 
couple as readily with the reagent and therefore colour formation is slower. 
The Ehrlich data in Table 2.12 have been described along the same 
lines by Badger46. Reducing the electron density of the pyrrole ring by N-
acylation slows down the appearance of the colour. Reduction of the formyl to 
the alcohol results in the loss of some of the electron withdrawing ability, ie: 
an increase in the ring electron density, as a consequence a positive Ehrlich 
test is ,observed at approximately the same rate as the unsubstituted p-2-c. 
A combination of the Ehrlich reaction and TLC monitoring was found 
to be a useful technique in determining the reaction progression. 
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2.8 Conclusion 
The designed mechanism based inhibitors. Section 1. 1. require that 
an acyl species be placed on the nitrogen of a pyrrole. A synthetic 
methodology has been developed for a variety of different acylating agents. 
Ultimately the amino acid chain. will be extended. in the N-direction (Figure 
2.9) to aid in enzyme recognition. see the next chapter. 
The DMAP methodology developed successfully places acyl groups on 
the nitrogen of pyrrole derivatives. No racemisation of amino acids was 
observed in the case of 2.51 using the DMAP method and thus satisfies one of 
the criteria for the N-acylation of pyrroles. The method also is versatile with 
both simple. and amino acid based acylating agents being promoted to N-
acylate several pyrrole derivatives in good yields. eg: p-2-c. pyrrole and 2.44. 
MeLi was also found to promote N-acylation of pyrrole derivatives. 
Amino acids with a proton on nitrogen seem to cause oxazolone 2.39 
formation and loss of activity of the amino acid. Oxazolone formation was 
manifest by decreased yields of N-acyl-pyrrole derivatives. There is evidence 
that amino acid acid fluorides do not undergo the same oxazolone formation 
as the acid chloride and therefore are expected to act as good acylating agents 
under DMAP conditions. 
The MeLi reaction would appear to overcome the problem of placing a 
removable amino acid protecting group on pyrrole with N-Cbz-Phe-p-
nitrophenyl ester, eg: 2.30, however MeLi mediated acylation of p-2-c with N-
Cbz-Phe-p-nitrophenyl ester does not proceed. The Vilsmeier-Haack 
formylation of N-acylated pyrrole 2.30 did not work. There exists the 
possibility that formylation with triflic anhydride may be successful. 
Thus. there are a few possible reactions which may in the future allow 
additional amino acids to be added to extend the peptide sequence in the N-
direction. Figure 2.9. 
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CHAPTER THREE 
EXTENSION OF AMINO ACID 
SEQUENCE 
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3.1 The Requirement to Extend the Amino Acid Chain in the C 
and N-Direction 
The DMAP methodology described in Section 2.4 allows access to 2-
substituted pyrroles N-acylated with a N-pth protected amino acid, eg: 2.52 as 
described in Section 2.4.3.1. This represents the first requirement for the 
synthesis of the designed enzyme inhibitors, Section 1.1. The amino acid Phe 
would occupy the PI subsite and pyrrole (Pyr), the PI' subsite and allow for 
partial enzyme recognition. The 2-pyrrole substituent allows the release of 
latent reactivity in the form of an azafulvene 1.3 on cleavage of the amino acid-
pyrrole bond. 
A large well defined hydrophobic pocket of chymotrypsin is known to 
accept Phe. This and other serine proteases also have an antiparallel ~-sheet 
arrangement in the SI-S3 subsites. see Section l.2.2. This is particularly 
important in the hydrogen bonding of the substrate (or inhibitor)l. The S2' 
enzyme subsite is also hydrophobic in nature, X-Ray crystal structures of 
chymotrypSin show multiple hydrogen bonding to the backbone of the 
enzyme. Chymotrypsin inhibition studies have shown that residues as far 
removed from the active site as P14', are important to binding2 , Residues 
closer to the scissile bond at positions P 4. P2, P2' and P3·. have also been 
found to be important to recognition. X-Ray crystal structures of HIV 
protease-inhibitor complexes also show multiple hydrogen bonding between 
the inhibitor and the enzyme. The C2 type inhibitors, Section l.2.4, of HIV 
protease. are the only potent inhibitors. containing as few as two amino acid 
residues. 
The hydroxymethyl pyrrole compounds, eg: 2.52 lack the extended 
peptide like sequence. eg: 3.1 Figure 3.1, usually found in the normal 
substrate of chymotrypsin and HIV protease. 
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3.2 Increase of Enzyme Recognition: Extension in the C-
Direction of PyITole Derivatives 
Replacement of Pro for Pyr, as in 3.2, Figure 3.1, does not produce a 
mechanism based inhibitor, as there is no leaving group for azafulvene 
formation. 
N tennini 
N termini 
N tennini 
N tennini 
N tennini 
° ?n~ ~~ N "~ ,s HI:: C tennini 
S"~N~ ° R 
II " ° 
°ph/ 
~~Jl 
N - ~ I~~~ ~ C tennini 
II - ° 
°ph/ Ph 
n ° ~ 'N~ "t1'" Y 
,s H I II N tennini 
S"~N~ ° 
II - ° 
° Ph/ 
Figure 3.1 
3.1 
Natural Substrate 
3.2 
Peptide "Sense" 
3.3 
Peptide "Sense" 
3.4 
Peptide "Sense" 
3.5 
Peptide "Anti-Sense" 
The addition of a leaving group, Pyr"CH2L, to the N-acylated pyrrole 
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amide as in 3.3, Figure 3.1, would then produce an inhibitor in the correct 
"sense", while maintaining the ability to form an azafulvene. 
Replacement of the hydroxyl group of hydroxymethyl pyrrole with an 
amino acid would form a pseudo dipeptide with the correct "sense'" relative 
to the substrate, ie: N-"tC. 3.4 Figure 3.1. 
Esterification of a hydroxymethyl pyrrole, eg: 3.5, using Mitsunobu 
conditions as described for the formation of the camphanate 2.53, Section 
2.4.6, would produce a pseudo dipeptide in the "anti-sense" direction, ie: 
C-"tN, 3.5 Figure 3.1. 
The relationship between a proline based natural peptide 3.1, in the 
correct sense, and the "sense" 3.3, 3.4 and "anti-sense" 3.5 pyrrole based 
mechanism based inhibitors described above, is summarised in Figure 3.1. 
3.2.1 Extension of the Pyrrole in the C-Direction - Peptide "Sense" 
Removal of the carbonyl group on the C side of pyrrole. outlined in 3.2 
Figure 3.2. would result in an pyrrole-amine 3.4. This exhibits all the 
characteristics required of a potential protease mechanism based inhibitor. 
3.2 3.4 
Figure 3.2 
These include a suitably pOSitioned leaving group for azafulvene 
formation, extended sites for hydrogen bonding to the enzyme active site and 
the possibility of further amino acid extension. Extension in the C-direction in 
this fashion was planned in accordance with the retrosynthesis presented in 
Scheme 3.3. 
Disconnection of the pyrrole-amine bond of 3.6 yields the N-acylated 
imine pyrrole derivative 3.7. The synthesis of the imine 3.7 can be envisaged 
via either the non-acylated p-2-c, eg: 3.8 pathway a. or via the N-acylated p-2-
c, eg: 3.9 pathway b. Subsequent selective reduction of the N-acylated imine 
3.7 would then produce the desired amine 3.6. 
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n!1 
"o/",H 
I HN R'~O 'R 
3.6 
n H "~/ II 
R,Ao N'R 
3.7 
pathway a 
~ 
II pathway b 
3.9 
Scheme 3.3 
n H "~'II 
H N 
'R 
3.8 
p-2-c 
84 
Acylation on the pyrrole nitrogen of the p-2-imine 3.8 using the DMAP 
methodology, pathway a, Scheme 3.4. to give 3.7. followed by reduction. 
would give the desired amine 3.6, Scheme 3.4. Acylation on the pyrrole 
nitrogen of the intermediate imine was expected to behave Similarly to the 
acylation of the formyl pyrrole, p-2-c. 
QyH DMAP ?yH p-2-c H2N-R N I Jo N I Jo H N R'COCI 
R·AON .... R .... R 
3.8 3.7 
Reduce j 
Qy N H 
AHN R' 0 'R 
3.6 
Scheme 3.4 
3.2.1.1 Formation of Pyrrole-2-Imlnes from P-2-C 
Imine formation is well known3 •4 •5 and occurs via a tetrahedral 
species 3.10, Scheme 3.5. 
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NH-R N-R 
R' R" ~N-R Y b R'+R" R,AR" 
o OH 
3.10 imine 
Scheme 3.5 
Imines formed from aromatic amines or aldehydes are usually stable 
and readily isolated, and are referred to as Schiff bases. Slow or unreactive 
systems have been found to form the desired imine when the equilibrium is 
shifted to the right by removal of water. 
Stirring p-2-c with one equivalent of the C protected amino acid H2N-
Ala-OEt 3.11 generated from the hydrochloride salt, Scheme 3.6, did not 
however, yield the desired imine 3.12. 
p-2-c 
3.ll 
Scheme 3.6 
~H "~; II 
N ......... C02Et 
<;;: 
CH3 
3.12 
Similar reactions where the water produced was removed in the 
presence of MgS04 or activated 4A molecular sieves, did not 
~H "~;" N, .... Ph 
C 
3.13 
produce the desired imine 3.12 either. Brunner3 described 
several methods for the formation of imines, eg: 3.13, 
including pyrrolic imines similar to those required in the 
present study. 
A similar reaction to that reported by Brunner was 
attempted using one equivalent each of HCl.H2N-Ala-OEt and 
p-2-c in Benzene/MeOH=2: 1. containing one equivalent of 
TEA. The 1 H NMR spectrum of the crude reaction mixture after twenty four 
hours indicated 78% of p-2-Ala-OEt imine 3.12, Scheme 3.6. The remaining 
22% was starting p-2-c. A diagnostic IH NMR spectral signal for the pyr-
CH=N-R signal was observed at 8.05ppm. 
Polymeric species were also formed. as apparent by the large amount 
of insoluble black precipitate in the crude reaction mixture. A polymer also 
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formed over three days in the NMR tube containing the imine. this was 
possibly due to traces of hydrochloric acid in the CDCI3. 
Azeotropic removal of water from p-2-c and the amino acid in pentane 
at reflux using a modified Dean-Stark apparatus produced 90% of the desired 
imine 3.12. Similar azeotrope reactions in CH2CI2, benzene and CHCl3 did not 
produce the imine. The reflux of p-2-c in pentane with the free amino acid 
Ala did not yield the corresponding imine. 
The addition of Ts-OH to the azeotrope reactions. described above. 
gave no apparent increase in the yield of the imine 3.12. 
The synthesised p-2-Ala-OEt imine 3.12 was found to be unstable on 
silica and after five days storage as a solid. decomposed. The crude reaction 
mixture was suffiCiently clean to allow characterization of the imine. once the 
polymer had been removed by filtration. The 1 H NMR spectrum of 3. 12 
lacked the formyl resonance. as described in the reduction work of Section 
2.7.2. The H-3. H-4 and H-5 signals shifted upfield. as did the NH signal with 
respect to p-2-c. see Section 3.2.1.2. The nitrogen withdraws less electron 
density from the pyrrole ring than the oxygen of the formyl derivatives, and 
therefore canonical forms of the type 2.14, Figure 2.8. are less important. 
Imine formation using the non-amino acid based amine, isobutylamine 
3.14. and azeotropic removal of water produced 100% 1 H NMR spectral yield 
of the deSired p-2-isoBuNH2 imine 3.15, Scheme 3.7. 
H2~ ~H pentane N I p-2-c • H~ azeotrope 
3.14 3.15 
Scheme 3.7 
Polymer was again formed, decreasing the yield of the imine. The 
continued formation of pyrrole decomposition polymers meant that yields of 
the final imine were drastically reduced. This is not the only work in the area 
of pyrrole imine formation in which trouble was reported with decomposition 
of product to polymer. Battersby also reported6 a similar phenomenon. as 
described in Section 3.2.1.4. 
The p-2-isoBuNH2 imine 3.15 was found to be unstable to 
chromatographic separation, but was fully characterised by 1 H NMR 
spectroscopy. The H-3, H-4 and H-5 IH NMR spectral signals again were 
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consistent with the absence of a formyl group. See Table 3.1 for a summary. 
Unlike the Ala based imine 3.12, the isobutylamine based imine 3.15 
does not present the possibility of further amino acid extension. 
3.2.1.2 NMR Spectral Comparison oj Pyrrole-2-Imines 
Table 3.1 summarises the 1H NMR spectra of imines 3.12 and 3.15. 
The average signal position is presented in Table 2.7.1.1 for comparison with 
p-2-c. 
Comparison of IH NMR Spectral Signals from Pyrrole-2-Imines 
3.12 and 3.15 
Pyrrole Derivative H-3 H-4 H-5 pyr-CH 
B B B B 
3.12 6.56 6.26 6.96 8.05 
3.15 6.46 6.22 6.86 8.01 
p-2-c 7.03 6.38 7.17 9.55 
average N-acyl-p-2-c* 7.19 6.32 7.32 10.24 
,. Data from Section 2.7.1.1 
Table 3.1 
3.2.1.3 N-Acylation oj Pyrrole-2-Imines 
The DMAP methodology described in Section 2.4 was expected to 
allow ready acylation of the imines 3.12 and 3.15. Reaction of freshly prepared 
p-2-Ala-OEt imine 3.12. with DMAP, TEA and acetyl chloride failed to yield 
the desired N-acyl imine 3.16. Scheme 3.8. The only products detected were 
N-acetyl-p-2-c 2.24 and p-2-c. Similar results were observed for the DMAP 
promoted acylation of the non-amino acid p-2-isoBuNH2 imine 3.15. 
//\H 
"~;' I( 
H N 
'R 
3.12 R=A1a-OEt 
3.15 R=CH2CH(CHsl2 
DMAP 
X" 
CH3COCI 
//\H 
"~;' I( A N, 
H3C 0 R 
3.16 R=A1a-OEt 
3.17 R=CH2CH(CHsl2 
Scheme 3.8 
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Imine hydrolysis occurred. either under the DMAP conditions to give 
the p-2-c. which was subsequently N-acylated to give 2.24. or alternatively the 
acylation of the imine occurred with subsequent hydrolysis to the aldehyde. 
The fact that the deSired N-acyl-p-2-imines 3.16 or 3.17 were not observed. 
tends to eliminate the latter hypothesis. N-Acylation of the p-2-imine's 
pathway a, Scheme 3.3, was therefore discontinued in favour of the strategy 
depicted in pathway b of the retrosynthesis, Scheme 3.3. 
3.2.1.4 Imine Formation from N-Acylated Pyrrole-2-Carboxaldehyde 
An alternative strategy for the formation of the desired N-acyl-p-2-
imine 3.7, pathway b, Scheme 3.3, was to form the imine of the N-acylated-p-
2-c 2.31, Scheme 3.9. 
2.31 
azeotrope 
Ph 
?i!H ~ J, 
) 0 R 
3.18 R=Ala-OEt 
3.19 R=CH2CH(CH3lz 
Scheme 3.9 
n H ~~~" H N 
"'R 
3.12 R=Ala-OEt 
3.15 R=CH2CH(CHsl2 
The N-cinnamoyl-p-2-c 2.31, dissolved in pentane containing one 
equivalent each of HCl.H2N-Ala-OEt and TEA, was heated under reflux with a 
modified Dean-Stark apparatus. After twenty-four hours a 1 H NMR spectrum 
of an aliquot of the crude reaction showed that the imine 3.18 had not formed 
and that only starting materials were present. Further reflux for two days 
showed that the non-acylated p-2-imine 3.12 had produced 50% yield. The 
remainder of the 1 H NMR spectrum was consistent with p-2-c. 
The addition of one equivalent of titanium isopropoxide has been 
reported7 to increase the rate of imine formation, see Section 3.2.2. An 
increase in the rate of formation of the non-acylated imine 3.12 production to 
60% over one hour was observed when this procedure was applied to the 
present stUdy. There was no evidence of the desired N-acylated imine 3.18 in 
this reaction. The final yield of non-acylated imine 3.12 was 65%, by IH NMR 
spectroscopy. The remaining material was p-2-c. 
Isobutylamine was used in an attempt to form the N-acylated imine 
from the N-acylated formyl pyrrole 2.31. High yields and' a rapid rate were 
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observed without the addition of titanium isopropoxide. The non-acylated 
imine 3.15 formed in 100% yield within one hour. No evidence for the 
desired N-acylated p-2-imlne 3.19 was obtained. 
An essentially quantitative conversion of 2.31 to the corresponding 
non-acylated imines 3.12 and 3.15. by reaction with H2N-Ala-C02Et and 
isobutylamlne. respectively, Reaction 1. Scheme 3.10, was observed. As 
previously described, Section 3.2.1.1, there was found to be a great deal of 
polymer and p-2-c formed in the reaction where the imine formation reaction 
was attempted using a non-acylated pyrrole, eg: p-2-c. Reaction 2, Scheme 
3.10. 
Reaction 1: 
2.31 
Reaction 2: 
p-2-c 
HZN-Ala-COzEt or 
isobutylamine 
isobutylamine 
n H '~~11 
H N 
"R 
Qn~ H N + H I N .. 
R 
3.12 R=Ala-OEt 
3.15 R=CHzCH(CHslz 
Scheme 3.10 
I Polymer I 
The yield of non-N-acylated pyrrolic imines 3.12 and 3.15 was found 
to increase, and the amount of polymer decrease, on using an N-acylated 
pyrrole derivative for the imine formation. This again provides evidence for 
the more aldehyde like nature of the pyrrole formyl group on N-acylaUon of 
the pyrrole, Section 2.1.2. Miller and Battersby6 found in the synthesis of 
precursors to porphyrins, that the pyrrolylmethyl peptide analogues 3.23 
were formed via similar imine compounds, 3.21, Scheme 3.11. Their 
reactions proceeded to give low yields with much decompOSition product. the 
same result observed in this study, Section 3.2.1.1. 
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CbZHN~N 
H o 
3.20 
o 
CbZHN~N 
H 
I 
o 
3.23 
Scheme 3.11 
3.21R=H 
3.22 R=COCH3 
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On the basis of the results of the imine work presented in this thesis, 
it is suggested that the synthesis of imines of p-2-c (and derivatives) is best 
carried out using an acylated derivative of p-2-c, eg: 3.22, Scheme 3.11. The 
N-acyl group would be expected to hydrolyse during the reaction to give the 
desired imine 3.23 in high yield. 
3.2.3 In Situ Reduction of the Pyrrolic Imine to Pyrrolic Amine 
Ultimately imines of the type 3.24 were to be reduced to the amine, 
eg: 3.25, Scheme 3.12, to incorporate a residue at the P2' sub site (see Section 
1.2.4)., Pyr occupies the PI' subsite, while providing a leaving group for 
azafulvene formation. 
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N ... 
R 
Reduction 
3.24 
Scheme 3.12 
r;NH 
R' HN 
'R 
3.25 
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Sodium cyanoborohydride has been reported to reduce carbonyls 
directly to an amine via an in situ generation of the imine8 • Mattson 7 found 
that titanium (IV) isopropoxide enhances the rate and yield of the in situ 
reduction with unreactive aldehydes. The titanium reagent is thought to 
function by forming a stable tetrahedral complex 3.26, Scheme 3.13. 
Reduction of the titanium complex then produces the amine 3.25. 
~H 
o 
-
Ti (OiPrh ()y6 
R' H NH 
I 
R 
3.26 
Scheme 3.13 
QyH 
R' HN 
'R 
3.25 
Titanium isopropoxide was also used in Section 3.2.1.4 successfully to 
increase the yield of the pyrrole imine 3.12. 
N-acetyl-p-2-c 2.24 followed by one equivalent of H2N-Ala-OEt were 
added to 1.25 equivalents of titanium isopropoxide and the resulting viscous 
solution was stirred under nitrogen for one hour. Absolute ethanol was added, 
followed by sodium cyanoborohydride. A 1 H NMR spectrum of the crude 
reaction mixture showed that the non-acylated amine 3.27 accounted for 80% 
of the pyrrolic content, Scheme 3.14, while the remaining 20% was starting 
material, N-acetyl-p-2-c 2.24. 
2.24 
1) Ti(OiPr)4 
HZN-A1a-OEt 
2) EtOH/NaCNBHs 
n ~ COEt "N~ Y 2 
H -CH3 
3.27 
Scheme 3.14 
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The corresponding reaction of p-2-c and H2N-Ala-OEt in the 
presence of titanium isopropoxtde was not attempted. as the results from 
Section 3.2.1.3. indicated polymer formation would occur. 
Numerous attempts to isolate the amine 3.27 failed. with the recovery 
of polymer and a low yield of p-2-c. This decomposition was rationalised as 
occurring via azafulvene formation. see Section 2.2.2.1 and Section 4.3.2.1 for 
a similar polymer formation. The reductive amination reaction was attempted 
on the N-cinnamoyl-p-2-c 2.31 using HCl.H2N-Ala-OEt amino acid and one 
equivalent of TEA. The products from this reaction were again: p-2-c and 
some polymeric species. 
The N-acylation of the pyrrole starting material was expected to 
decrease spontaneous azafulvene formation. The DMAP promoted N-acylation 
of the pyrrole-2-amine 3.27, from the dry crude reaction mixture did not 
proceed, as was found in work reported in Section 3.2.1.3. 
3.2.4 Amide Extension in the C-Directlon 
Extension to a true peptide like compound. structure 3.2. Figure 3.1. 
would be possible if the carboxyl group was retained for peptide extension as 
in 3.3. Scheme 3.15. This compound would have the recognition aspects of 
the designed mechanism based inhibitor and a suitable leaving group for 
azafulvene formation. Scheme 3.15 depicts the series of reactions that are 
required to form the desired mechanism based inhibitor 3.33. The leaving 
group would be introduced either via pathways a or b. Scheme 3.15. 
3.2.4.1 Preliminary Studies 
A literature report indicated that coupling pyrrole-2-carboxylic acid 
(p-2-COOH 3.29) couples with amino acid hydrochloride's in the presence of 
DCC and TEA to give the amide linkages9 • Scheme 3.16. Stirring p-2-COOH 
with an equivalent each of HCl.H2N-Gly-OEt, DCC and TEA for twelve hours in 
CH2CI2. gave the amide 3.28 in 75% isolated yield. Scheme 3.16. 
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DCC, TEA, ~OH 
HCl.HZN -Gly-OEt 
H 0 
pathway a 
3.28 I POC13 /DMF 
amino acid-X 
.. 
3.30 
I DCC, TEA, HCl.H2N-Gly-OEt pathway b 
fl OH 
OHC'" "~/ Y 
H 0 
3.32 
Scheme 3.15 
3.29 
fl H 0 OHC'''J('nN~OEl 
PHN0° 
_ 0 
R" 3.31 
lRedUce 
-JQyH 0 HO r ~ N II N ~OEt 
PHN0° 
_ 0 
R" 
3.33 
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The amide 3.34, Scheme 3.16 prepared from isobutylamine was also 
formed under the same conditions. The 1 H NMR spectral yield of this pyrrole 
amide was 22%, the remaining material was p-2-COOH. Polymer was also 
evident. Since there was no improvement in the yield over the amino acid 
based amide 3.28, no isolation attempts were made in this series. 
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Attempts to N-acylate the amide 3.28 with acetyl chloride using either 
the DMAP methodology, Section 2.4, or the NaH reaction, Section 2.2, were 
unsuccessful and yielded only polymer and p-2-COOH. 
The amide 3.28 lacks a leaving group to allow azafulvene formation as 
required for the designed mechanism based inhibitor. Formyiation10 at the 
pyrrole 5-position with ensuing reduction, could provide this leaving group, 
Scheme 3.17. 
n H 0 Vilsmeier-Haack ft H 0 "~/yN00Et formylaUon' OHC .... "~/yN00Et 
H 0 H 0 
3.28 3.30 
Scheme 3.17 
Preliminary Vilsmeier-Haack formylation of the amide 3.28 produced 
what appeared to be the formyl pyrrole 3.30 in approximately 10%. No 
acylation was attempted of this amide species. Clearly, the ideas outlined in 
Scheme 3.15 warrant further investigation. 
3.2.5 Extension of the Pyrrole C-Direction in the Peptide Anti-Sense 
Structure 3.5, Figure 3.1, describes what has been termed an "anti-
sense" peptide where the the final inhibitor would possess two N termini. 
These compounds still provide the possibility of enzyme recognition through 
hydrogen bonding. "Anti-sense" compounds have been developed by Erikson 
and Kempf to produce viable and potent inhibitors of the HIV protease. Figure 
Extension of Amino AcidSequence 
OH 
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The Kempf inhibitors were designed to utilise the known C2 
symmetry of the HIV protease. The positioning of the C2 axis was based on 
modelling studies and the fact that the two catalytic aspartic acids of the 
protease are close to the C2 axis of the enzyme. It has also been observed in 
other aspartic acid protease inhibitors (renin inhibitors l2) that the P region is 
more important for recognition than the P' region. The final inhibitors 
provide two distinct. chemically stable, pseudo-symmetric (3.34, Figure 3.18) 
or symmetric (3.35, Figure 3.18) units. 
Although chymotrypsin lacks the C2 symmetry of the HIV protease. it 
was still considered that the "anti-sense" extension would provide possible 
sites for hydrogen bonding to the enzyme. 
Using the knowledge that inhibitors of HIV protease have been 
developed with the peptides in the "anti-sense" fashion, the esterification of 
hydroxymethyl pyrroles. eg: 2.32 was attempted. Standard esterification 
reactions of alcohols via an activated acylating agent and pyridine13 or DMAP 
as promoters are well known. A trial acylation of N-cinnamoyl-p-2-0H 2.32 
using acetyl chloride was attempted. Dissolution of 2.32 in CH2Cl2 containing 
one equivalent each of DMAP and TEA was followed by the addition of acetyl 
chloride. The desired O-acetylated N-acylated pyrrole derivative, N-
cinnamoyl-p-2-0Ac 3.36, Scheme 3.19, was isolated in 87% yield. 
2.32 
n 0 CH 'N~y 3 
Ph~O 0 
DMAP,TEA 
3.36 
Scheme 3.19 
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The reaction was again tried, using N-Fmoc-Phe-CI as the acylating 
agent, as ultimately an amino acid is required for extension of the recognition 
sequence. Chromatography resulted in a 20% yield of 3.37. A good deal of 
other amino acid remnants were observed in the I H NMR spectrum and some 
pyrrolic polymer filtered off during work up. 
An alternative procedure using the Mitsunobu conditions was 
attempted as outlined in Scheme 3.20. 
2.32 
.......Ph 
~O § 
N IfNHFmOC 
N-FmoC-Phe-OH
Ill A 0 
Ph) 0 
DEAD, PhsP 
3.37 
Scheme 3.20 
N-Cinnamoyl-p-2-0H 2.32 was treated under Mitsunobu conditions 
and after three hours the I H NMR spectrum showed clean conversion to the 
desired ester. Chromatography of the crude product gave the dipeptide 3.37 
in 73% isolated yield. This method of esterification was used in all the 
subsequent esterification reactions. 
The C2 symmetry based inhibitors of Kempf and Erlckson11 •14 showed 
that although one amino acid extension from the SCissile bond to the PI' 
subsite produced satisfactory inhibition, two amino acids in the PI' and P2' 
subsites terminating with the Cbz group produced more potent inhibitors. 
The IC50 values for compounds where amino acids were added in the "sense" 
direction for P interactions and "anti-sense" for the P' interactions of 3.34 
are presented in Table 3.2. 
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IC50 Values of HIV Protease for Various Substituents on 3.34 
OH 
R~R 
Ph) lPh 
Substituent (R) 
Ac-
Ac-Val-
Ac-Val-Val-
N-Cbz-Val-
N-Cbz-Ile-
N-Cbz-Leu-
Table 3.2 
ICao.nM 
>10000 
12 
10 
3.0 
4.9 
>100 
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A trial Mitsunobu esterification with the dipeptide N-Cbz-Phe-Ala -OH 
gave the tripeptide N-cinnamoyl-p-2-0-Phe-Ala-Cbz 3.38, in 69% isolated 
yield. 
3.38 
Erickson and Kempf found that the most potent HIV protease 
inhibitors were obtained when the amino acid Val occupied the PI' and P2' 
subsites. Chymotrypsin inhibition is also known to be dependent on residues 
other than the primary PI (Phe) residue, Section 1.2.2, and Section 3.1. 
Hence, the Mitsunobu reaction using N-(N-Pth-Phe)-p-2-0H 2.52 and the 
amino acid N-Cbz-Val-Val-OH produced the tetrapeptide N-(N-Pth-Phe)-p-2-
O-Val-Val-Cbz (20%) 3.39. 
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PthN00 o. ~ 
Ph/ 
3.39 
This compound was the most advanced potential inhibitor developed 
in this work, and as such was tested for enzyme activity against chymotrypsin 
and HN protease. Section 5.1 and Section 5.2. 
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3.3 Increase of Enzyme Recognition: Extension in the N-
Direction of Pyrrole Derivatives 
The successful N-acylation of p-2-c with N-Pth-Phe-CI 2.36, Section 
2.4.2.1, suggested that other amino acids protected by Pth would also N-
acylate p-2-c. The N-acylation of p-2-c by these amino acids would provide 
evidence for the generality of the DMAP methodology. 
3.3.1 N-Direction Amino Acid Modification 
DMAP was used to promote the N-acylation of p-2-c with amino acid 
acid chlorides derived from N-Pth-Gly-OH 3.40 and N-Pth-Leu-OH 3.41. The 
product N-acylated formyl pyrrole derivatives 3.42 and 3.44, Scheme 3.21, 
that were produced, both had the characteristic triplet for H-4 at 6.38ppm 
(J=3.5Hz) and 6.31ppm (J=3.5Hz), respectively and the downfield shifted -
CRO signal. 10. 16ppm and 10.14ppm. respectively. 
p-2-c 
DMAP, Hunigs base 13.40 R=N-Pth-Gly 
RCOCI 3.41 R=N-Pth-Leu 
3.42 R=N-Pth-Gly 
3.44 R=N-Pth-Leu 
ether 
Scheme 3.21 
3.43 R=N-Pth-Gly 
3.45 R=N-pth-Leu 
Zinc borohydride reduction of the formyl derivatives 3.42 and 3.44 
proceeded to give the corresponding hydroxyrnethyl pyrroles 3.43 (22%) and 
3.45 (87%). respectively. The 1 H NMR spectra, again showed the 
characteristic pyr-CR20H signal at 4.63ppm for both compounds. The Gly 
derive~ pyrrole 3.43. was found to be unstable and decomposed to polymer 
and p-2-c in twenty four hours. 
The success in placing the N-Pth protected amino acids on the 
pyrrole nitrogen using the DMAP methodology suggested that a similar 
reaction might work with a N-Pth protected dipeptide. The addition of an 
THE LIBRARY 
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extra amino acid in the pyrrole N-direction would be advantageous to enzyme 
recognition. Section 1.2. 
N-Pth-Gly-Phe-CI, prepared from N-Pth-Gly-Phe-OH using oxalyl 
chloride/DMF, was added to a solution of DMAP, p-2-c and Hunigs base in 
CH2CI2. A black preCipitate formed. IH NMR spectroscopy gave strong 
evidence of the desired N-acylated pyrrole 3.46, Figure 3.22. with a signal at 
10.17ppm consistent with N-acylated formyl pyrrole. The triplet at 6.34ppm 
(J=3.1Hz) also gave credence to N-acylation. 
This compound decomposed rapidly and was not fully characterised. 
Reduction of the freshly prepared crude aldehyde 3.46, with zinc borohydride 
also presented problems. Strong evidence was again observed in the crude IH 
3.46R--CHO 
3.47 R=CH2OH 
NMR spectrum for the desired hydroxymethyl 
pyrrole 3.47, Figure 3.22. A characteristic singlet at 
4.56ppm was consistent with Pyr-CH20H. A triplet 
at 6.25ppm due to H-4 (J=3.0Hz) was also 
consistent with the other N-acylated hydroxymethyl 
pyrroles discussed previously, Section 2.7.2. This 
species was the only hydroxymethyl pyrrole to 
decompose on chromatography, p-2-c being the 
only pyrrole 
Figure 3.22 
compound recovered 
(21%). N-Cbz-Ala-Phe-CI was also used in an 
analogous reaction. This reaction produced no 
evidence of the desired N-acylated pyrrole 
3.48. 
3.3.2 N-Direction Non-Amino Acid Modification 3.48 
Many non-amino acid inhibitors of the HIV protease and chymotrypsin 
have been reported, Section 1.2.2 and 1.2.4. The carboxylates are thought to 
span, and block the active site of HIV protease15, Section 1.2.4. The charged 
residues at the end of the active site are postulated to interact with the 
carboxylates thus holding the inhibitors in place. The DMAP methodology was 
thought capable of promoting the acylation of activated acyl species, with the 
long cI:ain acid chlorides on pyrrole nitrogen. 
The acid chlorides of lauric acid 3.49 and adipic acid monomethyl 
ester 3.50 were prepared from the corresponding acids. The DMAP reaction 
under normal conditions, Ie: those in which the acid chloride was added to 
the p-2-c, Hunigs base and DMAP solution produced the N-Iauralyl-p-2-c 3.52 
and N-adipic monomethyl ester-p-2-c 3.54 in 90% and 89%, respectively, 
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Scheme 3.23. 
p-2-c 
DMAP, Hunigs base 3.50 R=(CH
z
)4COZMe 
.. J 3.49 R=(C~) lOCH3 
RCOCI 3.51 R=CHzCH(CHslz 
ether 
Scheme 3.23 
The reduction of 3.52 and 3.54 with zinc borohydride produced after 
chromatography the desired hydroxymethyl pyrroles 3.53 (58%) and 3.55 
(45%) respectively, Scheme 3.23. These derivatives were tested for activity 
against the HIV protease and chymotrypsin, Section 5.2 and Section 5.1. 
The formyl pyrrole 3.56 was prepared from the DMAP mediated 
reaction of p-2-c with isovaleryl chloride 3.51 and Hiln1gs base. The desired 
formyl pyrrole 3.56 was isolated in 88% yield. Zinc borohydride reduction 
gave the hydroxymethyl pyrrole 3.57 in 90% after chromatography. 
These long chain examples and the amino acid derivatives clearly 
demonstrate that the DMAP methodology is a versatile procedure for the N-
acylation of pyrrole derivatives. 
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3.4 Conclusion 
Extension of the amino acid chains in the N- and C-direction is known 
to be important in the recognition of an inhibitor by a protease. The work 
presented in this chapter was designed to incorporate these recognition 
features. 
Unfortunately. the C-direction extension in a "peptide like sense" was 
not practical. The imine. eg: 3.12. formation from p-2-c proved difficult, as 
was the acylation of this imine. The alternative imine formation, eg: 3.18, 
from an N-acylated-p-2-c produced in high yields, the non-acylated pyrrole 
imines, eg: 3.12 and 3.15. This may be useful in solving some of the problems 
that are often experienced in pyrrole chemistry. 
The amine 3.27 was formed from the imine 3.12. but was unstable in 
solution and could not be purified nor acylated. 
N-Acylation of the amide 3.28 suffered a similar fate. Encouraging 
results were obtained from formylation of the amino acid amide 3.28. The 
formylation at the 5-position of pyrrole-2-amide, eg: 3.30, can be expected to 
increase the ability for acylation to occur on nitrogen. The formylation would 
also provide a position for the leaving group necessary for azafulvene 
formation. This work should be investigated further. 
Extension of the pyrrole in the C-direction in the "anti-peptide 
sense" produced a series of peptides up to four amino acids, eg: 3.39, that 
would occupy the PI-P3' subsites. The hydroxymethyl pyrrole compounds 
were esterified via the Mitsunobu reaction conditions in high yields. The new 
pseudo pep tides were tested against the HIV protease. Section 5.2 and a-
chymotrypsin. Section 5.1. 
Extensions of the pyrrole in the N-direction by modification of the 
pyrrole N-acyl group to a non-amino acid species was based on known HIV 
protease inhibitors. The two long chain hydroxymethyl pyrrole compounds 
3.53 and 3.55 produced in this portion of work were found to be active 
against a-chymotrypsin, this is discussed in Section 5. 1. 
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CHAPTER FOUR 
PROTEASE INHIBITOR 
PROPERTIES 
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4.1 Hydrolysis Study 
A model hydrolysis system was designed to mimic enzyme action and 
to help understand the mechanism of the deacylation of N-acylated pyrroles1 , 
a key step in the proposed mechanism of inactivation. 
Potassium hydroxide was used to mimic the active site catalytic 
residues of the protease. Ser195 of chymotrypsin and Asp25 and Asp225 of 
the HN-1 protease. Reactions described in later sections of this work. 
Section 4.3.4. have an added external nucleophile, n-butylamine. This was 
designed to mimic the nucleophilic residues, His57 of chymotrypsin and 
Thr26 or the bound water of the HN protease, causing covalent inactivation, 
found in the enzyme. These nucleophilic residues are conSidered the likely 
candidates to attack the azafulvene 1.3 produced on cleavage of the amino 
acid-pyrrole amide bond. Figure 4.1. 
Enzyrne-Ser195, ~~ OH O"~N~ __ -I ...... 
HO~ ~ , 
R 0 
Enzyme 
Mimic 
Figure 4.1 
H1s57-Enzyrne 
r=< 
~ie~NH 
1.3 \ 
/'.../"-NH2 
The general reaction scheme for the hydrolysis study was as follows: 
The N-acyl pyrrole under study was dissolved in d4-methanol (0.6mL) or d3-
acetonitrile (0.6mL) in an NMR tube. To this was added an equivalent of the 
external nucleophile followed by the calculated amount of KOH. 1 H NMR 
spectra were recorded at appropriate times over twenty four hours or until no 
further significant reaction was observed. The reaction was monitored, and 
NMR spectral yields were obtained by integration of the Pyr-CH2X 1 H NMR 
resonances of all pyrrolic reaction species. relative to an internal standard, 
CH2CI2. The structures of all compounds formed in these reactions were 
confi~ed by comparison with authentic samples or by full characterisation. 
N-Acylation of 2-substituted pyrroles suppresses azafulvene formation. 
see Section 2.1.2 and Section 4.7.1. This is extremely important for the 
proposed mechanism of the inhibitors since release of the azafulvene before 
delivery to the enzyme would decrease the effectiveness of the inhibitor. The 
aim of the hydrolysis study was to analyse the subsequent reactions and 
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products formed on amide hydrolysis. The stability of the N-acylated pyrroles 
under the conditions of the hydrolysis study. without hydroxide present. is 
therefore central to the effectiveness of the study. The N-acylated pyrroles 
were subjected to the hydrolysis study conditions. without hydroxide. to 
ensure that no reaction occurred. The findings from these studies are 
descrtbed below. 
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4.2 Hydrolysis of N-Acyl Pyrrole 2.32 in d4-Methanol 
The stability of N -acylated pyrrole 2.32 under the hydrolysis 
conditions was determined. A sample of 2.32 was left in d4-methanol in an 
NMR tube at 23°C. The Pyr-CH20H. resonance of 2.32. 4.62ppm, was 
monitored over twenty four hours. The IH NMR spectrum was unchanged 
after thispertod. The addition of a twenty five fold excess of KOH produced an 
immediate deacylation to give hydroxyrnethyl pyrrole 4.1 2 • pyr-CH20H 
4.50ppm, in 100% NMR yield [1 H NMR (d4-MeOH) 04.50 (2H. s, pyr-
CH20H): 5.99 (IH, t, J=2.6Hz, H-4); 6.07 (1H, m, H-3); 6.67 (lH, m, H-5)]. 
Within fifty minutes the species 4.1 had equilibrated with the methoxymethyl 
pyrrole 4.2, pyr-CH20Me 4.36ppm, Scheme 4.2. [lH (d4-MeOH) 03.59 (3H. s, 
OMe); 4.36 (2H, s, pyr-CH20Me); 6.00 (IH. t, J=3.1Hz, H-4); 6.04 (IH. m, H-
3); 6.70 (lH, m, H-5)J. Compounds 4.1 and 4.2 were present in a ratio of 2:3 
(4.2:4.1). This ratio remained unchanged over two days. 
~OH HO' ~OH ~OMe N Ph~O II d4-MeOH N N H H 
2.32 4.1 4.2 
Scheme 4.2 
A second experiment was carrted out in which the amount of HO- was 
reduced to one equivalent (KOH in D20), represented in Figure 4.3. 
2.32 4.1 4.2 
] 100 100 
] 
80 (/) 80 
'"iii 
E 60 60 
..... 
.E 40 0 . 40 
..... 
~ 
P , 20 20 
. 
ttl , .... 
& 0 o , . 
'J! 0.0 2.5 5.0 7.5 10.0 12.5 15.0 02040 60 80 
time (min) 02.32 64.1 • 4.2 time (h) 
Figure 4.3 
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As expected the deacylation was slower with starting material 2.32 
still present after fifteen minutes. The product ratio of 4.1 to 4.2 after sixty 
minutes was also lower at 9:1 (4.2:4.1). This ratio remained unchanged over 
two days. 
Hydrocinnamate 4.3 was also evident in the IH NMR spectrum. Over 
two hours a three proton singlet at 3.67ppm appeared. This and other related 
signals compared directly to authentic methyl hydrocinnamate 4.4, [lH NMR 
(d4-MeOH) ~ 2.64 (2H, t, J=7.5Hz, CH2-Ph): 2.96 (2H, t, J=7.6Hz, CO-CH2); 
3.67 (3H, s, OCHa); 7.20-7.32 (5H, m, Ph)]. 
o 0 
Ph~O- Ph~OMe ~O~Ph H 0 
4.3 4.4 4.5 
The O-acyl pyrrole derivative 4.5, discussed in Section 4.3.2, was not 
observed in any of the hydrolysis studies conducted in d4-methanol. 
The conclusion drawn from these experiments is that deacylation of 
2.32 leads directly to 4.1, Scheme 4.4, which subsequently decomposes to 
the azafulvene 1.3, which is trapped by either HO- or MeO- to give 4.1 or the 
methoxymethyl pyrrole 4.2, respectively, see Section 4.5.1 for a discussion. 
The N-acyl pyrroles are stable in the absence of hydrOxide. 
The rate determining step in the hydrolysis of 2.32 is the formation of 
1.3, while the subsequent attack on 1.3 by a nucleophile is fast, Scheme 4.4. 
d4-MeOH 
slow 
~OH 
N 
H 
4.1 
HO-l1 fast slow 
1.3 
Scheme 4.4 
~OMe 
N 
H 
4.2 
Nucleophilic attack on pyrroles of this type are known to be SN 1 in 
Protease Inhibitor Properties 109 
nature3. Kinetic analysis has indicated that hydroxymethyl pyrroles react by an 
SN1 mechanism3 • Thus although MeO- is a better nucleophile than HO-14, the 
formation of 4.2 and 4.1 respectively are dependent only on the concentration 
of each of the nucleophilic species. 
To confirm the SN 1 nature of the reaction. it was reasoned that if the 
concentration of methanol was decreased with respect to HO- then the final 
equilibrium would favour the hydroxymethyl pyrrole 4.1. This was achieved by 
"diluting" the d4-methanol with the non-nucleophilic, di-polar, aprotic 
solvent. d3-acetonitrile. 
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4.3 Hydrolysis of N-Acyl Pyrrole 2.32 in d3-Acetonitrile 
The following work describes the hydrolysis study in d3-acetonitrile 
(0.6mL). The HO- added is dissolved in either d4-methanol or D20, the total 
volume of either solvent does not exceed 30J.LL. Therefore the solvent, d3-
acetonitrile, is in vast excess in all cases. 
4.3.1 HO- dissolved in d4-Methanol 
The addition of one equivalent of the HO- (KOH in d4-MeOH) to the N-
acylated pyrrole 2.32 in d3-acetonitrile solvent resulted in deacylation to give 
4.1 and 4.2 as predicted. The major product of the reaction was the 
rnethoxymethyl pyrrole 4.2, which equilibrated over one hour with the 
hydroxymethyl pyrrole 4.1 to give a fmal ratio of 7:3 (4.2:4.1), Figure 4.5. 
lequiv. HO-/d4-MeOH 
2.32 III 4.1 4.2 
d3-CD3CN 
l 100 
B 80 ..... II) 
~ 
~ 60 
c:: 
...... 40 8 
~ 20 ~ ~ &! 0 . 
'$ 0 10 20 30 40 50 60 
time (min) 02.32 64.1 • 4.2 
Figure 4.5 
Figure 4.5 shows a rapid formation of 4.2 to a maximum of 80% at t=2 
min. This decreased over one hour to give a final equilibrium concentration of 
7:3 (4.2:4.1), which has 4.2 lower than the 9: 1 (4.2:4.1) ratio observed in d4-
methanol experiment. Starting material 2.32 was totally consumed within 
twenty minutes. 
This result is consistent with the proposal that nucleophilic attack on 
1.3 occurs via an SNI like mechanism - a lower concentration of methanol 
results in a lower equilibrium concentration of 4.2, while a higher 
concentration of HO- leads to a higher equilibrium concentration of 4.1. The 
final ratio of products was 7:3 (4.2:4.1) in the d3-acetonitrile experiment. 
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A competition therefore exists between the HO- / H20 and 
MeO-/MeOH nucleophiles in these reactions. 
4.3.2 HO- dissolved in D20 
The KOH was dissolved in D20 rather than d4-methanol to avoid the 
complication of an extra nucleophile. This enabled the direct observation of 
HO- action on 2.32. 
No hydrolysis of 2.32 in d3-acetonitrile and D20 occurred on standIng 
at 23°C for three days. thus satisfying the criterion described in Section 4.1. 
in that the hydrolysis of 2.32 would be solely due to HO- mimicking the active 
site of an enzyme. 
4.3.2.1 One Equivalent HO- in D20 
The addition of one equivalent of HO- (KOH in D20) to 2.32 resulted in 
80% deacylation of the starting material 2.32 after ten minutes. 
2.32 
~OH 
N 
H 
4.1 
pathway a 
o ~O~Ph 
,,-N II 
-A 0 
4.5 
j 
1.3 
pathway b j pyrrole 
derivative 
I polymer I 
Scheme 4.6 
The O-acyl pyrrole derivative 4.5. pyr-CH20R. 5.07ppm appeared as 
2.32 was consumed. Scheme 4.6. A full description of compound 4.5 is given 
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in Section 4.3.2.3. The species 4.5 appeared to form via an intramolecular acyl 
transfer reaction. see Section 4.5 for a full discussion. 
Figure 4.7 presents the data for the hydrolysis of 2.32 and its 
subsequent reactions. Compound 4.5 reached a maximum of 80% with 
respect to the internal standard, CH2CI2. in ten minutes. This slowly 
decreased over three hours while the Pyr-CH20H (4.50ppm) resonance for 
hydroxymethyl pyrrole 4.1 increased at the same rate as the resonance of 4.5 
decreased. During the initial five minutes of reaction there was no evidence of 
4.1, while 2.32 was completely deacylated. Thus the direct deacylation of 2.32 
to 4.1, as observed in the d4-methanol, does not occur in d3-acetonitrile. 
lequiv. HO· /D2O 
2.32 .. 4.1 4.5 
d3-CD3CN 
100 
00-~ II II 
00 
40 
0 20 ~ 
,,- ... -
a . 
a 5 10 15 20 25 30 0.0 4.8 9.6 14.4 19.2 24.0 
time (min) 02.32 a 4.5 • 4.1 time (h) 
Figure 4.7 
The formation of hydroxymethyl pyrrole 4.1, from the O-acyl pyrrole 
derivative 4.5, can therefore be attributed to attack of HO- jD20 on the 
azafulvene 1.3, formed from 4.5, pathway a Scheme 4.6. The relative 
percentages of reaction products after four days was 18% 2.32, 71% 4.5 and 
12% 4.1. 
During this and the other hydrolysis reactions, the d3-acetonitrile 
solution was observed to became darker and the NMR tube stained. This 
observation can be attributed to polymer formation, pathway b, Scheme 4.6. 
Polymer formation is also discussed in Sections 2.4.2.1 and 3.2.1.1. However, 
in these cases polymer formation was acid catalysed. The polymer formed 
here is under basic conditions and therefore another mechanism must be 
operating, this is discussed in Section 4.3.3. The percentages and ratios of 
pyrroles given in this chapter ignores polymer formation. 
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4.3.2.2 liuo Equivalents HO- in D20 
A reaction of 2.32 in d3-acetonltrile with two equivalents of HO- (KOH 
in D20) gave a more rapid deacylation and N- to 0- acyl transfer to give the 0-
acyl pyrrole ~erivative 4.5. Within one minute there was no evidence of 
starting material 2.32. while 4.5 reached a maximum of 93%, Figure 4.8. The 
final substitution product 4.1 increased as an equilibrium between 4.1 and the 
O-acyl pyrrole derivative 4.5 was established, Scheme 4.6; the equilibrated 
finally was established at 2:3 (4.5:4.1) after twenty four hours. 
2.32 
------.. 4.1. 4.5 
'"d 
i 100 80 en 100 ..,.-------------, 80 
] 60 60 
~ ~ 
-
40 0 
.... 
~ ~ 20 
~ 0 o~~~~~~~~~~~~ 
'3 0.0 2.5 5.0 7.5 10.0 12.5 15.0 0.0 4.8 9.6 14.4 19.2 24.0 
time (min) 02.32 -4.5 • 4.1 time (h) 
Figure 4.8 
The excess HO- precludes pyrrole polymer formation. 
4.3.2.3 Characterisation oJ the O-Acyl pyrrole Derivative 4.5 
Deacylation of 2.32 in d3-acetonitrile with one equivalent of HO- was 
carried out at -20°C. The starting material 2.32 was converted cleanly to the 
O-acyl pyrrole derivative 4.5 in approximately ten minutes, Figure 4.9. 
The O-acyl pyrrole was stable at -20°C in the absence of an excess of 
HO-, and thus a 13C NMR spectrum was obtained. 
The IH and 13C NMR spectra were consistent with a 2-substituted 
pyrrole, without an N-acyl group. The IH NMR spectra showed H-3 (dd. J=2.5 
& 1.5Hz), and H-4 (1. J=2.2Hz), up field H-5 as a dd (J=2.3 & 1. 5Hz) 
downfield. A similar result was obtained from the 13C NMR spectra with C-3 
(108.9ppm) and C-4 (106.9ppm) upfield and C-5 (118.2ppm) downfleld. This 
pattern was similar to that observed for p-2-c, Section 2.7. The 13C NMR 
spectrum showed a signal was consistent with other acylated pyrroles, 
described in Section 3.2.5, for the pyr-CH20R at 58.012pm. 
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HO· 
Polymer 
2.32 4.5 
Figure 4.9 
After obtaining the 13C NMR spectrum at -20°C, the solution was 
allowed to warm to room temperature. Within five minutes the colour of the 
solution intensified and the NMR tube became stained, providing evidence 
that the O-acyl pyrrole derivative 4.5 was forming a polymer via the azafulvene 
1.3, see Section 4.3.2.1 and Schemes 4.6 and 4.9. 
4.3.3 Pyrrolic Polymer Formed in Base 
The production of polymers in pyrrole chemistry is common. As 
described in the N-acylation work (Section 2.2.2.1), many polymeriC pyrrole 
species were formed in the initial stages of this research work. However. 
pyrrole polymers are commonly formed under acid catalysis rather than 
under basic conditions as described in the present hydrolysis study. The 
formation of pyrrole polymers under basic conditions is strongly suggestive of 
azafulvene formation. The subsequent attack on the azafulvene by further 
pyrroles forms the polymer observed in the hydrolysis reactions. 
4.3.4 Addition of an External Nucleophile to the Deacylation of 2.32 in d3-
Acetonitrile 
Further evidence for azafulvene formation was necessary as its 
formation was central to the proposed mechanism of protease inhibition. An 
alcohol will not normally react with a primary amine, Figure 4.10, under the 
conditions of the hydrolysis study. 
R-OH + H2N-R' x~ 
Figure 4.10 
R-N-R' 
H 
An added external nucleophile. such as n-butylamine. in a deacylation 
reaction of 2.32 would be expected to trap the electrophilic azafulvene 1.3, as 
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it was produced from the O-acyl pyrrole derIvative 4.5. via pathway a. Scheme 
4.11. Alternatively. 1.3 produced dIrectly via the deacylatlon of 2.32. pathway 
b. Scheme 4.11. would also be trapped. 
HO' .. ~O~Ph 
pathway a H ~ 
2.32 
pathway b 
fast 
~~~ n-BuNH2 
N ~~---
H fast 
4.6 
Scheme 4.11 
4.5 
1.3 
The external nucleophile was designed to mimic an active site 
nucleophilic residue of the target protease. eg: HIs57 of chymotrypsin and 
Thr26 or the bound water of HIV protease. as described in Section 4.1. 
Trapping the azafulvene 1.3 by the amine would therefore mimic one of these 
nucleophilic residues. and demonstrate that the latent reactivity Is released 
on the hydrolysIs of a hydroxymethyl pyrrole in the form of the azafulvene 1.3. 
An equivalent of n-butylamine was added to the solution of 2.32 in d3-
acetonitrile. The addition of one equivalent of HO- (KOH in D20) to the 
solution then caused a rapid. partial conversIon of 2.32 to 4.5 as observed 
previously. Section 4.3.2. Over one hour the Pyr-CH20R IH NMR resonance of 
4.5 decreased and a correspondIng signal of the pyrrole amine 4.6. pyr-
CH2NHR 3.62ppm. increased. Figure 4.12 depicts a series of IH NMR spectra 
observed for this reaction. 
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18 NMR Spectra of 2.32, 4.5 and 4.6 Over One Hour for the 
Hydrolysis of 2.32 with 80· 
2.32 " 4.5' 4.6 
2.32 
4.5 
4.6 
t~O min ~"------- - -' '--____ 1<---
t=5 min 
t=lS min Jl-~ 
t=30 min ~'------,"----'''-'----''''-'' 
J I • I j • •••• d ' . , . I •••• d .. • 1 • 
Figure 4.12 
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Approximately 10% of the amine 4.6 was observed after one minute. 
Since the O-acyl pyrrole derivative 4.5 reacts slowly to give 4.6, it is suggested 
that HO- causes a rapid deacylation of 2.32 to fonn the azafulvene 1.3, which 
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yields 4.6 on attack by n-butylamine. pathway b Scheme 4.11. Two competing 
pathways for the formation of 4.6 therefore exist. 
Furthermore. the rates at which the signals for 4.5 and 4.6 decrease 
and increase respectively. Figure 4.13. after two minutes. suggests that once 
the a-acyl pyrrole derivative 4.5 has formed. the amine 4.6 is only formed by 
the subsequent formation of 1.3 from 4.5. The formation of the azafulvene 1.3 
from 4.5 is slow relative to pathway b. Figure 4.11. 
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Figure 4.13 
The kinetic analysis experiments. see Section 4.4. found, when two or 
more equivalents of HO- were added to 2.32. in this hydrolysis study, the 
pyrrole amine 4.6, was the only pyrrole species existing after three hours. 
The amine 4.6 was isolated, by the removal of solvents from the 
completed reaction, t=5 days. IH, 13C NMR spectra and a high resolution 
mass measurement were consistent with the proposed structure 4.6. The 1 H 
NMR resonances for the pyrrole protons were consistent with absence of an 
N-acyl group. H-3 (5 6.03, m) and H-4 (56.06, t, J=2.9Hz) were upfield while 
H-5 (0 6.67, m) was downfield, relative to a N-acylated pyrrole. eg: 2.32. This 
pattern is similar to p-2-c. discussed in Section 2.7. The increased 
multiplicity of H-3 and H-5 relative to a non-N-acylated pyrrole is due to 
coupling to the NH . 
. The reaction did not go to completion with one equivalent of HO-. 
10% of both the N-acylated pyrrole 2.32 and the a-acyl pyrrole derivative 4.5 
remained after three days. A second equivalent of HO- would. therefore 
appear necessary for the complete hydrolysis of 2.32. Amide hydrolysis is 
typically described as a second order process with respect to HO-. this is 
discussed in Section 4.5. 
Protease Inhibitor Properties 118 
4.3.4.1 Monitoring the Formation oj 4.6 and 4.3 in the Deacylation oj2.32 
The deacylation of 2.32 was also monitored via the appearance of 
hydrocinnamate 4.3 in the IH NMR spectra time course study. Species 4.3 is 
the non-pyrrole product formed from the deacylation of 2.32. Integration of 
the pyrrole amine 4.6 signals [IH NMR (d3-CD3CN) 00.87 (3H. t, J=7.3Hz); 
1.26-1.42 (4H. m. CH2CH2CH2CH3); 2.90 (2H, dt. J=7.4Hz. NHCH2): 3.62 
(2H. s, Pyr-CH2NH): 6.03 (IH. m. H-3); 6.06 (IH. t, J=2.9Hz. H-4); 6.67 (IH, 
m, H-5)] with respect to those of the hydrocinnamate 4.3 [IH NMR (d3-
CD3CN) 02.44 (2H. t, J=8.4Hz, Ph-CH2): 2.88 (2H, t. J=8.4Hz, CO-CH2); 7.29-
7.32 (5H. m. Ph)] indicated a ratio of 1: 1. The observation was carried out at 
the completion of the reaction. A decrease in the ratio of 4.6 to 4.3 would 
suggest that polymer formation was occurring, rather than the formation of 
the deSired pyrrole amine 4.6. Under the hydrolysis conditions of this study a 
decrease in the ratio of the hydrocinnamate 4.3 relative to 4.6 would be 
unlikely. as there was no methanol present to allow formation of the methyl 
hydrocinnamate 4.6, as was observed in the case presented in Section 4.2. 
The IH NMR spectral ratio of 4.6:4.3 remained at 1:1. giving strong evidence 
that no polymer was formed. The lack of colour in the NMR sample gave 
further support to the absence of polymerisation. 
4.3.5 Stability of N-Acylated Hydroxymetbyl Pyrroles 
The stability of N-acylated hydroxymethyl pyrroles in the presence of 
solvent and weak bases is of paramount importance to the succesful use of 
these compounds as mechanism based inhibitors, Section 1.1. The premature 
release of the latent reactivity would result in non-specific interactions. The 
N-acylation of pyrrole suppresses the formation of the reactive azafulvene; 
therefore a hydroxymethyl pyrrole would not be expected to react, in the 
absence of hydrOxide. The hydrolysis study mimics the enzyme: the hydroxide 
is designed to mimic the active site catalytic residue and the n-butylamine a 
nucleophilic residue within the enzyme, see Section 4.1. The stability of an N-
acylated hydroxymethyl pyrrole was observed when the hydroxymethyl 
pyrrole 2.32 was subjected to the following conditions: The N-acylated 
hydroxymethyl pyrrole 2.32 was dissolved in d3-acetonitrile (0.6mL) 
contai~ing D20 (50 J.t L) and n-butylamine (50J.tL). No change in the IH NMR 
spectrum was observed over two months. We therefore concluded that the 
deacylation of N-acylated hydroxymethyl pyrrole 2.32. as described in Section 
4.2 and 4.3. was the result of HO- catalYSiS. The hydroxymethyl pyrrole is 
therefore stable in a solution ofD20/n-butylamine in the absence of HO-. 
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4.4 Deacylation of 4.5: Kinetic Analysis 
The rate constant with respect to HO- concentration for the 
deacylation of 4.5 in d3-acetonitrile containing n-butylamine (lequiv.) at 
23.1°C was determined. 
Compound 2.32 was dissolved in d3-acetonitrile (0.6mL). One 
equivalent of n-butylamme was added and the solution was well mixed. Either 
one, one and a half, two or three equivalents of HO- (KOH in D20) were added 
in separate experiments. followed by vigorous shaking. The reaction was 
followed by recording the IH NMR spectra at t=0.5 min and subsequently at 
one minute intervals until the reaction slowed. 1 H NMR spectrum were then 
recorded at two, five. ten and/or fifteen minutes intervals as indicated in 
Table 4.1. The reaction was followed for two hours, or until no further 
Significant reaction was observed. 
1) One EQuivalent HO-: As described previously, Section 4.3.4. one 
equivalent of HO- caused immediate deacylation of 2.32 to give 4.5 and 
subsequently 4.6. The level of 2.32 decreased to a minimum of 10010, as 4.5 
reached a maximum of 80010. The level of 4.5 subsequently decreased over 
twenty four hours to 10010. 4.6 steadily increased to reach a maximum of 80010. 
After three days these ratios were unchanged. 
2) One and a Half Equivalents HO-: A similar result to that above was 
observed. The addition of one and a half equivalents of HO- caused immediate 
deacylation of 2.32 to give 4.5 with the subsequent formation of 4.6. 
Compound 2.32 was fully deacylated to 4.5 within two minutes. After one hour 
80010 4.5 was converted to 4.6. Section 4.3.2.2. The final ratio was 8:2 
(4.6:4.5). 
2) Two EQuivalents HO-: Two equivalents of HO- gave total conversion 
of the starting material 2.32 to 4.5 within one minute. 90010 of 4.5 was 
subsequently converted to the pyrrole amine 4.6. The ratios remained fixed at 
9: 1 (4.6:4.5), 
3) Three Eguivalents HO-: The only species remaining after thirty 
minutes hydrolysis with three equivalents of HO- was the pyrrole amine 4.6. 
The observed rate obtained from these deacylaUons is detailed in 
Table 4.2. 
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4.4.1 Determination of Rate of Decomposltion of 4.5 
The observed rate, k, of deacylaUon of 4.5 was obtained using the 
following method: 
1) The data for the kinetic analysis of 4.5 were based on the 
absorbance of the two proton pyr-CH20COCH2CH2Ph singlet (5.07ppm). 
2) Each IH NMR spectrum was placed in an array using Varian NMR 
spectrometer software. The signal at 5.07ppm was highlighted, and the full 
raw data, Table 4.1, were produced using a program provided in the Varian 
software4 based on work by Gelan5• 
1 H NMR Spectral Absorbance at 5.07ppm for Kinetic Analysis of the 
Hydrolysis of 4.5t in ds-Acetonitrlle 
Raw Data from One Experiment at Each Concentration Shown 
Time 
t (min) 
0 
1 
1.5 
2 
2.5 
3 
4 
5 
6 
7 
8 
10 
13 
15 
30 
45 
60 
90 
120 
1 (da;y:) 
Absoo 
1 Equlv. 1.5 Equlv. 2 Equlv. 
HO- HO- HO-
112.0 165.1 135.4 
98.6 154.8 116.4 
89.6 156.0 100.5 
77.3 147.0 91.9 
88.4 
76.4 147.7 83.5 
146.4 79.3 
67.5 
75.2 145.6 64.5 
138.9 63.8 
73.9 136.3 59.7 
68.3 135.1 56.4 
64.9 132.9 
59.4 132.0 55.4 
56.0 129.8 54.1-
54.7 118.9-
21.4-
21 130 56 
t Data Collected at 23.1 °C; • End of Data Collection 
Table 4.1 
3 Equlv. 
HO-
155.7 
106.7 
83.8 
74.2 
72.4 
60.9 
54.1 
45.0 
43.5 
27.4 
23.0 
21.1 
17.6 
4.5 
De 
0 
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3) The absorbance at t=inflnity (Absoo) was determined by observation 
of the accompanying graph, eg: Figure 4.14, that was produced from the 
calculation of the raw data. 
140~----------------------------' 
120 
100 
1000 2000 3000 4000 5000 
time (sec) 
Figure 4.14 
6000 
Absorbance 
4) The observed rate, k, was then obtained using the formula given in 
Figure 4.15. 
kt = In ( 
Abso-Absoo ) 
AbscAbsoo 
Figure 4.15 
AbsO is the absorbance at time t=O, Absoo the absorbance at t=oo, Abst is 
the absorbance at a given time t and k is the observed rate. The observed rate 
in Table 4.2 was obtained for the various HO- concentrations using this 
formula. and the data presented in Table 4.1. 
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Observed Rate of Hydrolysis of 4.5 with respect to 
HO· Concentration 
Concentration Equivalents Observed Rate 
HO· (M) HO- k 
O.66xl0-3 1 1.34x10-3 
1 1.33xl0-3 
1 1.30xl0-3 
O.95xl0-3 1.5 1.98x10-3 
1.29x10-3 2 2.79xl0-3 
2 2.81x10-3 
1.90xl0-3 3 3.96xl0-3 
Table 4.2 
5) The rate of disappearance of 4.5 was found to increase linearly with 
increasing HO- concentration. The plot of kobs versus HO- concentration gave 
a straight line, Figure 4.16, and the slope 0,458x represents kOH[HO-] or the 
kobs with respect to decomposition of 4.5. 
It) 
"a~ 
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~~ 
:8 
"t:1 ..... 
e~ :;i~ 
.00 
O~ 
q 
~0Y'-'Ph 
H 0 
HO' products 
4.0e-3 
3.0e-3 
2.0e-3 
1.0e-3 
O.Oe+O 
4.5 
• 
5.0e-4 1.0e-3 1.5e·3 2.0e-3 2.5e-3 
HO- Concentration (molL-I) 
Figure 4.16 
Observed Rate 
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The deacylation of 4.5 is therefore first order with respect to HO- at 
zero- to three equivalents of HO- and has a rate constant of k=0.458s- 1. 
Reactions can be forced to adopt pseudo-first order kinetics by using a 
large excess (greater than ten equivalents) of reagent for ease of kinetic 
analysis. The graph in Figure 4.16, is linear up to three equivalents of added 
HO-, indicating that the deacylation of the O-acyl pyrrole derivative 4.5 is 
genuinely first order with respect to HO-. 
A Y axis intercept of 4.285x10-5 indicated that there is no background 
hydrolysis within experimental error of zero, ie: kobs=O at zero HO-
concentration. This observation reinforces the evidence that the 
hydroxymethyl pyrrole 2.32 is stable in solution, Section 4.3.5. 
The overall rate of the deacylation reaction could be obtained using 
the equation given in Figure 4.17. 
Figure 4.17 
A kinetic analysis as outline in Figure 4.17 was not canied out. The 
hydrolysis of the pyrrole amide bond is likely to be first order at low HO-
concentrations and second order at higher HO- concentrations l , this will be 
discussed in detail in Section 4.5. The added complexity creates kinetics that 
are difficult to study. In any event, a simple analysis was deemed sufficient to 
establish the feasibility of the proposed mode of enzyme inhibition. 
The overall mechanism of the reaction is discussed in Section 4.5. 
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4.5 A Mechanistic Summary of the Deacylation of N-Acyl 
Hydroxymethyl Pyrrole 2.32 
124 
The overall mechanism of N -acyl hydroxymethyl pyrrole 2.32 
deacylation under various solvent conditions. outlined in this section, is 
complex. The mechanism can be Simplified into two separate sections. One is 
the mechanism in d4-methanol, Section 4.5.1, the second in d3-acetonitrile, 
Section 4.5.2. 
There are two aspects to the reaction of 2.32 with HO- in d3-
acetonitrile. The first involves the hydrolysis of the pyrrole-amide bond, and 
the second. the subsequent reactions of the O-acyl pyrrole derivative 4.5. 
The experimental observation that 2.32 is stable in solutions of d4-
MeOH/D20. d3-acetonitrile/D20 and d3-acetonitrile/D20/n-butylamine for 
extended periods, confirms the conclusion that N-acylation of a 2-substituted 
pyrrole suppresses azafulvene formation and hence subsequent reaction, 
Section 2.1.2, and 1.2.4 and 4.7.1. A hydroxymethyl pyrrole, eg: 2.32, would 
not be an effective mechanism based inhibitor if the latent reactivity was 
released before delivery to the targeted enzyme. 
4.5.1 Amide Hydrolysis in c4-Methanol 
The addition of HO- to compound 2.32, in d4-methanol results in 
deacylation via either pathway a, or by pathway b Scheme 4.18, to give the 
hydroxymethyl pyrrole 4.1 and the methoxymethyl pyrrole 4.2. 
b ~:\JH 
Ho-r'\JtN --Ia pathwaya 
o .. 
() H-OH 
Ph V 
2.32 
~OMe 
N 
H 
4.2 
MeOH 
Scheme 4.18 
~OH 
N 
H 
4.1 
1.3 
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Pathway a: The initial hydrolysis product via this pathway would be the 
hydroxymethyl pyrrole 4.1. There would be no evidence of the methoxymethyl 
pyrrole 4.2. 
Pathway b: The methoxymethyl pyrrole 4.2 would be observed in the 
initial stages of the hydrolysis, if the hydrolysis was occurring via pathway b, 
ie: an acyl loss with concerted azafulvene formation. This would also signify 
that 4.1 was forming via the azafulvene 1.3 and not from the loss of the acyl 
group from the pyrrole nitrogen. 
The deacylation of 2.32 initially produced a trace, but NMR observable 
amount of 4.1. Compound 4.2 was not observed initially. Section 4.2. This 
suggests an initial acyl loss to give 4.1, without immediate azafulvene 
formation. An equilibrium is then established (within two minutes) between 
4.2 and 4.1 most probably through the azafulvene 1.3. Nucleophilic attack on 
1.3 occurs via either HO-. to return to hydroxymethyl pyrrole 4.1, or 
methanol to produce the methoxymethyl pyrrole 4.2. Compound 4.2 was not 
observed initially. even with a vast excess of methanol over HO-. 
Therefore, it is proposed that the deacylation of 2 .• 32 in d4-methanol 
proceeds via pathway a, Scheme 4.18, to give the hydroxymethyl pyrrole 4.1. 
This then undergoes azafulvene 1.3 formation to give an equilibrium mixture 
of 4.2 and 4.1. Further support is obtained in the reaction of 2.32 with 
KOHl d4-MeOH in d3-acetonitrile. Again a trace amount of 4.1 was initially 
produced on deacylation of 2.32. A rapid build up of 4.2 was only observed 
after two minutes. The small amount of 4.1 «5%) is postulated to form 
directly from the initial deacylation of 2.32. The equilibrium favours 4.2 over 
4.1 since methanol is in excess, Section 4.3.1; formation of 4.4 requires 
pathway a. This is consistent with an SN 1 like mechanism via the azafulvene 
1.3 as described in Section 4.2. 
4.5.2 Amide Hydrolysis in d3-Acetonitrile 
The deacylation of 2.32 with one or more equivalents of KOH in D20 
(trace, lOIlL) in d3-acetonitrile (O.6mL) resulted in an N- to 0- acyl transfer to 
give compound 4.5. This acyl transfer can occur via an intramolecular 
mechanism. either by partiCipation of the hydroxymethyl group, pathway c, 
Scheme 4.19, or via the tetrahedral intermediate 4.8, pathway d, Scheme 
4.19. The intermolecular pathways band e are also possible. 
Scheme 4.19 summarises the reactions in d3-acetonitrile, Section 4.3. 
Pathways a and b were also postulated for the d4 -methanol reactions. Section 
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Only the second of these mechanisms, pathway c, does not involve 
cleavage of the hydroxymethyl pyrrole group. Studies on the elucidation of the 
mechanism is presented in Section 4.6. 
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4.5.2.1 Amide Hydrolysis and a-Acyl Pyrrole Derivative 4.5 Formation: 
Reaction Cube Analysis 
The hydrolysis of an amide bond is generally second order with 
respect to HO-6.7. although some first order cases are known8 . 
o 
0- XVII---......... -XVIIIO R+N+~ Elimination R)lO' 
O· 
Figure 4.20 
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The hydrolysis of compound 4.5 was shown to be first order. The 
reaction cube9 presented in Figure 4.20 outlines a typical amide hydrolysis. 
The complex amide bond hydrolysis mechanism Is represented simply by a 
reaction cube of this type. 
A reaction cube, In which one face represents the charge types of the 
reactants (points I. III. VlII, X on the reaction cube, Figure 4.20) and the 
opposite face represents the corresponding charge types of products (V, VlI, 
XVI, XVIII), can be used to display the multiple mechanistic paths of familiar 
reactions and systematically to generate mechanistic hypotheses for new 
reactions9 •1O• The cube describes the interrelation of all charge types of both 
reactants and products. Each charge type can be related to any of the others 
by either an edge, face diagonal or body diagonal operation, eg: the points I 
and II, on an edge, are related by a c-o bond forming step. Cubes can be 
constructed for each process Involved in a possible mechanism. 
Amide hydrolysis can be described with three cubes. One cube 
describes the addition of a nucleophlle to the amide bond and the second 
cube describes elimination of a tetrahedral intermediate to give the hydrolysis 
products. Since amide hydrolysis can also occur In basic media a third cube is 
required to describe any dianionic tetrahedral intermediates that may be 
involved. The corner of each of the three cubes represents a potential 
intermediate in the reaction. A reaction cube is relatively easy to create, and 
can simplify the complexity of a mechanism, eg: amide hydrolysis has 31 
edge, 34 face and 12 body diagonal processes available. Each process relates 
to a possible mechanistic pathway available for the reaction to undergo. 
The two cubes of addition and elimination for amide hydrolysis share a 
common edge: IV, XI. The cube for dianionic tetrahedral intermediates is 
placed on the bottom of the elimination cube. Further reaction of these 
possible intermediates leads to, in this case, the a-acyl pyrrole derivative 4.5. 
Figure 4.20 shows six of nine product charge types: V, VlI, XII, XIV, XVI, 
XVIII. There are eight tetrahedral charged intermediates: II. IV, Vl. lX, XI, 
XIII, XV, XVII of which only four are important for hydrolysis in base: IV, XI, 
XIII, XV. 
The amide hydrolysis in the reaction cube of Figure 4.20. was used to 
described the Initial N-acyl to a-acyl transfer reaction of compound 2.32 to 
give 4.5. This requires cleavage of the pyrN-C(O-) bond. but not the Pyr-CH20= 
C(O-)(R)N bond, 4.9. 
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9J f-O+.o 
this bond R '- this bond can 
to break not break 
4.9 
This requirement necessitates that 
the tetrahedral species XV, Figure 4.20, is not 
an intermediate on the pathway. The C-O 
bond, of 4.9, is broken in the formation of the 
species represented at point XV, and as such 
the -OCOCH2CH2Ph group would be lost. 
The N- to 0- acyl transfer to give 4.5 
that accompanies amide hydrolysis can conveniently be depicted by the 
simplified reaction cube given in Figure 4.21. 
The attack of HO- on the amide gives XI in the reaction cube of Figure 
4.21. 
The neutral N-acyl hydroxymethyl pyrrole 2.32 is represented at 
corner X and is the starting point for this cube. Under the baSic conditions of 
the current study, c-o bond formation occurs to give the structure at position 
XI. There are three possible pathways, in line with the guide lines established 
above, that will ultimately produce the O-acyl pyrrole derivative 4.5 point XIV, 
Figure 4.21. There are seven possible routes under basic conditions for the 
formation of 4.5 but these include the species XV, Figure 4.20, and therefore 
the final products result in the loss of -OCOCH2CH2Ph. 
The three routes are: 
1) XI, N, XIV A proton transfer to 0 to give N, which is 
followed by a concerted C-N bond cleavage 
and a proton transfer from 0 to N. 
2) XI, XIII, XIV From XI, a proton transfer to N gives XIII. A 
C-N bond cleavage follows to give XIV as the 
final structure. 
3) XI. XIV A concerted C-N cleavage, with a proton 
transfer to N to yield XIV. 
Each of these routes is possible and accounts for the observed 
products in the reaction. 
The O-acyl pyrrole derivative 4.5, represented at point XIV in Figure 
4.21, can lose hydrocinnamate via 1.3 to give the pyrrolic amine 4.6, as 
described in Section 4.4 (first order with respect to the concentration of HO-
). 
. The hydrolysis of a pyrrole-amide bond is second order with respect 
to HO- at high HO- concentration1•ll . When the leaving group of the nitrogen 
containing species is electron rich, a proton transfer to the nitrogen must 
occur, as in the case of pyrroles. This proton transfer must occur, even in 
base, for the N-C bond finally to break. This proton transfer is often the rate 
determining step12,13, Ingold14 has claSSified the hydrolysis of amides and 
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esters; under this classification, amide hydrolysis in basic conditions occurs 
via the BAC2 mechanism. This is a unimolecular base catalysed hydrolysis with 
acyl loss via a tetrahedral intermediate. 
o 
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4.6 Elucidation of the Mechanism of O-Acyl Transfer to give 4.5 
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4.6.1 Theory Behind the use of Chlra! Hydroxymethyl Pyrroles to Elucidate 
the ()'Acyl Transfer Mechanism to give 4.5 
The acyl transfer from 2.32 to 4.5 can be intramolecular, via either 
attack of the hydroxymethyl group on the amide carbonyl, pathway c, Scheme 
4.19, or via the tetrahedral intermediate 4.8 pathway d, Scheme 4.19, with 
hydroxide attack at the amide carbonyl. Pathways band e are also possible to 
give a third option via the intermolecular trapping of the acyl group by 1.3. 
pathway d A p.lathway c 
n / '" 
COfoH 9-xOH ~H" D HO' ~ H" D 
,J \0- ,J ~o 
Ph 0 Ph\} 
j 
~ 
j 
QxOy-vPh 
H H D 0 
4.12 
Scheme 4.22 
j 
~Oy-vPh 
H H D 0 
4.11 
As stated earlier, only the second of these mechanisms, pathway c, 
does not involve cleavage of the hydroxymethyl pyrrole group. 
The optically active, deuterated hydroxymethyl pyrrole 4.10 was 
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prepared to elucidate the mechanism, pathway cor d, of the O-acyl transfer. 
The observation of the -CHD- group in the products from the hydrolysis via 
pathway c and d described above is given here: 
1) The reaction via pathway c would proceed with retention of 
configuration at the 2-methylene position of 4.11, as the CHD-OH bond Is not 
broken. 
2) Formation of 4.12 via the azafulvene 1.3. pathway d. would result in 
the racemisation of the -CHD- group. 
This is summarised in Scheme 4.22. 
3) An SN2 displacement would also give inversion of configuration of 
the methylene position of 4.11. The SN2 mechanism was considered unlikely. 
The N-acylation of the hydroxymethyl pyrrole, eg: 2.32 was intended to 
discourage an SN2 type mechanism. This is experimentally shown in Section 
4.7.1, where displacement of the OH via the Mitsunobu reaction (known to 
favour an SN2 process) occurs with SN 1 character indicating azafulvene 
chemistryl5. 
Since enantIomers are not distinguishable by 1 H NMR spectroscopy in 
the absence of a further chiral species (eg: solvent, shift reagent) the direct 
observation of the configuration of the -CHD- group of the chiral pyrrole 
products 4.11 and 4.12 is not possible. Diastereoisomers are, however, NMR 
distinguishable, this is expected in the case where the signals are 
arllsochrouous. 
Initial experiments using chiral shift reagents 16,17 to separate the 1 H 
NMR spectra of the products 4.11 and 4.12 were unsuccessful. The obvious 
solution to the problem of observing the -CHD- group configuration was to use 
a chiral N-acyl group. A chiral N-acyl group would cause diastereoisomers to 
be formed and hence the -CHD- signal should be clearly resolved. The chiral 
N-acyl group, N-pth-Leu, was chosen. A trial deacylation of the non-labelled 
hydroxymethyl pyrrole N-(N-Pth-Leu)-p-2-0H 3.45 in d3-acetonltrile 
containing HO- (1 equiv. KOH in D20) gave 4.13 after five minutes. 4.13 
produced from this reaction was analogous to the deacylation of 2.32 to give 
4.5 discussed in Section 4.3. 
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H rt R' 0 
4.13 R=R'=H 
Scheme 4.23 
The doublets due to pyr-CH20R group of the O-acylated pyrrole 
derivative 4.13 at 5.09ppm and 5. 13ppm were clearly resolved. The IH NMR 
spectrum of 4.13 is shown in Figure 4.30. 
The clear doublet observed for 4.13 indicated that an analogous 
reaction using optically pure, deuterated hydroxymethyl pyrrole 4.14, as in 
Scheme 4.23. would give clear evidence as to the stereochemical fate of the 
pyr-CH2R group of the O-acylated pyrrole derivative produced on the 
hydrolysis of 4.14. 
4.6.2 Preparation of the Chiral Hydroxymetbyl Pyrrole Derivative 4.14 
The DMAP methodology, described in Section 2.4, was employed in 
the synthesis of the chirallY-acylated formyl pyrrole 4.16, Scheme 4.24. 
Cl Q-yD pthN0 DMAP .. 
_ 0 Hiinigs base 
Leu H 0 
3.41 4.15 
Scheme 4.24 
QyD 
FthN0 0 
. 0 
Leu 
4.16 
R-alpine j 
borane 
~OH 
FthN0H' D 
_ 0 
Leu 
4.14 
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D I-Pyrrole-2-carboxaldehyde 4.15 (p-2-CDO) was prepared via the 
Vilsmeier-Haack formylation of pyrrole using d7-DMF. The addition of p-2-
CDO 4.15. DMAP and Hunigs base to N-pth-Leu-CI 3.41 caused polymerisatlon. 
A report on microscale preparations of acid chlorides under the same 
oxalyl chloride/DMF conditions used here. indicated that N-
(chloromethylene)-N-methanaminium chloride 4.17 was a likely product in 
the oxalyl chloride/DMF preparation of 3.4118. 
Compound 4.17 is more reactive than an acid chloride and hence 
reacts preferentially with alcohols to produce alkyl halides19. 4.17 was 
conveniently removed in a hexane preparation of the acid chloride. by 
filtering. 
We found that when the crude reaction from the oxalyl chloride/DMF 
reaction conducted in benzene was evaporated to dryness and hexane added. 
the required acid chloride was taken into the organic layer. An insoluble 
yellow oil remained in the reaction vessel; the 1 H NMR spectrum of this oil 
indica ted the presence of 4.17. 
Use of the purified acid chloride in the DMAP reaction with p-2-CDO 
4.15. Scheme 4.24. gave the desired N-acylated p-2-CDO 4.16 in high yield. 
Inspection of the IH NMR spectrum of the failed preparations of 4.16 showed 
signals due to 4.17 [lH NMR 0 1.93. 2.93. 3.01. 8.05]18. 
+ CI The acid chloride fonnation is probably best carried out in 
(CH3h N=< cr H hexane. 
chloromethylene 
4.17 
R-Alpine borane2o reduction [(+)-a.-pinene and 9-
BBN. Scheme 4.24] of the aldehyde 4.16 gave the chiral 
hydroxymethyl pyrrole 4.14 in 51 % yield. after silica 
chromatography. The IH NMR spectrum of 4.14 showed a 
one proton singlet corresponding to pyr-CHDOH at 4.63ppm. The IH NMR 
spectrum of the unlabelled N-(N-Pth-Leu)-p-2-0H 3.45. Section 3.3.1 had a 
two proton Singlet in the same position. 
R-Alpine borane is known to yield 'S' alcohols21 .22 on reduction of the 
corresponding aldehyde. The determination of the absolute stereochemistry 
in this work was not possible. The assumption was that R-alpine borane 
reduced the fonnyl group of 4.16 in the same sense as reported in a related 
system21 • ie: to give the 'S' stereochemistry. as drawn in 4.14. In any event 
the exact chirality was not important in the present studies. 
4.6.3 Hydrolysis of Chiral Hydroxymetbyl Pyrrole Derivative 4.14 
(S)-N-(N-Pth-Leu)-p-2-CHDOH 4.14. Section 4.6.2. was dissolved in 
d3-acetonltrile and HO- (lequiv. KOH in D20) was added. The IH NMR 
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spectrum after fifteen minutes showed one signal at 5.08ppm indicating one 
diastereoisomer 4.19, Figure 4.25. 
IH NMR Spectra of Methylene Region of 
()'Acetylated Pyrrole 4.19 
'.N 1,1f I.M 
Figure 4.25 
~OH 
PthN~H D 
~ 0 
Y +HO-
4.14 
pathway d A pathway c 
scheme4.2Y ~cheme4.22 
,.K •.•• 
Qxo/,Plli 
H H D 0 
no~ "N~ 0 Npth 
H H D 0 
4.18 4.19 
Scheme 4.26 
". 
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Racemisation had clearly not occurred to give 4.18. This implies that 
the formation of the O-acylated pyrrole derivative, eg: 4.5 did not form via an 
azafulvene, as in pathway d Scheme 4.26. The determination of the 
configuration of 4.19 is described in Section 4.6.4. 
The mechanism of formation of 4.5 must therefore be via a pathway 
analogous to pathway c, Scheme 4.26 or much less likely via an SN2 
displacement. see Section 4.6.1 for a discussion. The N- to 0- acyl transfer 
occurs via an intramolecular attack of the hydroxymethyl group on the amide 
carbonyl. 
4.6.4 Determination of the Configuration of the Chiral H-6 Position of the 
Pyrrole Derivatives 4.14 and 4.19 
The direct observation of the configuration of the 2-methylene 
position of pyrroles 4.14 and 4.19 was not possible. The configuration was 
determined by analogy with other known e:xamples21 ,22. The following three 
observations were used to determine the configuration of the -CHD- group. 
1) R-Alpine borane is known to reduce aldehydes to alcohols with the 
'So configuration. 
2) The pyrrole camphanate derivative 4.20. Scheme 4.27, had been 
prepared in optical purity via R-alpine borane reduction23• Ozonolysis of 4.20 
produced one of the two enantiomeric glycolates 4.21 or 4.22: each has a 
known 1 H NMR spectrum. The 1 H NMR spectrum of the glycol was compared 
to the known standards 4.21 and 4.22. The chirality of the camphanate 4.20 
was determined as the'S' configuration. 
pMc AMc 
~o~~ 
R" H D ° 
4.20 
pMc::::CH2CH2C02Me 
AMc::::CH2C02Me 
R"=S02Me or S02CF 3 
Scheme 4.27 
4.21 R=H. R'=D 
4.22 R=D, R'=H 
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The ozonolysis reaction is relatively simple; however the yields are 
very low «10%), and hence the reaction was not attempted in the present 
study. 
3) A further analogy was derived from the corresponding series using 
the optically active hydroxymethyl pyrrole 4.10 as the base pyrrole. 
Sa) The racemic camphanate 4.25 was synthesised by the reduction of 
4.23 with Zn(BH4)2, Scheme 4.28, as described in Section 2.4.5, followed by 
camphanate 4.25 formation with H-camphanic chloride and DMAP, Section 
S.2.5. IH NMR spectral analysis identified the camphanate 4.25 pyr-CHDO-
camph signals at 5.38ppm and 5.S9ppm in a ratio of 1: 1 for the 'R' and'S' 
isomers, Figure 4.34. 
Sb) The optically active camphanate 4.26 was prepared from the 
reaction of H-camphanic chloride and DMAP with the chiral hydroxymethyl 
pyrrole 4.10, Scheme 4.28. IH NMR spectral analysis of the optically active, 
labelled pyrrole camphanate 4.26 gave a singlet at 5.38ppm for the pyr-CHDO-
camph proton, Figure 4.S4. Using the knowledge that R-alpine borane 
reduces aldehydes to the'S' alcohol we attributed the upfield signal to the 'S' 
enantiomer. 
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Using the information given in steps 1) to 3b) above. the configuration 
of the -CHD- group of the labelled O-acyl pyrrole derivative 4.19 was 
determined as follows: 
1) The achiral. non-labelled hydroxymethyl pyrrole N-(N-Pth-Leu)-p-
2-0H 3.45 was deacylated by the addition of HO- (lequiv. KOH in D20) in d3-
acetonitrile. Scheme 4.29. to give 4.13. The well resolved doublet of pyr-
CH20R was centred at 5.09ppm and 5. 13ppm. Figure 4.30. 
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2) Hydrolysis of the labelled N-(N-Pth-Leu)-p-2-CHDOH 4.14. as 
described above. gave the a-acyl pyrrole derivative. eg: 4.19. Scheme 4.29. IH 
NMR s~ectral analysis of the labelled a-acyl pyrrole derivative gave an upfield 
signal at 5.09ppm. Figure 4.30. Therefore the chirality was assigned as 'S' for 
the product 4.19. 
The single signal indicates that the reaction to form 4.19 (and 4.5) 
proceeds with retention of configuration and therefore most likely via an 
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intramolecular reaction, pathway c Scheme 4.19. This also gives further 
support to the notion that an SN2 mechanism is not operating in the N- to 0-
acyl transfer reaction. 
4.6.5 Hydrolysis of D-Acetylated Pyrrole 3.36 
Hydrolysis of 3.36 in d3-acetonitrile with HO- (lequiv. KOH in D20) 
containing one equivalent of n-butylamine gave a slow conversion to 4.6, to 
give a final ratio of 7:3 (4.6:3.36) after three hours, Figure 4.31. No other 
pyrroles were observed by IH NMR spectroscopy. 
2equiv. HO-/D2O 
3.36 .. 4.6 
n-BuNH2 • d3-CD3CN 
~ 100 ~ 80 ~ ...... en ... Ii 3.36 
'a 
S 60 .. 4.6 
<I) 
:8 40 
0 
...... I( <I) 20-~ 
& 0 
~ 0 3.8 7.6 11.4 15.2 19.0 
time (h) 
Figure 4.31 
As described in Section 4.5.2, two pathways for the formation of 4.6 
are possible. The first involves the N- to 0- acyl transfer via the intramolecular 
attack by the hydroxymethyl group, pathway c Scheme 4.19. The second 
slower pathway. previously occurred only before the O-acyl pyrrole derivative 
4.5 had formed. The slow rate observed on the hydrolysis of 3.36 is equivalent 
to this process. The mechanism of formation of 4.6 in this case, is therefore 
likely to be via pathway b Scheme 4.19. 
4.6.6 Summary of the Evidence for Intramolecular Acyl Transfer 
The rate of hydrolysis of 3.36, Section 4.6.5, indicates that hydroxide 
attack on hydroxymethyl pyrroles, occur at the CH20H group. The rate 
observed for the protected hydroxymethyl pyrrole is consistent with 
intramolecular acyl transfer. 
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The chiral labelling experiment showed that the pyr-CHDR centre is 
not racemised during the formation of 4.19 under hydrolysis of 4.14. The 
mechanism of formation of 4.19 (and 4.5) is therefore via an intramolecular 
reaction, pathway c Scheme 4.19. 
This hydrolysis provides an example of neighbouring group 
partiCipation in the hydrolysis of an amide bond. Other nucleophilic 
substitutions, are known to be catalysed by the presence of a neighbouring 
nucleophile. The hydrolysis of phthalamic acid 4.27. Scheme 4.32. has been 
shown to be 105 times faster than benzamide (PhCONH2) at a similar pH6. 
cG: 
o 
+NHa 
4.27 
Scheme 4.32 
The rate enhancement of phthalamic acid 4.27 over benzamide is not 
the result of the electron withdrawing ability of the -COOH group, but is an 
example of neighbouring group partiCipation. Another good example is the 
catalytic triad of serine protease. 
This form of catalYSiS has been suggested in the nucleophilic 
hydrolysis of esters and amides by enzymes24• The catalytic triad of serine 
proteases. Section 1.2.2, consists of an arrangement of nucleophilic residues 
that are able to promote neighbouring group participation in the cleavage of 
peptide bonds. 
Protease Inhibitor Properties 142 
4.7 Azafulvene Chemisb.y: Experlmental Evidence 
4.7.1 The Suppression of Azafulvene Formation by N-Acylation of 
Hydroxymetbyl Pyrroles 
The N-acylation of pyrroles with a 2-substituted leaving group, has 
been shown to suppress the formation of azafulvenes. Section 2.1.2. Pyrrole N-
acylation removes electron density from the nitrogen thereby decreasing the 
ability of the nitrogen lone pair to promote azafulvene formation. The more 
electron withdrawing the N-acyl substituent. the more suppressed the pyrrole 
is to azafulvene formation. see Section 2.1.2 for a discussion. 
4.7.1.1 Stability oj N-Acylated Hydroxymethyl Pyrrole 2.32 with respect to 2-
Hydroxymethyl Pyrrole 4.1 
The observation that the hydroxymethyl pyrrole 2.32 dissolved in d3-
acetonitrile did not react with n-butylamine or with D20 i~ the absence of 
HO- supports the theory that N-acylation of 2-substituted pyrroles suppresses 
azafulvene formation, Section 1.1. Nucleophilic displacement at the 2-
methylene group of pyrrole 2.32 does not occur due to N-acylation, only after 
the N-acyl group is removed. eg: as in 4.5, does reaction occur. 
This was demonstrated when the hydroxymethyl pyrrole 4.1 2 was 
prepared independently by zinc borohydride reduction of p-2-c, see Section 
2.4.5. The p-2-c was dissolved in d3-acetonitrile and IH NMR spectra were 
recorded over two hours. During the first hour the signal for pyr-CH20H 
4.62ppm (d3-CD3CN) gradually decreased, while the baseline noise increased. 
At the end of the second hour, the baseline noise obscured all of the pyrrole 
signals. This was accompanied by an intense colour in the NMR tube 
attributed to pyrrole polymer formation, see Sections 2.4.2, 3.2.1.4 and 
4.3.2.1. 
The N-acylated pyrrole 2.32 was found to be stable under the same 
conditions (and conditions with n-butylamine present) for two days. This 
indicates that a non-N-acylated pyrrole undergoes azafulvene formation 
readily, while N-acylation of 2-substituted pyrroles suppresses azafulvene 
formation. 
4.7.1.2 Labelled Hydroxymethyl Pyrroles 4.10 and 4.24 used to Determine the 
Stereochemical Consequence oj AzaJulvene Chemistry 
The labelled formyl pyrrole 4.23 was prepared using the DMAP 
methodology, Section 2.4. Hydrocinnamoyl chloride was added to p-2-CDO 
4.15 in the presence of DMAP and Hiinigs base. The resultant deuterated 
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formyl pyrrole 4.23 was then reduced under each of the conditions. outline in 
Scheme 4.33 and summarized below: 
1) Achirally with Zn(BH4)2 in ether. to give the racemiC deuterated 
hydroxymethyl pyrroles 4.24. and 
2) Chirally with R-alpine borane to give the'S' labelled hydroxymethyl 
pyrrole 4.10 (R-alpine borane is known to reduce aldehydes to alcohols with 
the'S' configuration). 
The conformation at the 2-methylene position was then determined 
by making the camphanate derivatives 4.25. 4.26 and 4.28. 
Cl 
Ph~O 4.15 
4.24-
(-)-camphanlc I chloride. DMAP 
4.25 
DMAP. 
II< 4.23 
Hftnlgs base 
Zn(BH2)4 j R-A1p!ne 
borane 
4.10 
(-)-camphanic aC!d/ j (-) -camphanlc 
DEAD. PPh3 
chloride. 
DMAP 
Ph 
4.28 
Scheme 4.33 
o 
Q-xOO"?: 
~~- D 0 
4.26 
Hydroxymethyl pyrroles 4.10 and 4.24 were dissolved in CH2Cl2 
followed by the addition of one equivalent of H-camphanlc chloride and 
DMAP to give the desired camphanates 4.26 and 4.25. respectively. The 
hydroxymethyl pyrrole 4.10 was also subjected to camphanate formation 
under the Mitsunobu conditions25 (the addition of excess DEAD. PPh3 and (-)-
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camphanic acid to 4.10 in THF) to give the camphanate 4.28. 
IH NMR spectral analysis of the resultant camphanates 4.25,4.26 and 
4.28 was performed to determine the stereochemical fate of the ~CHD- group 
in the formation of the camphanates 4.26 and 4.28. 
1) The achiral camphanate 4.25 was used as a reference as signals for 
the pyr-CHDO-camph group of both enantiomers were evident at 5.38ppm 
and 5.39ppm, Figure 4.34. The upfield signal at 5.38ppm was assigned to the 
'S' enantlomer by analogy with N-(N-Pth-Leu)-p-2-CHDOH 4.14, Section 
4.7.1.2. 
2a) The chiral labelled camphanate 4.26 prepared by the acid 
chloride/DMAP method showed a single one proton signal at 5.38ppm, Figure 
4.34. The acid chloride/DMAP method ensures the racemisation does not 
occur, since the CHD~OH bond is not broken. azafulvene chemistry is 
therefore not possible. 
2b) The labelled camphanate 4.28 prepared from the Mitsunobu 
reaction showed two signals, a downfield signal at 5.39ppm and an upfield 
signal at 5.38ppm for pyr-CHDO-camph, Figure 4.34. 
IH NMR Spectra of pyr~CIIDO-camph Signal for the Camphanates: 
4.25. 4.26 and 4.28 
4.25 4.26 
Figure 4.34 
4.28 
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The high stability of hydroxymethyl pyrroles towards nucleophilic 
displacement was evidenced by the lack of reaction of the pyrrole 2.32 after 
several months in a solution containing n-butylamine, Section 4.3.4. The 
Mitsunobu reaction forces a nucleophilic displacement to occur without HO-. 
The Mitsunobu conditions are known to favour an SN2 mechanism. The 
formation of 4.28 under SN2 conditions would yield a 1 H NMR spectrum with 
a single downfield signal at 5.39ppm, the result of inversion. Similarly, if the 
displacement occurred solely due to azafulvene chemistry, a one to one ratio. 
of'S' (5.38ppm) to 'R' (5.39ppm) signals would be expected. 
1 H NMR spectral analysis of the camphanate 4.28 from the Mitsunobu 
reaction showed two signals at 5.38ppm and 5.39ppm, Figure 4.34. The signal 
at 5.39ppm (61%) indicated an inversion of configuration, ie: an SN2 reaction 
had occurred to give the 'R' configuration. The signal at 5.38ppm (39%) 
indicates that azafulvene chemistry was also evident during the camphanate 
formation. 
Since a single signal was not observed from the Mitsunobu reaction we 
concluded that azafulvene chemistry had occurred, in part, to give the'S' 
enantiomer. However, the ratio of 61:39 ('R':'S') indicates that azafulvene 
formation had been partially suppressed by N-acylation of pyrrole. 
This result also discounts the SN2 mechanism for O-acyl pyrrole 
derivative 4.5 formation, eg: even under Mitsunobu conditions, which give the 
best possible chance for an SN2 process, azafulvene chemistry still occurs to a 
significant extent. 
The more strongly electron withdrawing the N-acyl group, the greater 
the expected suppression of azafulvene formation. The suppression of 
azafulvene formation by N-acylation of 2-substituted pyrroles is supported by 
other work21 in which the mesylate (S02Me) and triflate (S02CF3) groups 
were placed on the pyrrole nitrogen to give 4.20, Scheme 4.27. 
A similar camphanate formation to that described in the present study 
using the'S' labelled hydroxymethyl pyrrole enantiomer, gave the 'R' 
camphanate 4.20 in 96% enantiomeric excess via the Mitsunobu reaction. The 
configuration was confirmed by the degradation to the corresponding 
glycolate 4.21 of which the chirality and IH NMR spectra are known; this is 
described in Section 4.7.1.2. 
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4.7.2 Azafulvene 1.3 Formation: Evidence from Hydrolysis of Hydroxymethyl 
Pyrroles 
4.7.2.1 Racemisation of Chiral Labelled -CHD- Group of Hydroxymethyl Pyrrole 
4.14 
The N-acylation of pyrroles has been shown to suppress azafulvene 
formation, Sections 1.2.4, 2.1.2 and 4.7.1. We required evidence that the 
postulated azafulvene 1.3 does form on deacylation of N-acyl pyrroles. 
Azafulvene formation was shown by Battersby26 to occur in the release 
of hydroxymethylbilane 4.30, Scheme 4.35, after assembly from 
porphobilinogen (PBG, 4.29) in the enzyme hydroxymethylbilane synthase23 • 
The release of the bilane was postulated to occur via the azafulvene 4.31. 
The reaction of chiral [ll-DI-R] or [ll-DI-S] labelled PBG gave a 
racemic product 4.33 at the ll-PBG position, under non-enzymic cond1t1~ns. 
The chirality is retained when the cyc1isation is carried out in the presence of 
hydroxymethylbilane synthase to produce 4.32. 
It was suggested that in the active site of an enzyme the attack is 
carried out stereospecifically to give 4.32, while attack in solution would 
occur from both faces of the azafulvene, thus leading to the racemic product 
4.33. 
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Chiral labelling was also used in the current work. to gain an insight 
into the reactions of hydroxymethyl pyrroles. eg: 2.32. with a nucleophile. eg: 
an amine. The amine was designed to mimic a nucleophilic residue of an 
enzyme. that is expected to react with the electrophilic azafulvene to give 
enzyme inhibition. 
A trial reaction using the unlabelled hydroxymethyl pyrrole 3.45. 
Scheme 4.36, in the presence of racemic sec-butylamine and HO-, showed a 
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clearly resolved doublet centred at 3.54ppm and 3.56ppm. Figure 4.37 for 
pyr-CH2NHR group of 4.35. Therefore, the hydrolysis using the optically 
active, labelled hydroxymethyl pyrrole 4.14 and optically active (S)-(+)-sec-
butylamine would clearly indicate the stereochemical outcome of the chiral 
centre. 
QxOH 
PthN~ R' R' 
_ 0 
Leu 
3.45R=R'=H 
4.14 R=H, R'=D 
9x~Y" 
H R R' CH3 
4.35R=R'=H 
4.36 R=H/D, R'=D/H 
O~ 
Scheme 4.36 
4.13 R=R'=H 
4.19 R=H, R'=D 
4.34 
IH NMR Spectra of Methylene Region of Pyrrole Amines 4.35 and 4.36 
)k 
i • iii' , . , 
"n ,," ".. ".. ,." 
4.35 4.36 
Figure 4.37 
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The hydroxymethyl pyrrole 4.14 was subjected to the hydrolysis 
conditions described in Section 4.6.2. Addition of the chiral amine (S}-(+)-
sec-butylamine to 4.14 in d3-acetonltrile was followed by HO- (lequiv. KOH in 
D20). The deacylation immediately produced the O-acylated pyrrole derivative 
4.19, shown previously to be the'S' enantiomer, Section 4.7.1.2. 
The desired labelled amine 4.36 was also formed within ten minutes. 
IH NMR spectral analysis of 4.36 showed two, one proton signals at 3.54ppm 
and 3.56ppm. Figure 4.37. This clearly indicated that racemisation of the -
CHD- group has occurred. 
Therefore there is strong evidence that the azafulvene 4.34 does form 
on the hydrolysis of 4.14. The hydrolysis of 4.14 forms the optically active 
4.19. This then deacylates to give the azafulvene 4.34, in which subsequent 
nucleophilic attack on 4.34 by sec-butylamine clearly shows racemisation of 
the -CHD- group. 
The implication is that enzymic catalysed cleavage of the amino acid-
pyrrole bond will release the latent reactivity thereby allowing inhibition. 
4.7.2.2 Formation of Pyrrole Amine 4.6, 4.35 and 4.36 
Evidence that the azafulvene 1.3 forms is obtained when the reaction 
between an alcohol and a primary amine does not give a secondary amine, 
Scheme 4.38, is conSidered, see Section 4.3.4. 
HO' 
R-OH + H2N-R' X· R-N-R' H 
~OH H2N-R' ~~'It 
flo 
H H 
4.1 
~ / 
~ N 
1.3 
Scheme 4.38 
The pyrrole amines 4.6, 4.35 and 4.36 are suggested to form via 
attack of an added external nucleophile, n-butylamine and sec-butylamIne, 
respectively on the azafulvene 1.3. It is felt that this reaction can only occur 
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via the azafulvene. 
When the reaction was carried out, without sufficient nucleophile 
being present. the azafulvene was attacked by the hydroxymethyl pyrrole 4.1 
to produce polymeric pyrrole material, as evidenced by the colour of the 
solution and the staining of the NMR tube. Base catalysed pyrrole polymer 
formation is strongly suggestive of azafulvene formation. 
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4.8 Conclusion 
The hydrolysis studies discussed in this chapter have shown that the 
deacylation of hydroxymethyl pyrrole derivatives. eg: 2.32, produces an 
electrophilic species, probably the azafulvene 1.3. This electrophilic species is 
rapidly trapped either by an external nucleophile, added to mimic an 
enzyme's nucleophilic residues. or by another hydroxymethyl pyrrole to give 
polymeric products. The activation of 2.32 proceeds. in part. by an initial N-
to 0- acyl transfer, with the subsequent release of the postulated azafulvene 
1.3. 
The decomposition of 4.5 to produce the hydroxymethyl pyrrole 
amine 4.6 was shown to be first order with respect to HO- concentration from 
zero to three equivalents. 
The use of optically active, deuterated hydroxymethyl pyrrole 
derivatives enabled the elucidation of the stereochemical fate of the pyr-
CH20R group in nucleophilic displacement reactions and the deacylation 
reactions catalysed by HO-. The results suggest that HO- attacks the 
hydroxymethyl pyrrole. followed by attack of the oxyanion at the amide 
carbonyl in an intramolecular cyclisation. The cyclised product is not 
observed, but rapidly breaks down to produce 4.19 with retention of 
configuration. 
N-Acylation of hydroxymethyl pyrroles was shown to suppress 
azafulvene formation. There was no reaction of 2.32 in a n-butylamine solution 
after two months. Deacylation of the pyrrole by HO- caused rapid formation of 
products produced via the displacement of the OH group. The Mitsunobu 
reaction was also shown to proceed with partial SN2 character if azafulvene 
formation had not been suppressed by N-acylation, racemisation would have 
occurred. A full SN2 process would have occurred if no azafulvene chemistry 
was involved. thus resulting in exclusive inversion of chirality. 
The azafulvene 1.3 was shown to form. since the pyrrole amine pyr-
CHDNHR group of 4.36 was found to have racemised. 
The designed mechanism based inhibitors are expected to produce an 
azafulvene in the enzymes' active site. Section 1. L This may then be attacked 
by a further nucleophilic residue on the enzyme. thus binding the pyrrole to 
the em;yme. The end result should be inhibition of the enzyme. 
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CHAPTER FIVE 
ENZYME TESTING 
AND 
MOLECULAR MODELLING 
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5.1 a-Chymotrypsin Assay of Selected Hydrox:ymethyl 
Pyrroles 
The pyrroles 2.52. 2.55. 3.39, 3.45. 3.53 and 3.55, Figure 5.1, were 
tested as potential inhibitors of a-chymotrypsin as outlined by CanneUl,2. The 
a-chymotrypsin assay was based on a colourimetric technique, where enzymic 
release of a coloured derivative, from the substrate, indicates activity. 
~OH 
N 
~OH 
N 
~OH 
N 
pthN0. PthN~o pthN0. _ 0 _ 0 
Ph"""'" Y Ph 
2.52 2.55 3.45 
~ Val 0 ~N~orr~JYNH Coo 
pthN0. 0 Val 
_ 0 
3.39 
Figure 5.1 
Solutions of the pyrroles to be tested were made up to 12.5J.Lg mL-l 
and 125J.Lg mL- 1 as standard solutions in methanol. The buffer, Tris-HCI (pH 
7.6), the pyrrole test solution and an a-chymotrypsin solution (50mM in Tris-
HCI buffer, pH 7.6) were added to each well of a microtitre plate. 
Preincubation of this solution at 37°C for thirty minutes was followed by the 
addition of the substrate N-succinyl-phenylalanine-4-nitroanilide 5.1, Scheme 
5.2. The enzyme and test solutions were preincubated to ensure maximum 
inhibition before addition of the substrate. Mer the addition of the substrate 
5.1, the optical density was measured over apprOximately two hours. The 
absorbance was read at 410nm at t=O, and after incubation at 37°C when 
Significant colour change had taken place. 
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5.1 5.2 
. Scheme 5.2 
Control samples were included in all assay cases and each sample was 
tested in duplicate. Methanol was used to dissolve the proposed inhibitor and 
for subsequent sample dilution as it was water soluble and hence compatible 
with the assay system. 
The assay was based on the breakdown of the colourimetric substrate 
5.1 by the enzyme to produce a coloured product 5.2, Scheme 5.2. The colour 
development. due to enzymic release of 4-nitroanilide 5.2. indicated that the 
enzyme was active. Lack of colour development, therefore. indicated 
inhibition. 
The results obtained, Table 5.1, indicate that the pyrrole derivatives 
designed as mechanism based inhibitors of proteolytic enzymes, Section 1.2, 
are modest inhibitors of a-chymotrypsin. 
Compound 
2.52 
2.55 
3.45 
3.53 
3.55 
3.39 
% Inhibition 
(12.5J.Lg mL- 1) 
24.1 
15.2 
20.5 
14.3 
22.8 
42.9 
% Inhibition 
(125J.Lg mL-I) 
42.9 
31.8 
24.7 
53.3* 
9.2 
95.4* 
... Precipitation occurs in Reaction Well. 
Table 5.1 
These data are represented in Figure 5.3. 
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There is a 150% decrease in the activity of the 'D' amino acid 
hydroxymethyl pyrrole 2.55 with respect to the 'L' derivative 2.52, Figure 5.4. 
The value represented here for the 'D' amino acid 2.55 has been corrected 
for the 35% 'L' component. caused by racemisation, Section 2.4.6. The 
decrease indicates that the natural amino acid configuration is important for 
enzyme recognition. as would be expected in an enzyme system. 
ex-Chymotrypsin Assay of Pyrroles 
2.52 and 2.55 
50.,.-------------~ 
d 40 
o 
E ~ 30 
..... 
~ o 20 
10~~~~~--~~~~~~~_i 
10 30 50 70 90 110 130 
Concentration {jlg mL- 1) 
Figure 5.4 
o 
• 
2.52 
2.55 
The 'L'-Phe derivative 2.52 shows 42.9% inhibition at 125J.Lg 
ml-l. The tetrapeptide 3.39 also shows 42.9% inhibition. but at a lower 
concentration. This inhibition is the best observed. excluding the derivatives 
that precipitated. The inhibition is consistent with the known fact that ex-
chymotrypsin cleaves amide bonds on the C-terminal side of aromatic amino 
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acids, Section 1.2.3. The extension of the peptide chain in 3.39 to increase 
hydrogen bonding to the enzyme, also increases the inhibition of the enzyme. 
The inhibitor properties of the other pyrrole derivatives are 
satisfactory, since they are not ideally suited for targeting ex-chymotrypsin. 
The preCipitation of 3.39 and 3.53 in the reaction well, indicates that the 
compounds are unstable (or not soluble) to the assay conditions. The same 
result is observed and discussed in Section 5.2. 
The results shown in Table 5.1 indicate that the compounds designed 
as mechanism based inhibitors of proteases were active against ex-
chymotrypsin. 
Potential lead compounds have been established. These pyrroles 
contain the required aspects that were incorporated into the designed 
mechanism based inhibitors, Section 1.1. The latent reactivity is contained in 
the N-acylated, 2-substituted pyrrole. The hydroxymethyl pyrroles 2.52, 2.55, 
3.45, 3.53 and 3.55 contain the latent reactivity. There is however little 
opportunity for hydrogen bonding to the enzyme. This has been shown to be 
important to the inhibition of ex-chymotrypsin, Section 1.2.1 and to the HIV 
protease, Section 1.2.3. Hydrogen bonding has been addressed in the 
extension in the C-direction, PI' and P2' residues. by the addition of the 
dipeptide Cbz-Val-Val-OH to give 3.39. To make a better inhibitor of ex-
chymotrypsin, additional hydrogen bonding must be included by further 
extension in the Px' direction. The effect of varying the residues in the Px' 
direction should also be examined. The methodology outlined in Chapter Two 
and Three enables this to be possible. The removal of the N-Pth protecting 
group would also enable extension in the N-direction, by adding more Px 
residues. This possibility was described in Section 2.4.7. 
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5.2 HIV-l Protease Assay of Selected Hydroxymethyl Pyrroles 
The selected pyrroles 2.32, 2.52, 3.39, 3.53 and 3.55 were tested 
against the HlV-l protease3 • The testing conditions used were first described 
by Dreyer4. The compound under study was dissolved in DMSO and placed in 
the acidic MENDT buffer (50mM Mes. pH 6.0/lmM EDTA/200mM 
NaCI/lmM dithiothreitol/O.l% Triton X-100). The inhibition of the HlV-l 
protease was observed by incubating the protease (llOng) at 37°C for one 
hour with 2~Lg of the polyprotein p55, a substrate for the HlV-l protease, 
Section 1.2.3. Reactions were quenched by boiling for two minutes in 
NaDodS04/PAGE buffer. The rates of cleavage were determined by HPLC 
analysis of the peptidolysis products. 
Initial results of the simple, non-peptide based, potential inhibitor 
2.32 and the one amino acid hydroxymethyl pyrrole 2.52 showed that there 
was no inhibition at concentrations <lmg mL-I. There was slight inhibition 
above these concentrations. This was encouraging as 2.32 and 2.52 showed 
some similarity to a HlV-l protease substrate, Section 1.2.3, but lacked the 
extended hydrogen bonding also known to be important for inhibition of the 
protease5,6. The improvement of the proposed inhibitor is possible by the 
addition of extended hydrogen bonding pOSitions in the molecule, and overall 
hydrophobic interactions within the enzyme/inhibitor complex. 
The syntheSiS of the tetrapeptide pyrrole derivative 3.39, as deSCribed 
in Section 3.2.5, and the long chain derivatives, 3.53 and 3.55, Section 3.3.2, 
were thought of as the next generation of inhibitors. 
The C2 inhibitors7 , Section 1.2.3 and Section 3.2.5 showed that amino 
acid extension in the "anti-sense" fashion produced potent inhibitors of HlV-
1 protease. The tetrapeptide 3.39 was synthesised along these lines, it 
contains the crucial PI and PI' interactions of Phe and "Pro"s respectively, 
Section 1.2.3. The extension of the peptide chain in the C-direction, Section 
3.2.5, increases the important hydrogen bonding interactions between the 
inhibitor and enzyme at the P2' and P3' subsites. The large aromatic amino 
acid protecting group, Pth, at the P2 sub site is also consistent with known 
inhibitors of the HlV-l protease9 • 
The long chain hydroxymethyl pyrrole 3.53 was designed on the basis 
of the known inhibitors cerulenin 5.3, and 5.410, Figure 5.5. 
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This work found that an eleven carbon chain was the optimal length 
for inhibition of the HIV-1 protease, using long chaIn aliphatic resIdues, eg: 
5.3. Figure 5.6. 
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The researchers postulated that the interaction between the 
hydrophobic chain and the HIV proteases' hydrophobic pocket. was 
responsible for the inhibition. In general. they found that a hydrophobic 
residue of a correct length Is required for efficient inhibition of the HIV 
protease10• 
In contrast to the long chain hydrophobic residues described above 
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are the shorter chained carboxylatesll . This work found that the inhibition of 
the HIV-1 protease was likely to occur via interaction of the carboxylates. eg: 
5.5, Figure 5.6. with the charged residues at the ends of the hydrophobic tube 
created around the active site of the 
HIV-1 protease. Section 1.2.4. The optimal length was found to be eight CH2 
groups flanked at each end by a terminal carboxylic acid group. 
The shorter chain N-acylated methyl ester hydroxymethyl pyrrole 
3.55 was designed on the basis of the work of non-peptide carboxylates. It was 
proposed that four CH2 groups and the methyl ester would position the latent 
reactivity at the active site in the 3.55 proposed inhibitor. 
The three inhibitors. 2.32. 2.52, 3.39, 3.53 and 3.55. were tested 
against an HIV-1 protease assay. All the pyrrole derivatives showed <lmg mL-
1 inhibitory properties. The low activity of 2.32. 2.52. 3.39. 3.53 and 3.55 was 
attributed to the instability of the pyrrole derivatives to the assay conditions. 
5.2.1 Stability of Hydroxymetbyl Pyrroles to Enzyme Assay Conditions 
It was felt that the acidic conditions under which the assays were 
conducted caused the decomposition of hydroxymethyl pyrroles. 
The stability of the hydroxymethyl pyrrole 2.52 was tested under the 
HIV-1 protease assay conditions. The hydroxymethyl pyrrole 2.52 was 
dissolved in DMSO and placed in an acidic buffer (potassium 
phthalate/phthalic acid pH 5.9) at 37°C for one hour. After fifteen minutes a 
precipitate had formed. This preCipitate was insoluble in water and 
chloroform. and was attributed to the formation of a pyrrolic polymer. 
The hydroxymethyl pyrrole compounds may be potential mechanism 
based inhibitors of HIV-l protease. The decompOSition of the inhibitor clearly 
shows that the inhibition of the enzymes under these conditions may not be 
observed due to the pyrrole polymer forming. 
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5.2.2 Increase in Stability of Hydroxymetbyl Pyrrole SclssUe Bond 
The pyrrole derivatives were found to be unstable under the assay 
conditions described in Sections 5.1 and 5.2. The stability of the scissile bond 
to the assay conditions may be increased by the addition of electron donating 
substituents on the leaving group. The leaving group governs the lability of the 
amide bond. An increase in the electron density at the amino acid-pyrrole 
amide bond, would increase the stability of the amide bond. The most obvious 
target would be the methyl hydrox:yrnethyl pyrrole derivative 5.S. 
Me Me 
H OH Me,J(N~ 
RHN~ 
_ 0 
Ph"""'" 
5.S 
The methyl groups would not be expected to form destabUising 
interactions between the inhibitor and the enzyme. An increase in electron 
density would be expected to stabilise this bond and thereby increasing the 
stability of the proposed hydroxymethyl pyrrole inhibitors to the assay 
conditions. This aspect of work was not attempted. 
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5.3 Molecular Modelling of a Simple Hydroxymethyl Pyrrole 5.7 
Molecular modelling and associated graphics is frequently used to 
visualise enzyme-inhibitor interactions. The generation of low energy 
conformers of a potential inhibitor allows the observation of enzyme-inhibitor 
interactions 1 2. There is no guarantee that the enzyme-inhibitor structure data 
obtained from the modelling. relate to the actual enzyme-inhibitor complex. 
The simple hydroxymethyl pyrrole 5.7 was subjected to a modelling 
study. to give an indication of the possible interactions between the 
hydroxymethyl pyrroles and ex -chymotrypsin and the 
HIV -1 protease. 
5.3.1 Generation of Minlmised Low Energy Conformers 
The dipeptide H2N-Phe-p-2-0H 5.7. Figure 5.7. was constructed 
using the INSIGHTII package13 and subjected to a Monte Carlo14 
conformational search by BATCHMIN15.16 using the all atom AMBER force 
field 17. All the rotatable bonds. Figure 5.7. were searched to find the set of 
low energy conformers. 
5.7 
N-pth-Phe-p-2-0H --Bonds Rotated during 
Conformational Search 
Figure 5.7 
After fifteen hundred increments of a Monte Carlo search. 116 low 
energy conformers had been found. A further five hundred increments found 
no new low energy conformers. Each of these were minimised using a 
conjugate gradient minimisation until the minimisation had converged to a 
value of 0.01kJ mol- I A-I. This was followed by a Full Matrix Newton-Rapson 
minimisation of each conformer until the gradient converged to <0.001kJ 
mol- I A-I. A final second derivative analysis was performed on the output of 
the final Newton-Rapson minimisation to ensure that none of the conformers 
found were at turning pOints. The result from the grid search and subsequent 
minimisations gave twenty-two low energy conformers within 11kJ mol- I of 
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the lowest energy conformer, these are shown in Figure 5.9. 
5.3.2 Docking Calculations: Low Energy Conformers of 5.7 with HIV-l 
Protease 
A docking calculation evaluates the interaction energies of many 
orientations (conformers) between all the atoms of two molecules. The 
calculation determines those orientations with the lowest energy interactions. 
The interactions may point to a possible conformation of one molecule. that 
interacts with the second molecule better than any other conformation. A 
compound can therefore be synthesised with the conformation of the better 
interactions expressed. 
The coulombic energy and the van der Waals potentials can readily be 
calculated. The combination of these energy terms can be thought of as an 
indication of the "goodness-of-fit" for a particular conformer in the active 
site. Ideally a docking interaction would be calculated while one molecule is 
moved in relation to the second molecule. in real time. The computation of 
the interactions is easy but computation time increases rapidly. with an 
increase in the size of the two molecules. An energy grid that encompasses 
the regions of interest of one molecule. eg: the active site of an enzyme. has 
been shown to approximate the whole molecule to a good degree1B• The 
energies between the molecule being docked and the energy grid changes. 
The energy grid itself does not alter. This allows real time docking. 
The X-ray crystal coordinates of the HIV-I protease complexed with 
the JG-365 inhibitor, 1.40 (Brookhaven 7I-IVP6) were used in the follOwing 
calculations19• 
JG-365 
1.40 
An energy grId of the inhibited HIV-I protease active site. was created 
taking all elements in a 4.2A radius from the JG-365 inhibitor. This subset 
contained the bound water molecule and the two aspartic acids of the active 
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site. Three atoms from the proposed hydroxymethyl pyrrole inhibitor 5.7 
were superimposed on corresponding atoms of the JG-365 inhibitor 1.40, 
Figure 5.B. These three atoms from the JG-365 inhibitor were chosen because 
they positioned the Pyr "pseudo" amino acid of 5.7 at PI' and the Phe in the 
vicinity of the PI subsite, as described in Section 1.2.4. 
Figure 5.B 
Each conformer was "docked" into the active site of the JG-365 
inhibitor using the DOCKING protocol of the Biosym software. The values that 
the docking calculation produces are only relative to each conformer in the 
same series. This gives an indication of the "goodness-of-fit". The twenty-two 
low energy conformers depicted in Figure 5.9 are shown in order of 
increasing "docking energy". The lower the "docking energy" the more 
favourable are the interactions. The energy calculated by MACROMODEL is 
given in italics. 
I'" 
3.113 
114.5 
II'" 
3.442 
119.0 
III'" 
3.585 
118.9 
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IV 
3.603 
115.7 
VII 
3.791 
.119.8 
X 
3.822 
113.9 
XIII 
3.886 
123.3 
V 
3.706 
116.3 
VIII 
3.802 
121.5 
XI* 
3.841 
112.5 
XIV'" 
3.990 
112.8 
VI'" 
3.736 
113.1 
IX 
3.802 
'116.2 
XII * 
3.872 
115.6 
xv 
4.053 
114.9 
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XVI 
4.080 
123.3 
XIX 
4.163 
123.5 
XXII 
5.037 
121.9 
XVII 
4.125 
123.5 
xx 
4.270 
122.8 
Figure 5.9 
XVIII 
4.135 
119.8 
XXI * 
5.005 
123.2 
167 
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A visual inspection of t:p.e proposed inhibitor 5.7, and the results from 
the non-bonding energies obtained in the docking calculations, suggests that 
the inhibitor does fit into the active site. The first three conformers (and 
those denoted with a '" in Figure 5.9) have the phenyl ring of Phe (PI) in the 
hydrophobic pocket (81) of the enzyme. The lowest non-bonded energy 
conformer that showed hydrogen bonding to both the water molecule and the 
aspartic acids was conformer II. 
Computational time restraints did not permit a dynamics run of 
conformer II in the active site to see if the non-bonding interactions are 
improved20 nor studies on a-chymotrypsin. 
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5.4 Conclusion 
The assay results from (X-chymotrypsin and HIV-I protease are 
encouraging in regard to enzyme activity. ChymotrypSin is well known to 
cleave on the carboxyl side of aromatic amino acids. as is the HIV protease. 
The proposed mechanism based enzyme inhibitors have been shown to be 
active against these proteolytic enzymes. The inhibition of (X-chymotrypsin 
was modest. while the inhibition of HIV-I protease was very poor. This has 
been related to the instability of thehydroxymethyl pyrroles to the harsh 
assay conditions. No attempt has been made to optimise the activity. 
An increase in activity of the hydroxymethyl pyrrole derivatives can be 
expected if more sites for hydrogen bonding are added to the proposed 
inhibitor. Chapter Three addresses this possibility. The alternative. and most 
important in regards to a useful pharmaceutical agent. is to increase the 
stability of the amino acid-pyrrole amide bond so that decomposition does not 
occur as readily. This may be possible by the introduction of methyl groups in 
to the pyrrole ring. 
Molecular modelling was used as a tool to allowed the visualisation of a 
potential inhibitor in the active site of the HIV-I protease. This result showed 
that the Phe can sit at the PI subsite with Pyr at the Pl' subsite. indicating 
favourable interactions for hydrolysis and release of the latent reactive group. 
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6.1 General Experimental 
Melting pOints were recorded on a Reichert micro heating stage and 
are uncorrected. Infrared spectra were observed either on a PYE Unicam 
SP3-300 Infrared Spectrophotometer and referenced on the polystyrene 
absorbance at 1603cm-1• or on a Perkin-Elmer 1600 Series FTIR (denoted in 
the text as FTIR). UV spectra were observed in either CHCl3 or MeOH, as 
indicated in the text. on a Perkin-Elmer Lambda 2 UV /Vis spectrometer. ORD 
spectra were measured on a JASCO J-20C Recording Spectropolarimeter in 
MeOH at 589nm. 
1 Hand 13C NMR spectra were measured on a Varian CFT300 NMR 
spectrometer operating at 3'oOMHz for proton spectra and 75MHz for carbon 
spectra, in CDCl3 unless otherwise stated. 1 H NMR spectra were referenced 
on the internal standard trimethylsilane, O.OOppm. while 13C NMR spectra 
were referenced on the center resonance of the CDCl3 triplet at 77.01ppm. 
IH NMR spectra in d3-CD3CN were referenced on the center peak of the 
CH3CN signal at 2.00ppm and the corresponding 13C NMR spectral signal at 
11 7. 7ppm. 1 H NMR spectra in d4 -MeOH were referenced on the center peak 
of the CH30H signal at 3.30ppm and the corresponding 13C NMR spectral 
signal at 49.3ppm. Complete NMR aSSignment was based on COSyl. DEPT2 
and HETCOR3 (13C-lH) correlation experiments and NOE enhancement4 
relationships. 
Mass spectra were obtained using a Kratos MS80RFA magnetic sector. 
double focusing mass spectrometer. 
Solvents were purified by standard techiniques5 . The amino acids 
were obtained from the Sigma Chemical Company. with the exception of Cbz-
Val-Val-OH which was purchased from BACHEM Feinchemikalien AG. 
Switzerland. All other reagents were prepared by standard literature methods 
or obtained from the Aldrich Chemical Company. 
All reactions were carried out under a dry N2 atmosphere. 
Reaction work up usually entailed drying the organic phase (Na2S04). 
filtration. followed by evaporation under reduced pressure (Buchi Rotory 
Evaporator. H20 pump vacuum). Preparative chromatography was carried out 
using a Chromatotron (Harrison Research Inc.). a centrifugally accelerated. 
radial .. thin layer chromatograph. using glass plates coated with Merck Silica 
Gel (60 PF254) containing Florisil at 2mm thickness. Visualisation was 
achieved using an ultraviolet lamp at A.=254nm. 
6.1.1 Naming of Compounds Described in the Experimental 
For ease of comparison. the simple pyrrole derivatives and I-amino 
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acyl pyrroles are named as pyrroles, the larger pyrrole esters are named as 
amino acid esters. 
The pyrrole ring system and the aromatic rings are numbered as 
depicted in Figure 6.1. 
4 3 
51/1.2 
«NXR' 
I 1 
R 
Pyr 
5 
4~~a ~ I N-R 
~ I 
o 
Ph Pth Fmoc 
(Cbz, Ts. Ph, Phe) 
Figure 6.1 
The pyrrole ring components are described as H-x or C-x, while the 
aromatic rings are described as Phe-aromHx (phenylalanine aromatic ring), 
Cbz-aromHx (benzyloxycarbonyl aromatic ring). Fmoc-aromHx (for Fmoc 
protected amino acids), Ts-aromHx (tosyl aromatic ring) and Ph-aromHx (for 
other aromatic rings). The corresponding carbons are described as Phe-
aromCx, etc. 
6.1.2 General Procedure for the Preparation of Amlno Acid Acid Chlorides 
The amino acid acid chlorides (with the exception of N-Fmoc-Phe-
C16) used in this work were prepared under the following conditions. 
General Procedure: 
DMF (20j.lL, 1 drop), followed by freshly dis tiled oxalyl chloride 
(5equiv.) were added to the free amino acid (lequiv.) suspended in benzene 
(10mL, freshly distiled from CaH2) under N2. The resultant solution was 
stirred for 1 h at rt, the benzene was removed (H20 pump) and the solvent 
(10mL) used in the subsequent reaction was added. Further evaporation under 
reduced pressure gave a quantitative yield of the amino acid acid chloride. 
The re~ultant acid chlorides derived from Ts and Cbz protecting groups were 
generally yellow oils, while those from pth and Fmoc were white solids. 
N-Ts-Leu-Cl 
IH NMR 0 0.88 (3H. d, J=6.5Hz, (Leu-CH3)Al: 0.94 (3H, d, J=6.5Hz. 
(Leu-CH3)B): 1.53 (IH, m, A part ABX, Leu-CH2); 1.57 (IH, m, B part ABX, 
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Leu-CH2); 1.80 (lH, m, Leu-CH(CH3)2); 2.44 (3H. s, Ts-CH3); 4.25 (lH, X part 
ABX, Leu-CH); 5.13 (lH. bd, J= 10.5Hz. NH); 7.32 (2H, d. J=8.0Hz, Ts-
arornH3); 7.73 (2H, d. J=8.0Hz. Ts-aromH2). 
N-pth-Phe-Cl 
1 H NMR 0 3.56 & 3.63 (2H, ABX, Phe-CH2); 5.32 (lH, X part ABX, 
J=5.1Hz, Phe-CH); 7.13-7.21 (5H, m, Phe-arom); 7.74 (2H, dd, J=5.7 & 
3.3Hz, Pth-aromH3); 7.83 (2H, dd, J=5.8 & 3.2Hz. pth-aromH4). 
N-Pth-Leu-Cl 
IH NMR 0 0.95 (3H, d, J=5.0Hz, (Leu-CH3).Al: 0.97 (3H, d, J=5.0Hz. 
(Leu-CH3)B); 1.55 (lH, m, CH(CH312); 2.05 (lH, A part ABX, m, Leu-CH2); 
2.38 (lH, B part ABX, m, Leu-CH2); 5.12 (lH, X part ABX, J=4.5Hz, Leu-CH); 
7.79 (2H, dd, J=5.7 & 2.5Hz, Pth-arornH3); 7.91 (2H, dd, J=5.7 & 2.6Hz, 
Pth-aromH4). 
6.1.3 Non-Amino Acid Based Acid Chlorides 
The acid chlorides, hydrocinnamyl chloride, isovaleryl chloride. 
lauralyl chloride, monomethyl adipyl chloride and (-)-camphanic chloride 
were prepared as follows. 
General Procedure: 
DMF (20J.l.L, 1 drop) followed by freshly distlled oxalyl chloride 
(5equiv.) were added to the free acid (lequiv.) dissolved in benzene (lOrnL, 
freshly dis tiled from CaH2) under N2. The resultant solution was stirred for 1 
h at rt, and the benzene was removed (H20 pump). The crude acid chloride 
was distiled under high vacuum, and sealed under N2. All of these acid 
chlorides are known compounds. 
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6.2 Work Described in Section 2.2 
6.2.1 NaH Promoted Acylation of Pyrrole-2-Carboxaldehyde by N-Ts-Leu-CI, 
described in Section 2.2.1 
NaH (42mg. 0.88mmol as a 50% suspension in oil. washed twice with 
dry pentane) was added to a stirred solution of p-2-c (83mg, 0.87mmol) 
dissolved in THF (10mL, freshly distiled from sodium wire and 
benzophenone) in a flame dried, N2 filled flask. The mixture was stirred 
under N2 at rt for 15 min and the cooled to O°C. Ts-Leu-CI acid chloride 2.17 
(388mg. 0.94mmol) was dissolved in dry THF (lOmL) and added dropwise to 
the stirred mixture of the sodium salt of p-2-c. described above. at O°C over 5 
min. The addition of the acid chloride caused immediate production of a deep 
brown/black solution and an accompanying precipiate. Mter 15 min water 
(10mL) was added to quench the reaction; some effervescence was observed. 
The THF was removed under reduced pressure and CH2Cl2 (lOmL) was 
added. The aqueous phase was re-extracted with CH2Cl2 (3x15mL) and the 
combined organic phases washed with water (2x10mL). dried. and filtered to 
removed the considerable amount of black preCipitate. Repeated silica 
chromatography (EtOAc/Pet. Ether= 1 :2) produced two new pyrrole 
compounds. 
(2R,4S)-4-(2-Methylpropyl)-2-pyrrol-2-yl-3-toluenesulfonyl-5-
oxazolidinone 2.18 29mg (8%) as a mauve oil; Rf 0.48; [a]D26 -17° (cl, 
MeOH): IH NMR b 0.87 (3H. d, J=6.7Hz. Leu-CH3); 0.95 (3H. d. J=6.6Hz. Leu-
CH3); 1.41 (lH. ddt J=11.9 & 9.0Hz, Leu-CH2); 1.51 (2H. dd, J=11.8 & 5.7Hz. 
Leu-CH2); 1.92 (lH. sept. J=6.6Hz. CH(CH3)2) 2.47 (3H, s, Ts-CH3); 4.10 
(lH. ddt J=9.0 & 5.8Hz. N-CH(Leu)-CO); 6.18 (lH, m. H-4); 6.24 (lH. m. H-
3); 6.68 (lH. s, pyr-CH); 6.85 (lH. m, H-5); 7.39 (2H. d. J=8.5Hz, Ts-
aromH3); 7.74 (2H, d. J=8.4Hz, Ts-aromH2); 8.56 (lH, bs. pyr-NH); 13C NMR 
b 21.6. (Leu-CH3 & Ts-CH3); 22.6. (Leu-CH3); 24.2. (CH(CH312); 41.4, (Leu-
CH2); 56.2, (N-CH(Leu)-CO); 85.8. (pyr-CH); 107.6, (C-3); 109.1. (C-4); 119.8. 
(C-5); 126.5, (C-2); 127.7, (Ts-aromC2); 130.6, (Ts-aromC3); 132.9, (Ts-
aromC4): 145.7, (Ts-aromC1); 172.0, (CO); FTIR (neat) 3394.2, 2923.5, 
2854.0. 1798.3. 1711.3. 1462.5cm- l ; UV (MeOH) 250.4, 276.0. 300.8nm; 
m/ e (FAB) 362 (M, 18.8%); 334 (M-CO, 11.4%); 285 (M-C5H4N, 61.6%): 239 
(B, M-C6H5N02, 100%); HRMS (M) Found: 362.1300 (Calcd. for 
Cl8H22N204S1 362.1289). 
dihydropyrryl piperazine 2.19, 19m9 (5%) as a brown oil; Rf 0.46; IH 
NMR b 0.85 (3H. d, J=6.9Hz, Leu-CH3); 0.93 (3H, d. J=6.7Hz. Leu-CH3); 1.40 
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(IH. m, Leu-CH2): 1.70 (IH. m. Leu-CH2): l.B9 (IH. sept. J= 7. OHz. 
CH(CH312); 2.31 (3H. s. Ts-CH3): 5.55 (IH. bm, pyr-CH(OH)-N): 6.05 (IH, m, 
H-4): 6.73 (IH, m, H-3): 6.99 (IH, m, H-5); 7.00 (2H. d, J=B.2Hz, Ts-
aromH3); 7.35 (2H, J=8.3Hz, Ts-aromH2): 9.09 (IH, s. pyr-CH(OH)-N); 13C 
NMR () 21.4 (Leu-CH3); 21.9 (Leu-CH3); 24.4 (Ts-CH3); 30.9 (CH(CH3)2); 44.1 
(Leu-CH2); 56.2 (pyr-CH(OH)-N); 85.5 (C=C(Leu)-N): 109.4 (C-4); 120.7 (C-3); 
126.3 (Ts-aromC3):126.5 (C-5); 129.1 (Ts-aromC2); 132.2 (C-2); 137.5 (Ts-
aromC4): 142.8 (Ts-aromCl); 166.2 (pyr-CH(OH)-N); m/e (FAB) 363 (M+l. 
36.2%); 362 (M, 10.1%); 345 (M+I-H20 and M-NH3. 17.4%); 240 (B. M+l-
Ts. 100%); HRMS (FAB. M+ 1) Found 363.1373 (Calcd. for ClSH23N204S1 
363. 137B). 
6.2.2 NaB Promoted Acylation of Pyrrole-2-Carboxaldehydewith Acetyl 
Chloride to give 2.24. described In Section 2.2.3 
Acetyl chloride (IBttL, 0.25mmol. 1.2equiv.) was added dropwise to a 
stirred mixture of the sodium salt of p-2-c 2.16 as prepared above. A black 
solution and an accompanying precipiate was again observed after 15 min. 
Water (10mL) was added to quench the reaction, some effevessence was 
observed. Work up as described above produced N-acetyl-p-2-c 2.24 5.5mg 
(20%) mp 75-77°C (lit: 76-7BOC), IH NMR spectral data was consistent with 
that by reported Bohlman 7. 
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6.3 Work Described in Section 2.3 
6.3.1 MeLt Promoted Acylation of Pyrrole Derivatives. described in Section 
2.3.1 
6.3.1.1 Non-Amino Acid Acylating Agents to give 2.28 and 2.31 
P-2-c (100mg, 1.05mmol) or pyrrole (731lL, 1.05mmol) was dissolved 
in dry ether (10mL) under N2 at -78°C. MeLi (1.05mmol, 9.5mL of O.l1M 
solution in dry ether, 1equiv.) was added. The pale blue mixture was stirred 
for 5 min at -78°C, after which hydrocinnamoyl chloride (1721lL, 1. 16mmol, 
1.1equiv.) was slowly added. After a further 10 min stirring. citric acid (2mL. 
10% solution in H20) and H20 (2mL) were added, and the solution was 
allowed to warm to rt, at which time EtOAc (15mL) was added. The organic 
phase was washed with citriC acid (5mL, 10% solution in H20) and the 
aqueous phases' combined and re-extracted with EtOAc (10mL). The 
combined organic phases were washed with citric acid (5mL. 10% solution in 
H20), water (2x10mL). dried and evaporated to dryness. Chromatography on 
silica (EtOAc/Pet. Ether=1:2) yielded the corresponding N-acylated pyrrole. 
2.31 212mg (89%) data discussed in Section 6.4.1.1, and 
1-(3-Phenylpropanoyl)-pyrrole 2.28 205mg (98%) as a pale brown 
solid; Rf 0.40; 1 H NMR 03.12 (2H, m, CH2Ph); 3.14 (2H, m, COCH2); 6.28 
(2H, t, J=2.5Hz, H-2); 7.22 (2H. t, J=2.6Hz, H-3); 7.23-7.31 (5H, m, Ph); 13C 
NMR 030.4 (CH2Ph); 36.4 (COCH2); 113.2 (C-3); 118.9 (C-2); 126.5 (Ph-
aromC4); 128.4 (Ph-aromC2); 128.7 (Ph-aromC3); 140.2 (Ph-aromC1); 169.7 
(CO); IR (nujol) 2870, 1742. 1479cm-1; UV (CHCI3) 291.5nm; m/e (EI, 50eV) 
199 (M. 93%); 131 (M-C4HeNl+, 9.5%): 105 (M-CSH4NIOl, 45.9%); 91 (B, 
M-CeHeNIOlo 100%); 77 (B-CH2. 24.6%); HRMS (M) Found 199.09971 
(Calcd. for C13H13NIOl 199.09971). 
6.3.1.2 Amino Acid Acylating Agent to give 2.30 
Pyrrole (73IlL. 1.05mmol) was dissolved in dry ether (10mL). under 
N2 at -78°C. MeLi (1.05mmol. 9.5mL of 0.11M solution in dry ether. 1equiv.) 
was added. The pale blue solution was stirred for 5 min at -78°C. after which 
N-Cbz-Phe-p-nitrophenyl ester 2.29 (486mg. 1. 16mmol, 1.1equiv.) was added 
portionwise. After 15 min citric acid (2mL. 10% solution in H20) and H20 
(2mL) were added. The solution was warmed to rt, at which time EtOAc 
(15mL) was added. The organic phase was washed with citriC acid (5mL. 10% 
solution in H20). The aqueous phases were combined and re-extract with 
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EtOAc (10mL). The combined organic phases were washed with citric acid 
(5mL. 10% solution in H20), water (2x10mL). dried and evaporated to 
dryness. Chromatography (EtOAc/Pet. Ether=1:2) yielded the N-acylated 
pyrrole. 
l-(N-Benzyloxycarbonyl-L-phenylalanyl)-pyrrole 2.30 251mg (48%) as 
a pale brown solid; Rf 0.31; [a]D 1s -210 (c1, MeOH): IH NMR 0 3.10 (2H, m, 
Phe-CH2): 4.66 (lH, m. Phe-CH); 5.08 (2H. s. Cbz-CH2): 5.60 (lH. bd, 
J=8.8Hz, NH); 6.30 (2H, t, J=2.4Hz. H-3); 7.10 (2H, t. J=2.3Hz. H-2); 7.20-
7.25 (5H, m. Phe-arom); 7.30-7.37 (5H. m, Cbz-arom); 13C NMR 039.3 (Phe-
CH2); 54.1 (Phe-CH); 67.0 (Cbz-CH2); 113.9 (C-3); 122.1 (C-2); 127.0 (Phe-
aromC4); 127.2 (Cbz-aromC2); 128.1 (Phe-C9); 128.3 (Cbz-aromC4); 128.4 
(Phe-C8); 128.4 (Cbz-aromC3); 135.6 (Cbz-aromC1): 135.9 (Phe-aromC1); 
155.7 (Cbz-OCO); 171.9 (CO); FTIR (nujol) 3342.3, 2920.0. 1760.4, 1693.7, 
1529.7cm- 1; UV (MeOH) 293.6nm; m/e (EI. 70eV) 348 (M, 2.7%); 282 (M-
C4H4Nl. 30.0%); 131 (282-CSHgNI02+. 8.8%); 91 (B, PhCH2, 100%);' HRMS 
(M) Found 348.14738 (Calcd. for C21H20N203 348.14738). 
6.3.1.3 Attempted N-Acylation of P-2-C with N-Cbz-Phe-p-Nitrophenyl Ester 
2.29 using MeLi as the Base 
MeLi (1.05mmol, 9.5mL of O.11M solution in dry ether. 1equiv.) was 
added to p-2-c (100mg. 1.05mmol) dissolved in dry Et20 (10mL). After 5 min 
stirring. N-Cbz-Phe-p-nitrophenyl ester 2.29 (486mg. 1. 16mmol. 1.1equiv.) 
was added and stirring was continued for 15 min. The desired N-acylated-p-
2-c 2.33 was not detected by IH NMR spectroscopy. 
The identical reaction as above was set up. After addition of the 
activated amino acid. stirring was continued for 1 h. The desired N-acylated-
p-2-c 2.33 was not detected by 1 H NMR spectroscopy. 
The identical reaction as above was set up again. After addition of the 
activated amino acid stirring was continued for 24 h. The desired N-acylated-
p-2-c 2.33 was not detected by 1 H NMR spectroscopy. 
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6.3.2 n-BuLi Promoted Acylation of P-2-C to give 2.31. described in Section 
2.3.2 
Identical reaction conditions using n-BuLl (l.6M in hexane) rather 
than MeLl. using hydrocinnamoyl chloride as the acylating agent gave 2.31 
148mg (62%) 
6.4 Acylation Work Described in Section 2.4 and Section 3.2.5 
6.4.1 Acylation of pyrrole-2-Carboxaldehyde to give 2.31, 2.33, 2.37. 2.42, 
2.43, 2.45, 2.54, 3.42, 3.44, 3.52. 3.54, 3.56 using the DMAP Methodology 
6.4.1.1 Non-Amino Acid Based Acylating Agents to give 2.31, 2.42, 2.43, 2.45. 
3.52, 3.54 and 3.56, described in Section 2.4.1 
General Procedure: 
P-2-c (lOOmg, 1.05mmol) TEA (1 62J,.lL, 1.16mmol, l.lequiv.) [or 
Hiinigs base (202J,.lL, 1.16mmol. 1.1equiv.) for acid chlorides] and DMAP 
(13mg, O.llmmol, O.lequiv.) were stirring under N2 at rt in CH2Cl2 (lOmL, 
freshley distHed from CaH2). After stirring for 5 min the acid chloride (or 
anhydride) (l.16mmol. 1.Iequiv.) was slowly added. The resultant mixture 
was stirred for a further 24 h. EtOAc (30mL) was added and the organic phase 
was washed with citric acid (lxl0mL. 10% solution in H20), water (2xl0mL), 
dried and evaporated. The resultant oils were chromatographed (EtOAc/Pet. 
Ether=I:2) on silica to afford the N-acylated-p-2-c derivatives. as described 
below. 
6.4.1.1.1 Formyl Pyrroles 2.31, 2.42. 2.43 and 2.45, described in Section 
2.4.1 
I-Propanoyl-2-formylpyrrole 2.42, Acylatlng agent: CH3CH2COCI. gave 
144mg (90%) mp 80-82°C (EtOAc/Pet. Ether, colourless crystals); Rf 0.42; 
IH NMR 0 1.37 (3H, t, J=7.3Hz. CH2CH3); 3.02 (2H. q, J=7.2Hz, CH2CH3); 
6.39 (iH, dd, J=3.7 & 3.2Hz, H-4); 7.26 (lH. dd, J=3.7 & 1. 6Hz, H-3); 7.43 
(IH, dd, J=3.2 & 1.7Hz, H-5); 10.34 (lH, s, CHO); 13C NMR 0 8.6 (CH2CH3); 
29.4 (CH2CH3); 112.8 (C-4); 122.5 (C-3); 125.9 (C-5); 135.7 (C-2); 172.7 
(CO); 182.6 (CHO): IR (nujol) 1725, 1655, 1540, 1450cm-1; IN (CHCI3) 
296.4nm; m/ e (EI, 70eV) 151 (M, 45.0%); 123 (M-CO, 12.4%); 95 (B, 
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C5H5NO+, 100%): HRMS (M) Found 151.0634 (Calcd. for CSHgNI02 
151.0633): Anal. Calcd. for CSHgNI02 C 63.57: H 6.00: N 9.27: Found C 63.63: 
H 5.82: N 9.27. 
I-Phenacyl-2-formylpyrrole8 2.43, Acylating agent: PhCOCI, gave 
209mg (100%) mp 90-91°C (EtOAC/Pet. Ether, deep brown mass): Rf 0.45: 
IH NMR () 6.38 (lH, dd, J=3.5 & 3.1Hz, H-4): 7.22 (lH, dd, J=3.1 & 1. 5Hz, 
H-3): 7.31 (lH, dd, J=3.7 & 1. 6Hz, H-5); 7.65-7.81 (lH, m, Ph); 10.04 (lH, s, 
CHO)· 13C NMR () 112.0, (C-4). 122.8, (C-5). 128.4, (Ph-aromC1). 128.8, (Ph-, 
aromC3), 129.3, (C-3). 130.1, (Ph-aromC2): 133.6, (Ph-aromC4)' 135.3, (C-
2). 171.8, (CO), 181.0, (CHO); IR (neat) 1677, 1770, 1595cm- 1; UV (CHCI3) 
273.5 nm. 
Ethyl 3-(1-Acetylpyrrol-2-yl)-2-cyanoprop-2-enoate 2.45, Acylating 
agent: CH3COCI, gave 117mg (95%) mp 10 I-102°C (EtOAc/Pet. Ether, very 
pale yellow crystals); Rf 0.18: IH NMR () 1.40 (2H, t, J=7.1Hz, CH2CH3): 2.67 
(3H, s, COCH3); 4.38 (2H, q, J=7.1Hz, CH2CH3): 6.50 (lH, dd, J=4.0 & 3.5Hz, 
H-4); 7.43 (lH, dd, J=3.2 & 1. 5Hz, H-5); 7.79 (lH, dd, J=3.8 & 1. 5Hz, H-3): 
9.11 (lH, s, pyr-CH): 13C NMR () 14.2 (CH2CH3): 24.4 (COCH3): 62.4 
(CH2CH3): 99.7 (C(CN)(C02Et)): 114.0 (C-4): 118.6 (CN): 122.9 (C-3): 127.1 
(C-5): 129.0 (C-2): 143.9 (pyr-CH): 155.8 (C02CH2CH3): 163.2 (COCH3): IR 
(nujol) 2215, 1730, 1710, 1590, 1445cm- 1: UV (CHCI3) 356.1, 267.0nm: 
m/e (EI, 50eV) 232 (M, 15.8%); 190 (B, M-COCH2, 100%): 162 (B-CO, 
18.5%): 144 (B-C02CH2CH3, 34.5%): HRMS (M) Found: 232.0853 (Calcd. for 
C12H12N203 232.0848): Anal. Calcd for C12H12N203 C 62.05: H 5.21: N 
12.07: Found: C 62.10: H 5.39: N 11.96. 
1-(3-Phenylpropanoyl)-2-formylpyrrole 2.31, Acylating agent: 
PhCH2CH2COCl9, gave 63mg (95%) mp 89-90°C (CCI4, pale yellow crystals): 
Rf 0.51: IH NMR () 3.16 (2H, t, J=7.2Hz, COCH2): 3.27 (2H, t, J=7.2Hz, 
CH2Ph): 6.33 (lH, t, J=3.1Hz, H-4): 7.21 (lH, dd, J=3.1 & 1.6Hz, H-3): 7.24 
(2H, m, Ph-aromH2): 7.24 (lH, m, Ph-aromH4): 7.31 (2H, m, Ph-aromH3): 
7.32 (lH, dd, J=3.1 & 1.6Hz, H-5): 10.29 (lH, s, CHO): 13C NMR () 30.4 
(CH2Ph): 37.8 (COCH2): 112.8 (C-4): 122.9 (C-3): 125.9 (C-5): 126.7 (Ph-
aromC4): 128.4 (Ph-aromC2): 128.7 (Ph-aromC3): 128.9 (C-2): 139.7 (Ph-
aromC1): 171.2 (CO): 182.4 (CHO): FTIR (KBr) 3114.0, 1729.5, 1654.2, 
1540.2cm- 1: UV (CHCI3) 256.8, 296.8nm: m/e (EI, 50eV) 227 (M, 40.9%): 
167 (B-C12HgNl, 2.8%): HRMS (M) Found: 227.0945 (Calcd. for C14H13NI02 
227.0946): Anal. Calcd. for C14H13NI02 C 73.98: H 5.77: N 6.17: Found C 
73.71: H 5.69: N 6.07. 
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6.4.1.1.2 Formyl Pyrroles 3.52, 3.54 and 3.56, described in Section 3.3.2 
1-(3-Methylbutanoyl)-2-formylpyrrole 3.56, Acylating agent: 
(CH3)2CHCH2COCl (Section 6.1.3) gave 180mg (88%) as an orange oil; Rf 
0.56; IH NMR 0 1.06 (6H, d, J=6:8Hz, CH(CH312); 2.22 (IH, m, CH(CH312); 
2.80 (2H, d, J=6.6Hz, COCH2CH); 6.25 (IH, t, J=3.5Hz, H-4); 7.12 (IH, dd, 
J=3.5 & 1. 5Hz, H-3); 7.25 (IH, dd, J=3.5 & 1.5Hz, H-5); 10.32 (IH, s, CHO); 
13C NMR 022.0 (CH(CH312); 25.3 (CH(CH312); 44.3 (COCH2CH); 112.4 (C-4); 
122.0 (C-3); 126.0 (C-5); 135.4 (C-2); 171.3 (CO); 182.4 (CHO); FTIR (neat) 
2962.4, 2873.9, 1727.2, 1665.2, 1545.4cm- 1; UV (CHC13) 296.8, 258.4nm; 
m/e (EI, 50eV) 179 (M, 34.2%); 96 (B, M-C5H70+, 100%); 69 (B-HCN, 
37.8%); HRMS (M) Found 179.09462 (Calcd. for CIOH13NI02 179.09462). 
1-(UndecanoyJ.) -2-formylpyrrole 3.52, Acylating agent: 
CH3(CH2hoCOCl (Section 6.1.3) gave 520mg (90%) as a brown solid; mp 80-
81°C; Rf 0.46; IH NMR 00.88 (3H, t, J=6.5Hz. CH3); 1.22-1.26 (16H, m, 
CH2(CH2)SCH3); 1.81 (2H, pent, J=6.9Hz, COCH2CH2); 2.93 (2H, t, J=7.5Hz, 
COCH2); 6.35 (IH, t, J=3.7Hz, H-4); 7.22 (IH. dd, J=3.8 & 1. 8Hz, H-3); 7.35 
(IH, dd, J=3.7 & 1.9Hz, H-5); 10.32 (IH, s, CHO); 13C NMR 0 14.1 (CH3); 
22.7, 24.5, 29.0, 29.3 x2, 29.4, 29.6 x2 (CH2(CH2)SCH3); 31.9 (COCH2CH2); 
36.0 (COCH2); 112.7 (C-4); 122.4 (C-3); 125.9 (C-5); 135.7 (C-2); 172.1 (CO); 
182.6 (CHO); FTIR (KBr) 3127, 2918. 1731, 1651, 1539, 1471cm- 1; UV 
(CHCl3) 310.0. 266.0nm; m/e (EI, 70eV) 277 (M, 11.7%); 193 (M-C6H12+, 
2.7%); 183 (M-C5H4NO, 23.6%); 98 (B, 193-C5H5NO+, 100%); 71 (B-HCN, 
24.3%); HRMS (M) Found 277.20417 (Calcd. for C17H27NI02 277.20416). 
1-((5-Methoxycarbonyl)hexanoyl)-2-formylpyrrole 3.54, Acylating 
agent: CH30CO(CH2)4COC~ (Section 6.1.3) gave 220mg (89%) as a black solid; 
Rf 0.36; IH NMR 01.55 (2H, m, CH2CH2C02CH3); 1.78 (2H, m, COCH2CH2); 
2.40 (2H. t, J=7.0Hz. CH2C02CH3); 2.98 (2H, t, J=7.5Hz, COCH2); 3.69 (3H, 
s, C02CH3); 6.36 (IH, t, J=3.5Hz, H-4); 7.23 (IH, dd, J=3.5 & 1. 5Hz, H-3); 
7.36 (IH, dd, J=3.5 & 1. 5Hz, H-5); 10.30 (IH, s, CHO); 13C NMR 023.8 
(COCH2CH2); 24.2 (CH2CH2C02CH3); 33.6 (CH2C02CH3); 35.6 (COCH2): 51.6 
(C02CH3); 112.8 (C-4); 122.8 (C-3); 126.0 (C-5); 135.6 (C-2); 171.6 (pyr-CO): 
173.6 ,(C02CH3); 182.4 (CHO): FTIR (nujol) 2873.1, 1737.6, 1712.5, 1537.1, 
1463.1cm- 1; UV (CHC13) 295.2, 267.2nm; m/ e (EI, 70eV) 237 (M, 45.9%); 
143 (M-C5H4NO, 89.5%): 111 (B. 143-CH30H, 100%); 96 (C5H6NO+, 94.8%); 
83 (B-C2H4, 58.1%); HRMS (M) Found 237.10010 (Calcd. for C12H15NI04 
237.10009). 
6.4.1.2 Amino Acid Acid Chloride Acylating Agents in the Acylation oj P-2-C 
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and DMAP as the Base 
General Procedure: 
P-2-c (30mg, 0.31mmol), Hiinigs base (54IlL, 0.31mmol, 1equiv.) and 
DMAP (3.8mg, 0.03mmol. O.lequiv.) in CH2Cl2 (5mL) were added dropwise, 
under N2, over 5 min, to an ice cooled solution of amino acid acid chloride 
(0.31mmol) in CH2Cl2 (5mL). After 10 min, the resulting solution was poured 
onto citric acid (10mL, 10% solution in H20) and CH2C12 (lOmL) was added. 
The organic phase was washed with citric acid (10mL, 10% solution in H20), 
H20 (2x5mL), dried and evaporated (H20 pump). The N-acylated amino acid 
pyrrole derivatives described below were unstable to preparative silica 
chromatography. 
6.4.1.2.1 Formyl Pyrroles 2.37 and 2.54, described in Section 2.4.2.1 
1-(N-Phthalyl-L-phenylalanyl)-2-formylpyrrole 2.37, Acylating agent: 
N-Pth-L-Phe-CI, IH NMR spectral data in Section 6.1.2, gave 109mg (95%) as 
an unstable brown solid; Rf 0.44: [c::x]D26 -2100 (eI. MeOH); IH NMR 03.53 
(2H, m. A & B part ABX. Phe-CH); 5.77 (lH, X part ABX, J=9.2 & 6.4Hz. Phe-
CH2); 6.19 (lH, t. J=3.4Hz, H-4); 7.07 UH, dd, J=3A & 2.2Hz. H-3); 7.08-
7.11 (5H, m, Phe-arom); 7.18 (lH, dd, J=3A & 2.3Hz, H-5); 7.63 (2H, dd, 
J=5.5 & 2.6Hz, Pth-aromH3); 7.69 (2H, dd, J=5.5 & 2.6Hz, Pth-aromH4); 
10.10 (lH, s, CHO): 13C NMR 034.9 (Phe-CH2): 54.2 (Phe-CH); 113.3 (C-4); 
122.9 (C-3); 123.8 (Pth-aromC3); 125.7 (C-5); 127.2 (Phe-aromC4); 128.7 
(Phe-aromC2); 129.1 (Phe-aromC3): 131.0 (Pth-aromC3a): 134.5 (Pth-
aromC4); 135.3 (Phe-aromC1); 135.6 (C-2); 166.9 (Pth-CO); 167.7 (pyr-CO); 
181.6 (CHO); FTIR (neat) 3166.9,1780.9,1716.1, 1660Acm-1; UV (CHCI3) 
340.8, 279.2nm; m/e (EI, 70eV) 372 (M, 8%); 250 (M-C6H4N02, 72%): 225 
(M-C8H5N02+, 25%); 129 (225-C5H6NO+, 16%); 95 (B, C5H5NO+, 100%); 
HRMS (M) Found 372.11100 (Calcd. for C22H16N204 372.11099). 
1-(N-Phthalyl-D-phenylalanyl)-2-formylpyrrole 2.54, Acylating agent: 
N-Pth-D-Phe-CI (Section 6.1.2) gave 102mg (88%); [c::x]D26 +1960 (e1, MeOH). 
Spectral data identical to the L-isomer above. 
6.4.1.2.2 Formyl Pyrroles 3.42 and 3.44, described in Section 3.3.1 
1-(N-Phthalyl-L-leucyl)-2-formylpyrrole 3.44, Acylating agent: N-Pth-
L-Leu-CI gave 335mg (94%) as an orange oil; Rf 0040; [c::x]D 26 -1170 (el, 
MeOH); IH NMR 00.98 (3H, d, J=6.5Hz, (Leu-CH31Al: 1.04 (3H, d, J=6.5Hz, 
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(Leu-CH3)B); 1.50 (lH. m. Leu-CH2); 2.00 (lH. m. Leu-CH2); 2.42 (lH. m. 
CH(CH312); 5.67 (lH. X part ABX. J=10.5 & 4.5Hz. Leu-CH); 6.31 (lH. t. 
J=3.5Hz. H-4); 7.16 (1H. dd, J=3.5 & 1.5Hz, H-3); 7.29 (lH. dd, J=3.4 & 
1.6Hz. H-5); 7.77 (2H. dd. J=5.5 & 3.0Hz. Pth-H14): 7.85 (2H, dd, J=5.8 & 
3.1Hz, Pth-H15): 10.14 (lH, s, CHO); 13C NMR 021.4 (CH3)B); 23.0 (CH3).A); 
24.9 (CH(CH312); 37.5 (Leu-CH2); 51.5 (Leu-CH); 113.2 (C-4); 122.6 (C-3); 
123.8 (Pth-C14); 125.5 (C-5); 131.5 (pth-C13); 134.6 (Pth-C15); 135.3 (C-2); 
167.3 (Pth-CO); 168.7 (CO); 181.6 (CHO); FTIR (neat)' 2959.4, 1775.1. 
1737.8. 1721.2. 1667.7cm-1; UV (MeOH) 289.6. 239.2nm; m/e (EI, 70eV) 
338 (M, 33.0%); 244 (M-C5H5N 10 It 72.2%): 216 (244-CO. 96.7%); 174 
(216-C3H6+. 77.3%); 160 (B. 216-C4HS+, 100%); 148 (M-(CO)2NH2+, 50.3%); 
HRMS (M) Found 338.12665 (Calcd. for C19HlSN204 338.12664). 
1-(N-Phthalyl-glycyl)-2-formylpyrrole 3.42, gave 74mg (25%) as an 
unstable black solid; IH NMR 0 5.00 (2H. s. Gly-CH2); 6.38 (lH. t. J=3.5Hz. 
H-4); 7.23 (lH. m. H-3); 7.28 (1H, dd, J=2.0 & 3.6Hz, H-5); 7.69 (2H, dd, 
J=5.3 & 3.0Hz, Pth-aromH4); 7.80 (2H, dd, J=5.4 &3.0Hz, pth-aromH3); 
10.16 (lH, s. CHO). 
6.4.1.3 p-Nitrophenyl Ester Activated Amino Acid as the Acylating Agent oj p. 
2-C with DMAP as the Base to produce 2.33, described in Section 2.4.7.1 
P-2-c (10mg, 0.12mmol), TEA (18J.LL, 0.13mmol, 1.2equiv.) and DMAP 
(1.3mg, 0.01mmol, O.leqiuv.) were stirred in CH2Cl2 (10mL) at rt under N2. 
N-Cbz-Phe-p-nitrophenyl ester 2.29 (49 mg. 0.12mmol, 1.1equiv.) was slowly 
added portionwise. Over 24 h a yellow colour intensified in the flask, that was 
attributed to the release of p-nitrophenol. Dilution with EtOAc (5mLJ. 
followed by citric acid (5mL. 10% solution in H20), and water (5mL units) 
until the yellow colour of the p-nitrophenol had been removed from the 
aqueous phase, followed by drying and evaporation. The aldehyde was unstable 
to preparative chromatography. 
1-(N-Benzyloxycarbonyl-L-phenylalanyl)-2-formylpyrrole 2.33. gave 
5mg (13%) as an unstable brown oil: Rf 0.49; 1 H NMR 0 3.13 (2H, m, Phe-
CH2); 4.72 (lH, m, Phe-CH); 5.12 (lH, s, Cbz-CH2); 5.20 (lH. d, J=6.8Hz, 
NH); 6 .. 34(lH, t. J=3.5Hz, H-4); 7.04 (1H. m, H-3); 7.21 (lH, dd. J=3.4 & 
1. 7Hz, H-5); 7.27-7.52 (10H, m. aromatics); 10.38 (lH, s, CHO); 13C NMR 0 
33.1 (Phe-CH2); 54.2 (Phe-CH): 67.3 (Cbz-CH2); 112.4 (C-4): 121.6 (C-3); 
127.1 (C-5); 128.3 (Cbz-aromC2); 128.5 (Phe-aromC4); 128.5 (Cbz-aromC4); 
128.6 (Cbz-aromC3): 128.8 (Phe-aromC2); 129.2 (Phe-aromC3); 132.1 (Cbz-
aromCl); 135.3 (Cbz-aromC1); 135.5 (C-2); 155.8 (Cbz-CO); 172.0 (CO); 182.1 
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(CHO): HRES (M) Found 376.1424 (Calcd. for C22H20N204 376.1423). 
6.4.1.3.1 Further Attempts at Formation of 2.33. described in Section 2.4.7.1 
Modifica tions: 
1) Reagents and conditions as described above. except that activated 
4A molecular sieves (100mg) were added. After 24 h IH NMR spectral 
analysis indicated 11% desired N-acyl-p-2-c. the remaining 89% was p-2-c. 
2) Reagents and conditions as described above, except that IDA-1 
(3.6J.1L. O.Olmmol. O.lequiv.) was added. Stirring for 20 h showed no desired 
N-acyl-p-2-c by IH NMR spectroscopy. there was only p-2-c. 
3) 1equiv. of DMAP was added rather than O.lequiv. Stirring for 24 h 
gave 13% N-acylated product by IH NMR spectroscopy. the remaining 87% 
was p-2-c. 
4) The solution of p-2-c (lequiv.). TEA (1.2equiv.). DMAP (O.lequiv.) 
and activated amino acid (1.1equiv.) was heated at reflux for 1 h. 5 h or 24 h. 
IH NMR spectral analysis at each interval showed 5%. 4% and 0% of 2.33 
respectively. The remainder was p-2-c. At 24 h a noticable black precipitate 
had formed. 
5) The amount of the activated amino acid was increased from 
1.1equiv. to 2.2equiv. (98mg. 0.22mmol). Stirring for 24 h produced 8% of 
2.33 by 1 H NMR spectral analysis. the remaining pyrrole was starting 
material. 
6) The glassware used in the reaction was soaked in a KOH/EtOH 
solution for 24 h and then rigorously rinsed with distiled H20 and dried, 
prior to use. The N-acylated p-2-c 2.33 was not evident by IH NMR 
spectroscopy after 24 h reaction. 
7) The glassware used in the reaction was soaked in concentrated 
H2S04 for 24 h and then rigorously rinsed with dis tiled H20 and dried. prior 
to use. The N-acylated p-2-c 2.33 was not evident by 1 H NMR spectroscopy 
after 24 h reaction. 
8) Freshly distiled TEA and CH2C12 were extensively deoxygenated 
with dry N2. P-2-c. DMAP and amino acid were dried under high vacuum. 
Glassware was flame dried under vacuum and cooled under N2. The reaction 
was performed in a freshly regenerated "dry box". The N-acylated p-2-c 2.33 
was not evident by 1 H NMR spectroscopy after 24 h reaction. 
9) H20 (2.0J.1L. O.llmmol. 1equiv.) was added to the reaction. The N-
acylated p-2-c 2.33 was not evident by IH NMR spectroscopy after 24 h 
reaction. 
10) P-2-c. DMAP and TEA were added to a stirred solution of the 
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activated amino acid. The N-acylated p-2-c 2.33 was not evident by IH NMR 
spectroscopy after 24 h reaction. 
11) P-2-c and Cbz-Phe-OH (2equiv.) were dissolved in dry EtOAc 
(5mL). DCC (Iequiv.) was slowly added. The N-acylated p-2-c 2.33 was not 
evident by 1 H NMR spectroscopy after 24 h reaction. 
12) Number 11) above was repeated with the addition of HOBt (15mg. 
O.llmmol. 1 equiv.) before the DCC. The addition of DCC caused a white 
precipitate to form, indicating that the DCU had formed and therefore the 
activation of the amino acid. The N-acylated p-2-c 2.33 was not evident by IH 
NMR spectroscopy after 24 h reaction. 
IS) TEA was omitted from the reaction conditions. The N-acylated p-
2-c 2.33 was not evident by IH NMR spectroscopy after 24 h or after 2 
months reaction. 
14) Penta-fluoro phenyl ester activated PhelO was added to p-2-c. 
DMAP and TE2. The N-acylated p-2-c 2.33 was not evident by IH NMR 
spectroscopy after 24 h reaction. 
6.4.2 Reduction of N-Acylated Formyl Pyrroles 2.24. 2.31, 2.37, 2.54. 3.42, 
3.44, 3.52, 3.54 and 3.56 to give Hydroxymethyl Pyrroles 2.47,2.32,2.52, 
2.55, 3.43, 3.45, 3.53. 3.55 and 3.57 
6.4.2.1 Sodium Borohydride Reductionll oj2.24 to give 2.47, described in 
Section 2.4.4.1 
NaBH4 (8.7mg, 0.2Smmol, 1.5equiv.) was added portionwise to N-
acetyl-p-2-c 2.24 (20mg, 0.15mmol) in CH2CI2/MeOH (2mL: ImL) at O°C 
under N2. Mter 10 min the reaction was diluted with CH2Cl2 (5mL). the 
organic solvents were washed with oxalic acid (5mL. 5% solution in H20). 
water (2xl0mL), then dried and evaporated to dryness. Chromatography 
yielded the hydroxymethyl pyrrole 2.47 (84%) with spectral data consistent 
with the literature3 . 
A Similar reaction with N-(N-pth-Phe)-p-2-c 2.37 did not produce the 
desired hydroxymethyl pyrrole 2.52. 
6.4.2.2 Zinc Borohydride Reduction oj 2.31, 2.37, 2.54 to give 2.32, 2.52, 
2.55, 3.43, 3.45, 3.53, 3.55 and 3.57, deSCribed in Section 2.4.5 
General Procedure: 
The N-amino acid acylated pyrrole (0.28mmol) was dissolved in dry 
Et20 under N2. Zn(BH4)2 (0.S4mmol, S.lmL of O.IIM solution in dry Et20, 
1.2equiv.) was added and the resultant solution was stirred at rt for SO min. 
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The Et20 solution was decanted from the organic insoluble zinc salts. Further 
E t2 0 (2xSmL) was added, decanted and combined with the previous 
washings. H20 (2mL) and acetic acid (2mL. 10% solution in water) were 
carefully added to the Et20 extracts. The separated aqueous phase was re-
extracted with CH2Cl2 (2xSmL) and the combined organic solvents were 
washed with H20 (2x10mL). The organic phase was dried and 
evaporated.Zn(BH412 (0.34mmol. 3.1mL of O.llM solution in dry Et20, 
102equiv.) was added and the resultant solution was stirred at rt for 30 min. 
The Et20 solution was decanted from the organic insoluble zinc salts. Further 
Et20 (2xSmL) was added, decanted and combined with the previous 
washings. H20 (2mL) and acetic acid (2mL, 10% solution in water) were 
carefully added to the Et20 extracts. The separated aqueous phase was re-
extracted with CH2 Cl2 (2xSmL) and the combined organic solvents were 
washed with H20 (2x10mL). The organic phase was dried and evaporated. 
The resultant hydroxymethyl pyrroles were purified by sillca chromatography 
(EtOAc/Pet. Ether=1:2). 
6.4.2.2.1 Hydroxymethyl Pyrroles 2.S2. 2.52 and 2.55. described in Section 
2.4.S 
1-(S-Phenylpropanoyl)-2-hydroxymethylpyrrole 2.S2, gave 92mg 
(90%) as a mauve amorphous mass; Rf 0.33; IH NMR 03.08 (2H. dt. J=7.8 & 
1.SHz, CH2Ph); 3.17 (2H, dt, J=7.8 & 1.SHz. COCH2); 3.71 (lH. bs, CH20H); 
4.62 (2H. bs, CH20H); 6.17 (lH, t. J=3.3Hz. H-4); 6.21 (lH. m. H-3); 7.06 
(lH, dd, J=3.3 & 106Hz. H-S); 7.22 (lH, m, Ph-aromH3); 7.28 (2H, m, Ph-
aromH2); 7.30 (lH, m, Ph-aromH4); D20 exchange: bs at 3.71ppm is 
removed and bs at 4.62ppm collapses to sharp s; IH NMR 0 (d3-CD3CN) 3.10 
(2H, t, J=7.SHz, CH2Ph); 3.31 (2H, t, J=7.SHz, COCH2); 3.48 (lH, t, J=7.0Hz. 
CH20H); 4.6S (2H, d, J=7.0Hz, CH20H); 6.24 (lH, t, J=3.SHz, H-4); 6.29 (lH. 
m, H-31; 7.28 (lH. dd, J=3.S & 1. 6Hz, H-S); 7.30-7.38 (SH, m, Ph); 13C NMR 
(CDCI3) 0 30.3 (CH2Ph); 37.4 (COCH2); S7.9 (CH20H); 112.2 (C-4); 114.S (C-
3); 120.7 (C-S); 126.S (Ph-aromC4); 128.3 (Ph-aromC2); 128.6 (Ph-aromH3); 
13S.S (C-2); 139.9 (Ph-aromC1); 172.2 (CO); FTIR (neat) 3S19.9. 1703.2, 
160S.6. 149S.2. 1409.4cm- 1; UV (CHCI3) S48.0, 480.8nm; m/e (EI. SOeV) 
229 (1\1. 13.7%); 198 (M-CH2=OH+, 11.4%), lOS (M-C6H6NI02, 33.2%), 97 
(B, M-10S-HCN, 100%); HRMS (M) Found 229.1103 (Calcd. for C14H15NI02 
229.1103). 
1-(N-Phthalyl-L-phenylalanyl)-2-hydroxymethylpyrrole 2.52, gave 
26mg (62%) as a mauve solid; Rf 0.31; [0.]D26 -19So (e1, MeOH); IH NMR 0 
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3.52 (2H, d, J=7.8Hz, Phe-CH2); 4.59 (2H, bs, CH20H); 5.59 (lH, t. J=7.8Hz. 
Phe-CH); 6.e5 (lH, t, J=3.4Hz, H-4); 6.14 (lH, dd, J=3.4 & 1. 4Hz, H-3); 6.93 
(lH, dd, J=3.4 & 1. 5Hz, H-5); 7.09-7.19 (5H. m, Phe-arom); 7.63 (2H, dd, 
J=5.6 & 3.0Hz, Pth-aromH4); 7.70 (2H, dd, J=5.6 & 3.0Hz, Pth-aromH3); 13C 
NMR 035.0 (Phe-CH2); 53.9 (phe-CH): 57.6 (CH20H): 113.1 (C-4); 114.9 (C-
3); 120.2 (C-5); 123.8 (Pth-aromC3); 127.2 (Phe-aromC4); 128.7 (Phe-
aromC2): 129.2 (Phe-aromC3): 131.1 (Pth-aromC3a): 134.3 (Phe-aromC1): 
134.5 (Pth-aromC4); 135.9 (C-2); 167.0 (Pth-CO); 168.4 (CO); FTIR (neat) 
3477.8, 1772.1, 1713.9, 1613.6, 1494.2, 1454.5cm- 1; UV (MeOH) 486.4, 
301.2nm; mle (EI, 50eV) 374 (M, 14.0%); 278 (M-C4H6NIOl, 10.9%); 250 
(B, 278-C=O, 100%); HRMS (M) Found 374.12665 (Calcd. for C22H lSN204 
374.12665). 
1-(N-Phthalyl-D-phenylalanyl)-2-hydroxymethylpyrrole 2.55. gave 
26mg (62%) as a mauve solid; Rf 0.31; [a]D26 +1800 (eI. MeOH); Spectral 
data identical to the L-isomer, 2.52, above. 
6.4.2.2.2 Hydroxymethyl Pyrroles 3.43 and 3.45, described in Section 3.3.1 
1-(N-Phthalyl-glycyl)-2-hydroxymethylpyrrole 3.43, gave 16mg (22%) 
as an unstable black solid; IH NMR 0 4.63 (2H, s, CH20H); 5.03 (2H, s, Gly-
CH2); 6.31 (lH, m, H-3); 6.33 (lH, t, J=3.2Hz, H-4); 7.20 (lH, dd, J=3.3 & 
1.6Hz, H-5); 7.80 (2H, dd, J=5.6 & 3.3Hz, Pth-aromH3); 7.94 (2H, dd, J=5.6 
& 3.2Hz, Pth-aromH4); 13C NMR 0 29.7 (Gly-CH2); 58.4 (CH20H); 113.8 (C-
4); 115.1 (C-3); 119.7 (C-5); 123.9 (Pth-aromC3): 131.9 (Pth-aromC3a); 
134.5 (Pth-aromC4); 136.2 (C-2); 167.5 (Pth-CO); 170.0 (CO). 
1-(N-Phthalyl-L-leucyl)-2-hydroxymethylpyrrole 3.45, gave 299mg 
(87%) as a deep yellow oil: Rr 0.48; [a]D 26 -1140 (el, MeOH); IH NMR 0 0.98 
(3H. d, J=6.5Hz, CH(CH3)A); 1.05 (3H, d, J=6.5Hz, CH(CH3)B); 2.00 (2H, m, 
Leu-CH2); 2.46 (lH, m, CH(CH312); 4.63 (2H, s, CH20H); 5.54 (lH, dd, J=10.5 
& 4.5Hz, Leu-CH); 6.17 (lH, t. J=3.5Hz, H-4); 6.22 (lH, m, H-3); 7.06 (lH. 
dd, J=3.4 & 1.5Hz, H-5); 7.76 (2H, dd, J=5.5 & 3.4Hz, Pth-aromH3); 7.86 
(2H, dd, J=5.6 & 3.4Hz, Pth-aromH4): 13C NMR 021.4 (CH(CH3)B): 23.0 
(CH(Cij3)Al; 25.0 (CH(CH312); 37.7 (Leu-CH2); 51.3 (Leu-CH); 57.6 (CH20H); 
113.0 (C-4); 114.9 (C-3); 120.1 (C-5); 123.8 (Pth-aromC3); 131.3 (Pth-
aromC3a); 134.5 (Pth-aromC4); 136.1 (C-2); 167.5 (Pth-CO); 169.4 (CO); 
FTIR (neat) 3477.2. 1775.1, 1716.5cm- 1; UV (MeOH) 279.6, 242.8nm; mle 
(EI. 70eV) 340 (M, 30.8%); 244 (M-C5H6NO+, 16.7%); 216 (244-CO, 89.9%): 
174 (216-C3H6+, 50.6%); 160 (B, Ph-(C012-NH-CH2+, 100%): HRMS (M) 
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Found 340.14230 (Ca1cd. for Cl9H20N204 340.14229). 
6.4.2.2.3 Hydroxymethyl Pyrroles 3.53, 3.55 and 3.57, described in Section 
3.3.2 
1-(Undecanoyl)-2-hydroxymethylpyrrole 3.53, gave 60mg (58%) as a 
deep brown oil; Rf 0.55; IH NMR 0 0.88 (3H, t, J=6.5Hz, CH3); 1.03, 1.08, 
1.16 (16H, m, (CH2)SCH3); 1.78 (2H, sept, J=7.5Hz, COCH2CH2); 2.86 (2H, t, 
J=7.5Hz, COCH2); 3.75 (lH, vbs, CH20H); 4.62 (2H, bs, CH20H); 6.19 (IH, t, 
J=3.0Hz, H-4); 6.22 (IH, m, H-3); 7.12 (IH, dd, J=3.0 & 1.0Hz, H-5); 13C 
NMR 0 14.0 (CH3); 22.6, 29.0, 29.2, 29.3, 29.4, 29.5 x2, 31.8 ((CH2)SCH3); 
24.5 (COCH2CH2); 35.6 (COCH2); 57.9 (CH20H); 111.9 (C-4); 114.4 (C-3); 
120.9 (C-5); 135.5 (C-2); 173.3 (CO); FTIR (nujol) 3340.4, 2852.2, 1716.0, 
1497.7cm- l ; UV (CHC13) 268.0, 258.4nm; m/e (EI, 70eV) 279 (M, 25.4%); 
248 (M-CH20H, 1.8%); 183 (M-C5H6NIOlo 1.9%); 97 (B, M-CI2H2201+, 
100%); 80 (B-OH, 74.2%); HRMS (M) Found 279.21982 (Calcd. for 
CI7H29NI02279.21981). 
1-((5-Methoxycarbonyl)hexanoyl)-2-hydroxymethylpyrrole 3.55, gave 
25mg (45%) as a brown oil; Rf 0.36; I H NMR 0 1.77 (2H, m, 
CH2CH2C02CH3); 1.81 (2H, m, COCH2CH2); 2.40 (2H, t, J=7.0Hz, 
CH2C02CH3); 2.91 (2H, t, J=7.3Hz, COCH2); 3.68 (3H, s, C02CH3); 4.63 (2H, 
s, CH20H): 6.21 (IH, t, J=3.5Hz, H-4); 6.23 (IH, m, H-3); 7.11 (IH, dd, 
J=3.5 & 2.0Hz, H-5); irradiation at 4.63ppm collapses m at 6.23ppm to dd 
(J=3.4 & 2.0Hz); 13C NMR 0 23.8 (CH2CH2C02CH3); 24.3 (COCH2CH2); 33.6 
(CH2C02CH3); 35.2 (COCH2); 51.6 (C02CH3); 57.9 (CH20H); 112.2 (C-4); 
114.6 (C-3); 120.8 (C-5); 135.5 (C-2); 172.7 (CO); 173.6 (C02CH3); FTIR 
(nujol) 3319.1, 2854.9, 1737.0, 1712.9, 1461.2cm- l ; UV (CHCI3) 273.6, 
259.2nm; m/e (EI, 70eV) 239 (M, 11.8%); 153 (M-C4H602+, 2.1%); 143 (M-
C5H6NIOlo 5.8%); 97 (B, M-C7HI603+, 1000Al); 80 (B-OH, 54.1%); HRMS (M) 
Found 239.11575 (Calcd. for Cl2H 17N 1 04 239.11575). 
1-(3-Methylbutanoyl)-2-hydroxymethylpyrrole 3.57, gave 150mg 
(90%) as a deep mauve oil; Rf 0.42: IH NMR 0 1.05 (6H, d, J=7.0Hz. 
CH(CH3)2); 2.30 (IH, sept, J=7.0Hz, CH); 2.74 (2H, d, J=7.0Hz, CH2); 4.63 
(2H, bs, CH20H); 6.19 (IH, t, J=3.5Hz, H-4); 6.22 (IH, m, H-3); 7.11 (lH, 
dd, J=3.5 & 2.0Hz, H-5); irradiation at 4.63ppm collapses m at 6.22ppm to 
dd (J=3.5 & 2.0Hz); 13C NMR 0 22.5 (CH(CH312); 25.5 (CH); 44.4 (CH2); 57.9 
(CH20H); 111.9 (C-4); 114.5 (C-3); 121.0 (C-5); 135.4 (C-2); 172.7 (CO); 
FTIR (neat) 3430.1, 2960.3, 1702.8, 1619.9cm- l ; UV (CHC13) 283.6nm; m/e 
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(EI, 70eV) 181 (M, 27.5%); 97 (B, M-CSHSO+, 100%); 80 (B-OH, 70.8%); 
HRMS (M) Found 181.11027 (Calcd. for ClOHISNI02 181.11027). 
6.4.3 Determination of Enantiomerlc Excess of the Hydroxymethyl Pyrrole 
2.52 and 2.55 via the Camphanates 2.53 and 2.56. described in Section 2.4.6 
6.4.3.1 Mitsunobu Esterification of 2.52 and 2.55 to give the Camphanates 
2.53 and 2.56 
The hydroxymethyl pyrrole under investigation 2.52 and 2.55 were 
esterified under the Mitsunobu conditions lO• 
General Procedure: 
A solution of hydroxymethyl pyrrole (lOmg, 0.03mmol), 
triphenylphosphine (15mg, 0.056mmol, 2.1equiv.) and (-)-camphanic acid 
(12mg, 0.059mmol, 2.2equiv.) in dry THF (ImL) was stirred for 5 min. 
Diethylazodicarboxylate (DEAD, 9t.tL, 0.056mmol, 2.1 equiv.) was added and 
the reaction was stirred for a further 3 h at rt under N2. The solvent was 
evaporated (H20 pump, followed by oil pump). The resultant crude product 
was then dissolved in CH2C12 (0.5mL) and passed through silica gel column 
(2cm, EtOAc/Pet. ether=1:2 elutent), to remove all non-pyrrole material. The 
product camphanate was then purified by radial chromatography (EtOAc/Pet. 
Ether=1:2) as below. 
(IS)-( -)-I-(N-Phthaloyl-L-phenyla1anoyl)pyrrol-2-ylmethyl Camphanate 
2.53, gave 13mg (90%) as a mauve oil; Rf 0.32 and Rf 0.88 on Diol F2S4S; 
[a]D26 .900 (c1, MeOH); IH NMR 00.89 (3H, s, camph-CH3); 0.99 (3H, s, 
camph-CH3); 1.03 (3H, s, camph-CH3l; 1.65 (IH, m, camph-CH2); 1.95 (2H, 
m, camph-CH2): 2.40 (lH, m, camph-CH2); 3.50 (2H, m, Phe-CH2); 5.35 (lH, 
dd, J=13.2 & 0.8, CH20-camph); 5.49 (lH, dd, J=13.2 & 0.9Hz, CH20-
camph); 5.57 (IH, dd, J=9.3 & 6.2Hz, Phe-CH); 6.09 (lH, t, J=3.4Hz, H-4); 
6.28 (lH, ddd, J=3.5 & 0.9 & 0.8Hz, H-3): 7.07 (lH, dd, J=3.5 & 2.0Hz, H-
5); 7.09-7.12 (5H, m, Phe-arom); 7.68 (2H, dd, J=5.5 & 3.0Hz, Pth-aromH4); 
7.75 (2H, dd, J=5.6 & 3.0Hz, Pth-aromH3); FTIR (neat) 2970.9, 1783.4, 
1732.4, 1716.2, 1698.9cm- l ; UV (CHCI3) 284.4nm; HRMS (FAB, M+K+) 
Found ,593.16899 (Calcd. for C32H30N207K 593.16899). 
(IS)-( -)-1-(N-Phthalyl-D-phenylalanyl)pyrrol-2-ylmethyl Camphanate 
2.56, gave 12mg (84%) as a mauve oil; Rf 0.32 and Rf 0.74 on Diol F2S4S; 
[a]D26 +1140 (el, MeOH); IH NMR 00.92 (3H, s, camph-CH3): 0.96 (3H, s, 
camph-CH3); 1.03 (3H, s, camph-CH3); 1.65 (lH, m, camph-CH2); 1.90 (2H, 
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m. camph-CH2): 2.40 (lH. m. camph-CH2): 3.50 (2H. m. Phe-CH2); 5.34 (IH. 
ddt J=13.2 & 0.9. CH20-camph): 5.50 (lH. ddt J=13.2 & 1.0Hz. CH20-
camph); 5.57 (IH, dd, J=9.3 & 6.2Hz, Phe-CH); 6.09 (IH, t, J=3.4Hz, H-4); 
6.27 (IH, ddd, J=3.4 & 1.1 & 1.0Hz, H-3); 7.02 (lH. ddt J=3.3 & 1. 6Hz. H-
5): 7.09-7.12 (5H. m, Phe-arom); 7.68 (2H. ddt J=5.5 & 3.0Hz. Pth-aromH4): 
7.75 (2H. ddt J=5.6 & 3.0Hz. Pth-aromH3): HRMS (FAB. M+K+) Found 
593.16899 (Caled. for C32H30N207K 593.16899). 
6.5 Work Discussed in Section 2.5 
6.5.1 Attempted Acylation of P-2-Acetal 2.67 
P-2-acetal 2.67. was prepared via the Loader method12• 
Acetyl chloride (7.8!!L. O.llmmol. lequiv.) was added to p-2-acetal 
(20mg. O.llmmol). DMAP (1.2mg, O.Olmmol. O.lequiv.) and HOnigs base 
(l9.2J..lL. O.llmmol. lequiv.) in CH2Cl2 (5mL). After 24 h a non-acidic work up 
was used. The reaction was diluted with EtOAc (lOmL). the organic layer was 
washed with NaHC03 (3x5mL. 5% solution in H20). dried and evaporated. 1 H 
NMR spectral analysis of the resulting crude product showed negligable 
decomposition of the p-2-acetal 2.67 to p-2-c. There was no desired N-
acylated pyrrole 2.68 detected. 
6.6 Work Discussed in Section 2.6 
6.6.1 Attempted Formylation of the N-Acylated Pyrroles 2.28 and 2.30 
Vilsmeier-Haack formylation conditions13 were employed to attempt 
the formylation of N-acylated pyrroles 2.28 and 2.30. 
General Procedure: 
The Vilsmeier-Haack reagent (POCI3/DMF, 1.1equiv.) was prepared. 
Either N-(N-Cbz-Phe)-pyrrole 2.30 (30mg, O.09mmol) or N-cinnamoyl-
pyrrole 2.28 (50mg, 0.22mmol) was added portionwise to the formylating 
reagent. After I h the solution was heated at reflux for 15 min. NaOAc.3H20 
(5mL. 20% solution in H20) was added and the mixture was heated at reflux 
for a further 15 min. 
The N-acylated p-2-c 2.33 or 2.31, respectively. were not evident by 
1 H NMR spectroscopy. 
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6.7 Work Discussed in Section 3.2 
6.7.1 Amino Acid Extension in the Peptide "Sense" Direction - Imine 3.12 
and 3.15, and Amine 3.27 
6.7.1.1 Fonnation of the [mines 3.12 and 3.15, described in Section 3.2.1 
P-2-c (lOOmg. 1.05mmol). TEA (146IlL. 1.05mmol, lequiv.) and 
HCl.NH2-Ala-OEt 3.11 (161mg, 1.05mmol, lequiv.) were dissolved in dry 
pentane (15mL) and the solution was heated at reflux in a modified Dean-
Stark apparatus for 18 h. The solvent was evaporated, purification of the 
crude product by silica chromatography resulted in decomposition to 
polymer. The crude product was sufficiently clean to obtain the following data. 
N-(2-Pyrrolylmethylene)-L-alanine Ethyl Ester 3.12, gave 184mg 
(90%) as a deep mauve oil; IH NMR 01.28 (3H, 1. J=7.0Hz, C02CH2CH3); 1.49 
(3H, d, J=7.0Hz, Ala-CH3); 4.07 (IH, q. J=7.0Hz, Ala-CH); 4.20 (2H, q, 
J=7.1Hz, C02CH2CH3); 6.26 (IH, dd, J=6.5 & 3.1Hz, H-4); 6.56 (IH, dd, 
J=6.5 & 3.7Hz, H-3); 6.96 (1H, dd, J=3.7 & 3.1Hz, H-5); 8.05 (IH, s, pyr-
CH=N); 13C NMR 0 14.2 (C02CH2CH3); 19.7 (Ala-CH3); 61.1 (C02CH2CH3); 
66.6 (Ala-CH); 110.2 (C-4); 116.3 (C-3); 123.2 (C-5); 142.7 (C-2); 152.7 (pyr-
CH=N); 172.8 (C02CH2CH3); IR (nujol) 2185, 1655. 1414cm-1; UV (CHCI3) 
237.6nm; m/e (EI, 50eV) 194 (M); 151 (M-COCH3); 137 (M-COCH2CH3); 121 
(B, M-C02CH2CH3); 106 (B-CH3); 94 (B-HCN); HRMS (M) Found: 194.1056 
(Calcd. for ClOH14N202 194.1055). 
P-2-c (100mg, 1.05mmol) and iBuNH2 (104mg, 1.05mmol, 1equiv.) 
were dissolved in dry pentane (l5mL) and the solution was heated at reflux in 
a modified Dean-Stark apparatus for 14 h. The solvent was evaporated, 
purification of the crude product by silica chromatography resulted in 
decomposition to polymer. The crude product was sufficiently clean to obtain 
the following data. 
2-Methyl-N-(pyrrol-2-ylmethylene)propanamine 3.15, gave 158mg 
(100%) as a red/mauve oil; IH NMR 00.92 (6H, d, J=6.7Hz, CH(CH312); 1.91 
(lH, sept, J=6.7Hz, CH(CH312); 3.34 (lH, d, J=6.7Hz, CH2CH(CH3)2); 6.22 
(lH, t, J=2.8Hz, H-4); 6.46 (lH, dd, J=2.8 & 1. 7Hz, H-3); 6.86 (lH, m, H-5); 
8.01 (1H, s, pyr-CH=N); 13C NMR 0 20.6 (CH(CH3)2); 29.8 (CH(CH312); 69.1 
(CH2CH(CH312): 109.6 (C-4); 114.0 (C-3); 121.6 (C-5); 130.3 (C-2); 151.7 
(pyr-CH=N); m/e (EI, 70eV) 150 (M, 45.3%); 107 (B, M-C3H7, 100%); 123 
(M-HCN, 3.1%); 80 (B-HCN, 37.6%): HRMS (M) Found 150.1159 (Calcd. for 
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CgH14N2 150.1157). 
6.7.1.2 Further Attempts at Imine Formation using P-2-C, described in 
Section 3.2.1.1 
H2N-Ala-OEt 3.11 was freshly generated by dissolving HCl.H2N-Ala-
OEt in CH2Cl2 (2mL) followed by TEA (l.lequiv.) and water (2x2mL). The 
organic layer was dried and evaported and used immediately. 
Modiftca tions; 
1) P-2-c (10mg. O.llmmol, lequiv.) and freshley generated H2N-Ala-
OEt (13mg, O.llmmol, lequiv.) were stirred in benzene (5mL). The desired 
imine 3.12 was not evident by IH NMR spectroscopy after 24 h reaction. 
2) P-2-c (lOmg, O.llmmol, lequiv.), freshley generated H2N-Ala-OEt 
(13mg, O.llmmol, lequiv.) and activated 4A molecular sieves (500mg) were 
heated at reflux for 3 h in benzene (5mL). then left to stir at rt for 18 h. The 
deSired imine 3.12 was not evident by 1 H NMR spectroscopy after 24 h 
reaction. 
3) P-2-c (10mg. O.llmmol, lequiv.). freshley generated H2N-Ala-OEt 
(13mg, O.llmmol, lequiv.) and MgS04 (100mg) were stirred for 3 h in 
CH2Cl2 (5mL). The desired imine 3.12 was not evident by IH NMR 
spectroscopy after 24 h reaction. 
4) A solution of p-2-c (10mg, O.llmmol, lequiv.) and H2N-Ala-OEt 
(9.9mg, O.Ilmmol, lequiv.) in MeOH (2.5mL) and EtOH (5mL) were stirred 
for 5 d. The solution was evaporated to dryness and Et20 was added. 
Unreacted amino acid was removed by filtration. The desired imine 3.12 was 
evident by IH NMR spectroscopy in <1%. 
5) P-2-c (lOmg, O.Ilmmol, I equiv.) , freshley generated H2N-Ala-OEt 
(l3mg, O.llmmol, lequiv.) TsOH (2mg, O.OImmol) were stirred in CH2CI2. 
The desired imine 3.12 was not evident by 1 H NMR spectroscopy after 24 h 
reaction. 
6) P-2-c (10mg, O.Ilmmol, lequiv.) HC1.H2N -Ala-OEt (17mg, 
O.llmmol, lequiv.) and TEA (18I-LL, 0.13mmol. 1.2equiv.) were dissolved in 
benzene (5mL) and MeOH (2.5mL) and stirred for 24 h. A IH NMR spectral 
analysis showed imine 3.12 (50%), the remaining material was starting 
material. 
7) P-2-c (lOmg, 0.1 Immol, Iequiv.). HCl.H2N-Ala-OEt (l7mg. 
O.llmmol, lequiv.) and TEA (18I-LL, 0.13mmol, 1. 2 equiv.) were dissolved in 
benzene (5mL). The solution was heated at reflux using a Dean-Stark 
apparatus. The deSired imine 3.12 was not evident by IH NMR spectroscopy 
after 10 h reaction. 
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8) P-2-c (lOmg, O.llmmol, lequiv.), HCl.H2N-Ala-OEt (l7mg. 
O.llmmol. lequiv.) and TEA (18IlL, 0.13mmol. 1.2equiv.) were dissolved in 
CH2C12 (5mL). The solution was heated at reflux using a modified Dean-Stark 
apparatus. The desired imine 3.12 was not evident by IH NMR spectroscopy 
after 10 h reaction. 
9) P-2-c (10mg, O.llmmol, lequiv.). HCl.H2N-Ala-OEt (17mg, 
O.l1mmol, lequiv.) and TEA (18IlL, 0.13mmol, 1.2equiv.) were dissolved in 
CHC13 (5mL). The solution was heated at reflux using a modified Dean-Stark 
apparatus. The desired imine 3.12 was not evident by IH NMR spectroscopy 
after 10 h reaction. 
6.7.1.3 Further Attempts at Imine Formation using N-Acyl-P-2-C, described in 
Section 3.2.1.4 
Modifica tions: 
1) N-Acetyl-p-2-c 2.24 (lOmg. 0.07mmol) and H2N-Ala-OEt 3.11 
(8.2mg. 0.07mmol. lequiv.) were dissolved in benzene (5mL) and MeOH 
(2.5mL). IH NMR spectroscopy indicated p-2-imine 3.12 (77%) and p-2-c 
(23%) after 24 h stirring. 
2) N-Acetyl-p-2-c 2.24 (10mg, 0.07mmol) and H2N-Ala-OEt 3.11 
(8.2mg. 0.07mmol. lequiv.) were dissolved in THF (10mL). IH NMR 
spectroscopy indicated p-2-imine 3.12 (7%). p-2-c (35%) and starting 
material (58%) after 24 h stirring. 
3) N-Acetyl-p-2-c 2.24 (lOmg. 0.07mmol), HCl.H2N-Ala-OEt 3.11 
(1Img. 0.07mmol. lequiv.) and TEA (IOIlL. 0.07mmol. lequiv.) were 
dissolved in pentane (10mL) and heated at reflux in a modified Dean-Stark 
apparatus. The 1 H NMR spectrum of an aliquot after 24 h showed no reaction 
had occurred. IH NMR spectroscopy indicated p-2-imine 3.12 (50%) and p-
2-c (50%) after 3 d further refluxing. 
4) N-Acetyl-p-2-c 2.24 (10mg. 0.07mmol). HCl.H2N-Ala-OEt 3.11 
(11mg. 0.07mmol. lequiv.). TEA (lOIlL. 0.07mmol. lequiv.) and titanium(IV) 
isopropoxide (20.8IlL. 0.07mmol. lequiv.) were dissolved in pentane (lOmL). 
IH NMR spectroscopy indicated p-2-imine 3.12 (65%) and p-2-c (35%) after 
2 h of azeotropic removal of water. 
6.7.1.4 Attempted Amine 3.27 Formatlonjrom N-Acetyl-P-2-C 2.24, described 
in Section 3.2.3 
Modifications: 
1) N-Acetyl-p-2-c 2.24 (lOmg. 0.07mmol) and freshly generated H2N-
Ala-OEt 3.11 (62mg. O.53mmol. 7.5equIv.) were dIssolved in dry MeOH 
(5mL). After 5 min NaCNBH3 (lequiv .• O.07mmol. 4.5mg) was added and 
stirring continued. H20 (5mL) was added and the mixture was washed with 
saturated NaHC03 solution (5mL) followed by immediate extraction with 
CH2C12 (IOmL). IH NMR spectroscopy indicated p-2-c (89%) and starting 
material (11%) after 24 h reaction. 
2) N-Acetyl-p-2-c 2.24 (IOmg. O.07mmol). freshly generated H2N-Ala-
OEt (62mg. O.53mmol. 7.5equiv.) and activated 4A molecular sIeves (lOOmg) 
were stirred in dry MeOH (5mL). After 5 min NaCNBH3 (lequiv .• O.07mmol. 
4.5mg) was added and stirring continued. 1 H NMR spectroscopy indicated p-
2-c as the only pyrrole after 24 h reaction. polymer was evident in· the 
reaction vessel. 
3) N-Acetyl-p-2-c 2.24 (lOmg. O.07mmol). HCl.H2N-Ala-OEt (llmg. 
O.07mmol. lequiv.) and TEA (IO~L. O.07mmol. lequiv.) were dissolved in dry 
DMF (5mL). After 5 min NaCNBH3 (4.5mg. O.07mmol. lequiv.) was added and 
stirring continued. 1 H NMR spectroscopy indicated p-2-c as the only pyrrole 
after 3 d reaction. 
4) N-Acetyl-p-2-c 2.24 (IOmg. O.07mmol). HCl.H2N-Ala-OEt (llmg. 
O.07mmol. lequiv.) and TEA (lO~L. O.07mmol. lequiv.) were dissolved in dry 
THF (5mL). After 5 min NaCNBH3 (lequiv .• O.07mmol. 4.5mg) was added and 
stirring continued. 1 H NMR spectroscopy indicated p-2-c as the only pyrrole 
after 3 d reaction. polymer was evident in the reaction vessel. 
6.7.1.5 Attempted Amine 3.27 Formation from P-2-C, described in Section 
3.2.3 
Modifications: 
1) A mixture of p-2-c (lOmg. O.llmmol), HCl.H2N-Ala-OEt 3.11 
(I7mg. O.llmmol, lequiv.) and TEA (lequiv .• O.llmmol. 15~L) were stirred 
for 1 h at rt. EtOH (2mL) and NaCNBH3 (6.9mg. O.llmmol. leqiuv.) were 
added and stirring continued. A 1 H NMR spectral analysis of the crude 
product gave no evidence of the desired amine 3.27. 
2) A mixture of p-2-c (IOmg. O.l1mmol). HCl.H2N-Ala-OEt 3.11 
(17mg, O.llmmol. lequiv.), TEA (lequiv .• O.llmmol. 15~L) and titanium(IV) 
isopropoxide (33~L, O.llmmol, lequiv.) were stirred for 1 h at rt. EtOH 
(2mL) and NaCNBH3 (6.9mg, O.l1mmol, leqiuv.) were added and stirring 
continued. A 1 H NMR spectral analysis of the crude product gave evidence of 
the desired amine 3.27 (5%), but this decomposed on standing in solution. 
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6.7.2 Amino Acid Extension in the Peptide "Sense" Direction - Amides 3.28 
and 3.34. described in Section 3.2.4 -
P-2-COOH 3.29 (20mg. 0.18mmol). DCC (37mg. 0.18mmol. 1equiv.). 
TEA (25J.LL. 0.18mmol. 1equiv.) and HC1.NH2-Gly-OEt 3.11 (25mg. 0.18mmol. 
1equiv.) were dissolved in CH2Cl2 (IOmL) under N2. After 15 h stirring the 
solvent was removed to give the crude amide 3.28 which crystallised from 
EtOAC/Pet. Ether. 
Ethyl 2-(Pyrrol-2-ylcarbonylamino) Ethanoate 3.28, 168mg (95%); mp 
113.5-115°C (EtOAC/Pet. Ether, very pale yellow crystals); Rr 0.14; IH NMR 0 
1.34 (3H. t. J=7.0Hz. C02CH2CH3); 4.19 (2H. d, J=5.4Hz, CH2C02CH2CH3); 
4.26 (2H, q, J=7.1Hz, C02CH2CH3); 6.25 (lH, m, H-4); 6.32 (lH, bm, CONH); 
6.65 (lH, m, H-3); 6.94 (lH, m, H-5); 9.33 (lH, bm, pyr-NH); Irradiation of 
CONH collapses NHCH2CO to s; 13C NMR 0 14.1 (C02CH2CH3); 41.3 
(CH2C02CH2CH3); 61.6 (C02CH2CH3); 109.7 (C-3); 110.0 (C-4); 121.9 (C-5); 
125.2 (C-2); 161.1 (pyr-COCH2); 170.1 (CH2C02CH2CH3); IR (KBr) 3205, 
3135, 1755, 1655, 1575, 1535cm- 1: UV (CHCI3) 295.4, 265.0nm; m/ e (EI, 
70eV) 196 (M. 46.2%); 150 (B-CH2CH30H, 6.9%); 123 (B-C02C2H5+, 32.1%); 
110 (B-C4H9CH=NH2+, 2.5%); HRMS Found 196.0847 (Calcd. for C9H12N203 
196.0848); Anal. Calcd. C 55.08; H 6.17; N 14.28 Found C 55.19; H 6.01; N 
14.39. 
The pyrrole amide 3.34 
P-2-COOH, DCC and iBuNH2 (18J.LL, 0.18mmol. lequiv.) in CH2Cl2 
(10mL) were stirred for 15 h gave the desired amide 3.34 (22%) by IH NMR 
spectral analysis. IH NMR 0 0.86 (6H, d, J=4.5Hz, (CH3)2); 2.05 (lH, m, 
CH(CH3l2); 2.36 (2H, m, CH2); 5.98 (IH, bs, NH); 6.44 (lH, m, H-4); 6.62 
(lH, m, H-3); 7.19 (IH, m, H-5). 
6.7.2.1 Attempted Formylation oj the P-2-Gly-OEt Amide 3.28, described in 
Section 3.2.4.1 
DMF (13J.LL, 0.17mmol) was added dropwise to POCl3 (16J.LL, 
0.17m~01) in l,2-dichloroethane under the Vilsmeir-Haack formylation 
conditions (187). P-2-Gly-OEt amide 3.28 (30mg, 0.15mmol) was added 
portionwise and the soultion stirred for 1 h followed by 15 min reflux. 
NaOAc.3H20 (5mL, 20% solution in H20) was added to the cooled solution. 
After reflux for a further 15 min a IH NMR spectrum of an aliquot showed 
evidence of the desired formylated pyrrole «2%) [lH NMR 0 9.82 (IH, s, 
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CHO)]. Further stirring and refluxing before addition of the NaOAc solution 
did not increase the yield. 
6.7.3 Extention of Amino Acids in the Peptide MAnti-Sense" Direction to give 
3.36. 3.37. 3.38 and 3.39 
6.7.3.1 Preparation oj 3.36 and 3.37 via the Acid Chloride/ DMAP 
Methodology, described in Section 3.2.5 
1) N-Cinnamoyl-p-2-0H 2.32 (20mg. 0.09mmol). DMAP (llmg. 
0.09mmol. 1equiv.) and Hiinigs base (19~L, O.llmmol, 1.2equiv.) were 
dissolved in CH2Cl2 (10mL) at rt. Acetyl chloride (8~L, O.llmmol, 1.2equiv.) 
was added and the resultant solution was stirred for 24 h. EtOAc (10mL) was 
added and the organic phase was washed with citric acid (10mL, 10% 
solution in H20), water (2x10mL), dried and evaporated to dryness. The 
resultant pyrrolic ester was purified by silica chromatography (EtOAc/Pet. 
Ether= 1 :2). 
1-(3-Phenylpropinoyl)-2-acetoxymethylpyrrole 3.36, gave 21mg (87%) 
as a brown oil; Rf 0.63; IH NMR S 2.08 (3H, s, CH3); 3.14 (2H, m, CH2Ph); 
3.19 (2H, m, COCH2); 5.35 (2H, bs, pyr-CH2); 6.21 (lH, t, J=3.4Hz, H-4); 
6.31 (lH, m, H-3); 7.12 (lH, dd, J=3.4 & 1. 7Hz, H-5); 7.23 (2H, m, Ph-
aromH2); 7.29 (2H, m, Ph-aromH3): 7.31 (lH, m, Ph-aromH4); Irradiation at 
pyr-CH2 and H-3 collapsed to dd (J= 1. 7 & 0.9 Hz); 13C NMR S 20.9 
(OCOCH3); 30.3 (CH2Ph); 37.4 (COCH2); 60.0 (CH20COCH3); 111.8 (C-4); 
115.4 (C-3); 121.0 (C-5); 126.5 (Ph-aromC4); 128.4 (Ph-aromC2); 128.6 (Ph-
aromC3); 130.3 (C-2); 140.1 (Ph-aromC1); 170.5 (CH20COCH3); 170.7 (CO): 
FTIR (nujol) 3159.0, 2725.0, 1603.1cm- 1; UV (CHCI3) 340.0, 267.2nm: m/e 
(EI, 50eV) 271 (M, 17.6%); 228 (M-CH3CO, 16.2%1; 198 (M-CH20COCH3, 
10.2%); 133 (B, M-PhCH2CH2CO, 100%); HRMS (M) Found 271.1211 (Calcd. 
for C16H17NI03 271.1208). 
2) N-Fmoc-Phe-CI (45mg, O.llmmol, 1.2equiv.) was added to N-
cinnamoyl-p-2-0H 2.32, DMAP and Hiinigs base as described above. The 
resultant pyrrolic dipeptide 3.37 was purified by silica chromatography 
(EtOAc/Pet. Ether= 1 :2), after the polymer was removed by filtration. 
1-{3-Phenylpropinoyl)-2-[{{9-fluorenylmethyl)oxy)carbonyl-L-
phenylalaninoxylmethylpyrrole 3.37, gave 13mg (20%) as a brown oil; Rr 0.36; 
[a]D25 -230 (el, MeOH); 1 H NMR S 3.07 (2H, m, Fmoc-CH2); 3.09 (2H, m', 
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CH2CH2Ph); 3.14 (2H, m, COCH2CH2Ph); 4.20 (lH. t. J=7.0Hz. Fmoc-CH); 
4.34 (lH, B part ABX, J=7.5 & 3.5Hz, Phe-CH2): 4.40 (lH, A part ABX, J=7.5 
& 3.5Hz, Phe-CH2): 4.70 (lH, X part ABX & d, J=8.0 & 3.6Hz, Phe-CH); 5.27 
(lH, d, J=8.0Hz, NH); 5.40& 5.45 (2H, bABq. J=13.0Hz, Pyr-CH2); 6.21 (lH, 
t. J=3.5Hz, H-4); 6.23 (lH, m, H-3): 7.10 (2H, m, Phe-aromH3); 7.13 (lH, 
dd, J=3.5 & 2.0Hz, H-5); 7.21-7.32 (8H, m, Phe-aromH4 & Fmoc-aromH3 & 
Ph); 7.40 (2H. t, J=7.5Hz, Fmoc-aromH3); 7.54-7.58 (4H, m, Phe-aromH2, 
Fmoc-aromH4); 7.76 (2H, d, J=7.5Hz, Fmoc-H5); irradiation at 6.23ppm, the 
bABq at 5.40ppm & 5.45ppm collapses to sharp ABq; I3C NMR 0 30.2 
(COCH2CH2Ph); 37.5 (COCH2CH2Ph); 38.1 (Phe-CH2); 47.1 (Fmoc-CH); 54.6 
(Phe-CH); 60.9 (pyr-CH2); 67.0 (Fmoc-CH2); 111.8 (C-4); 116.2 (C-3); 120.0 
(Fmoc-C5); 121.2 (C-5); 125.0 (Fmoc-aromC4); 125.1 (Phe-aromC2); 126.5 
(Ph-aromC4); 127.0 (Fmoc-aromC3); 127.7 (Fmoc-aromC2); 128.4 (Ph-
aromC2); 128.5 (Ph-aromC3); 128.6 (Phe-aromC4); 129.3 (C-2); 129.4 (Phe-
aromC3); 135.7 (Phe-aromCl); 140.0 (Ph-aromC1); 143.7 (Fmoc-aromC2a); 
143.9 (Fmoc-aromC5a); 155.5 (OCO-Fmoc); 170.5 (pyr-CH20CO); 171.1 (CO); 
FTIR (neat) 3338.0, 3028.3, 2855.1, 1736.8, 1713.7, 1689.8, 1650.4, 
1514.1cm- l ; UV (MeOH) 302.8, 291.6, 281.2nm; m/e (FAB) 599 (M+1, 
65.1%); HRMS (M+1. FAB) Found 599.2551 (Calcd. for C3SH35N205 
599.2546). 
6.7.3.2 Preparation of 3.37, 3.38 and 3.39 via the Mitsunobu Reaction14, 
described in Section 3.2.5 
The methodology is identical to that described for the camphanate 
formation given in Section 6.4.3.1. 
1) N-(N-pth-Phe)-p-2-0H 2.52 (30mg, 0.08mmol), triphenyl 
phosphine (45mg, 0.17mmol, 2.1equiv.) and N-Cbz-Val-Val-OH (62mg, 
0.18mmol, 2.2equiv.) were dissolved in dry THF (10mL). After stirring for 5 
min followed DEAD (27JlL, 0.17mmol, 2.1equiv.) was added. The reaction was 
stirred for 3 h at rt under N2. The solvents were evaporated, and the residue 
then dissolved in a minimal amount CH2CI2. The solution was passed through 
a silica column (2cm, EtOAc/Pet. ether=1:2 elutent). Chromatography 
(EtOAc/Pet. Ether=1:2) of the resultant oil then yielded 3.39. 
l-eN-Pbthalyl-L-pbenylallnylJ-2-{N-benzyloxycarbonyl-L-valinyl-L-
vaUnoxy)metbylpyrrole 3.39, gave llmg (20%) as a brown oil; Rr 0.54; [a]D23 
-150 (el, MeOH); IH NMR 00.77 (3H, d. J=7.0Hz, Val-(CH3)A-Cbz); 0.89 (3H, 
d, J=7.0Hz, Val-(CH3)B-Cbz); 0.96 (3H, d, J=7.0Hz, pyr-Val-(CH3)A); 1.04 
(3H, d, J=6.5Hz, pyr-Va!-(CH3)B); 2.19 (lH, m, pyr-Val-CH(CH3)2); 2.22 (lH, 
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m, Val-CH(CH312-Cbz); 3.54 (2H, m. Phe-CH2); 4.24 (lH, ddt J=6.5 & 2.5Hz, 
pyr-Val-CH); 4.67 (lH, dd, J=5.0 & 4.5Hz, Val-CH-Cbz); 5.12 (2H, s, Cbz-
CH2); 5.45 (lH, bABq, J=14.0Hz, Pyr-CH2); 5.4B (lH, bABq, J=14.0Hz, pyr-
CH2); 5.60 (lH, dd, J=9.5 & 5.5Hz, Phe-CH); 6.09 (lH, t, J=3.5Hz, H-4); 6.24 
(lH, d, J=6.3Hz, Val-NH-Val); 6.29 (lH, m, H-3); 6.67 (lH, bd, J=5.3, NH-
Cbz); 7.00 (lH, dd, J=3.5 & 1.5Hz, H-5); 7.19 (2H, m, Phe-aromH3); 7.20-
7.24 (3H, m, Ph-aromH2 & aromH4); 7.32-7.36 (5H. m. Cbz-arom); 7.70 (2H, 
dd, J=5.5 & 3.0Hz. Pth-aromH3); 7.BO (2H. ddt J=5.4 & 3.0Hz. Pth-aromH4); 
13C NMR 0 17.3 (Val-(CH31A-Cbz); 17.7 (Val-(CH3)B-Cbz); 19.0 (pyr-Val-
(CH3)A); 19.4 (pyr-Val-(CH3)B); 31.3 (Val-CH(CH312-Cbz); 31.4 (pyr-Val-
CH(CH312); 35.0 (Phe-CH2); 53.B (Val-CH-Cbz); 57.3 (pyr-Val-CH); 59.6 (Phe-
CH); 60.2 (pyr-CH2); 66.B (Cbz-CH2); 112.4 (C-4); 116.9 (C-3); 120.9 (C-5); 
123.9 (Cbz-aromC4); 127.2 (Phe-aromC4); 127.9 (Cbz-aromCl); 12B.0 (Cbz-
aromC3); 12B.5 (Cbz-aromC2); 12B.7 (Phe-aromC2); 129.2 (Phe-aromC3); 
131.0 (Pth-aromC3a); 134.5 (Phe-aromCl); 134.6 (Pth-aromC4); 135.B (C-2); 
135.9 (Cbz-aromCl); 156.4 (CO-Cbz); 166.6 (Pth-CO); 167.1 (Val-CO-Val); 
170.7 (pyr-OCO-Val); 171.4 (CO); FTIR (neat) 3147.9, 1777.2, 1736.9, 
1714.65. 1666.9. 1530.Bcm-1; UV (MeOH) 264.B. 216.0nm; m/ e (FAB) 707 
(M+l. 19.7%); 507 (M-C13HllNl03+, Pth-Phe, 23.4%): 357 (507-NHCbz. 
53.0%): HRMS (M+l, FAB) Found 707.30B07 (Calcd. for C40H43N40S 
707.30B06). 
2) N-Cinnamoyl-p-2-0H 2.32 (IBmg, O.OBmmol), triphenyl phosphine 
(45mg. 0.17mmol. 2.1equlv.) and N-Fmoc-Phe-OH (69mg. O.IBmmol. 
2.2equiv.) were dissolved in dry THF (10mL). After stirring for 5 min followed 
DEAD (27IlL. 0.17mmol, 2.1equiv.) was added. The reaction was stirred for 3 
h at rt under N2. The solvents were evaporated. and the residue then 
dissolved in a minimal amount CH2CI2. The solution was passed through a 
silica column (2cm, EtOAc/Pet. ether= 1:2 elutent). Chromatography 
(EtOAc/Pet. Ether= 1 :2) of the resultant oil then yielded 3.37 19m9 (73%) as a 
brown oil described in Section 6.7.3.1. 
3) N-Cinnamoyl-p-2-0H 2.32 (IBmg. O.OBmmol), triphenyl phosphine 
(45mg, 0.17mmol. 2.1equiv.) and N-Cbz-Ala-Phe-OH (67mg. O.IBmmol, 
2.2equiv.) were dissolved in dry THF (10mL). After stirring for 5 min followed 
DEAD (27JlL. 0.17mmol, 2.lequiv.) was added. The reaction was stirred for 3 
h at rt under N2. The solvents were evaporated, and the residue then 
dissolved in a minimal amount CH2CI2. The solution was passed through a 
silica column (2cm, EtOAc/Pet. ether= 1:2 elutent). The resultant oil was 
chroma tographed (EtOAc/Pet. Ether= 1 :2). 
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1-(3-Phenylpropinoyl)-2-(N-benzyloxycarbonyl-L-alanyl-L-
phenylalaninoxy)methylpyrrole 3.38, gave 52mg (69%) as a brown oil: Rf 
0.20: [a]D25 -210 (c1, MeOH): IH NMR 0 1.25 (3H, d, J=7.0Hz, Ala-CH3): 3.00 
(2H, m, CH2CH2Ph): 3.03 (2H, m, CH2CH2Ph): 3.12 (2H, m, Phe-CH2): 4.13 
(lH, m, Ala-CH): 4.80 (lH, m, Phe-CH): 4.98 (lH, ABq, J= 12.1Hz, Cbz-CH2): 
5.06 (lH, ABq, J= 12.1Hz, Cbz-CH2): 5.16 (lH, bd, J=7.9Hz, NH-Cbz): 5.30 
(lH, bABq, J=13.1Hz, Pyr-CH2): 5.38 (lH, bABq, J=13.1Hz, pyr-CH2): 6.15 
(lH, t, J=3.3Hz, H-4): 6.23 (lH, dbb, J=3.3 & 1.5Hz, H-3): 6.29 (lH, bd, 
J=6.9Hz, Phe-NH-Ala): 6.99 (2H, m, Phe-aromH3): 7.08 (lH, dd, J=3.3 & 
1.5Hz, H-5): 7.15-7.28 (l3H, m, Phe-aromH2, aromH4 & Cbz-arom & Ph): 
Irradiation at 5.34ppm and bdd at 6.23 collapses to dd: 13C NMR 0 18.5 (Ala-
CH3): 30.2 (CH2CH2Ph): 37.3 (CH2CH2Ph): 37.6 (Phe-CH2): 50.4 (Ala-CH): 
53.0 (Phe-CH): 60.9 (pyr-CH2): 67.0 (Cbz-CH2): 111.9 (C-4): 116.3 (C-3): 
121.3 (C-5): 126.5 (Ph-aromC4): 127.0 (Cbz-aromC2): 128.2 (Cbz-aromC4): 
128.3 (Cbz-aromC3): 128.4 (Ph-aromC2): 128.5 (Phe-aromC2): 128.5 (Ph-
aromC3): 128.7 (Phe-aromC4): 129.2 (C-2): 129.4 (Phe-aromC3): 135.6 (Phe-
aromC1): 135.8 (Cbz-aromC1.): 140.0 (Ph-aromC1): 155.8 (CO-Cbz):. 170.5 
(Phe-CO-Ala): 170.8 (pyr-CH20CO): 171.6 (CO): FTIR (neat) 3319.9, 2962.0, 
1722.6, 1720.1, 1701.6, 1666.4, 1531.2, 1492.8cm- 1: UV (MeOH) 259.6, 
236.8, 204.5nm: HRMS (M+1, FAB) Found 582.26245 (Calcd. for C34H35N306 
582.26039). 
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6.8 Work Described in Section 4.2 to Section 4.5 
6.S.1 Hydrolysis of 2.32 with KOH in d4-MeOH, described in Section 4.2 
1) N-Cinnamoyl-p-2-0H 2.32 (Img, 4llmol) was dissolved in d4-MeOH 
(0.6mL). KOH (5mg, 0.089mmol, 22equiv.) was added. IH NMR spectroscopy 
indicated immediate deacylation to give two non-N-acylated pyrroles 4.1 and 
4.2. The final IH NMR spectra yield was 4.1 (60%) and 4.2 (40%). 
The final yields varyied depending on the concentration of KOH and 
solvent used in the reaction, these are described in Section 4.2. 
hydroxymethyl pyrrole 4.1 15 : 1 H NMR (d4-MeOH) 04.50 (2H, s, 
CH20H); 5.99 (lH, t, J=2.6Hz, H-4); 6.07 (IH, m, H-3); 6.67 (lH, m, H-5) 
methoxymethyl pyrrole 4.2: IH (d4-MeOH) 03.59 (3H, s, OMe); 4.36 
(2H, s, CH20Me); 6.00 (IH, t, J=3.1Hz, H-4); 6.04 (IH, m, H-3); 6.70 (lH, m, 
H-5). 
2) N-Cinnamoyl-p-2-0H 2.32 (Img, 4llmol) was dissolved in d4-MeOH 
(0.6mL). KOH (lOIlL, 0.44mmole solution of KOH in D20, lequiv.). IH NMR 
spectroscopy indicated deacylation to produce the two pyrrole non-N-acylated 
pyrroles 4.1 and 4.2. The final IH NMR spectra yield was 4.1 (10%) and 4.2 
(30%). 
3) A larger scale reaction using pyrrole 2.32 (10mg, 40llmol) was 
carried out to ensure the reproducability of the small scale method described 
above. 
N-Cinnamoyl-p-2-0H 2.32 (10mg, 40llmol) was dissolved in d4-MeOH 
(0.6mL). KOH (lOIlL, 4.4mmole solution of KOH in D20, lequiv.) was added. 
1 H NMR spectroscopy indicated deacylation to produce the two pyrrole non-
N-acylated pyrroles 4.1 and 4.2. The final IH NMR spectra yield was 4.1 
(10%) and 4.2 (30%), the same as for the smaller scale reaction, 2) above. 
6.S.2 Hydrolysis of 2.32 with KOH in d3-Acetonitrile, described in Section 4.3 
1) N-Cinnamoyl-p-2-0H 2.32 (lmg, 4llmol) was dissolved in d3-
CD3CN (0.6mL). KOH (lOIlL, 0.44mmole KOH solution in d4-MeOH, lequiv.) 
was added. 1 H NMR spectroscopy indicated deacylation to produce the two 
pyrrole non-N-acylated pyrroles 4.1 and 4.2. The final IH NMR spectra yield 
was 4.1 (30%) and 4.2 (70%). 
2) N-Cinnamoyl-p-2-0H 2.32 (Img, 4llmol) dissolved in d3-CD3CN 
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(0.6mL). KOH (10~L, 0.44mmol solution KOH in D20. 1equiv.) was added. IH 
NMR spectroscopy indicated deacylaUon to produce the pyrrole 4.5 (80%) 
and starting material 2.32 (20%). The yield of 4.5 dropped (to 71%) as 4.1 
(12%) formed, with starting material present (18%) over 4 d. Recovery of the 
material from the NMR tube found approximately 60% as polymer. 
4.5 was found to be unstable in solution, but was characterised by 
NMR spectroscopy at -20°C. 
2-Methylpyrrol-2-yl-3-phenylpropanoate 4.5, 1 H NMR (CD3CN) 02.66 
(2H, t, J=7.5Hz, CH2Ph): 2.95 (2H, t, J=7.5Hz, COCH2): 5.07 (2H, s, pyr-
CH2): 6.10 (lH, t, J=2.2Hz, H-4); 6.18 (lH, dd, J=2.5 & l.5Hz, H-3); 6.80 
(lH, dd, J=2.3 & 1. 5Hz, H-5); 7.25 (lH, m, Ph-aromH4); 7.30 (lH, m, Ph-
aromH2); 7.33 (lH, m, Ph-aromH3): 13C NMR (CD3CN) 029.7 (CH2Ph): 34.7 
(COCH2); 58.0 (Pyr-CH2); 106.9 (C-4); 108.9 (C-3); 118.2 (C-5); 125.2 (C-2); 
125.4 (Ph-aromC4): 127.6 (Ph-aromC2); 127.7 (Ph-aromC3); 140.1 (Ph-
aromC1l; 172.3 (CO). 
3) N-Cinnamoyl-p-2-0H 2.32 (lmg, 4~mol) was dissolved in d3-CD3CN 
(0.6mL). KOH (20~L. 0.44mmol solution KOH in D20. 2equiv.) was added. 1 H 
NMR spectroscopy indicated deacylation to produce the pyrrole 4.5 (95%) 
and starting material 2.32 (5%) in 1 min. The yield of 4.5 dropped (to 40%) 
as 4.1 (60%) formed over 3 d. None of the material recovered from the NMR 
tube was polymeric. 
4) N-Cinnamoyl-p-2-0H 2.32 (lmg, 4~mol) dissolved in d3-CD3CN 
(0.6mL) and n-BuNH2 (0.45~L, 4j..lmol, 1equiv.) was added. A 1 H NMR 
spectrum prior to deacylaUon was run for analysis purposes. KOH (1 OJ..lL , 
0.44mmol solution KOH in D20, 1equiv.) was added. IH NMR spectroscopy 
indicated deacylation to produce the pyrrole 4.5 (70%). starting material 2.32 
(20%) and the pyrrole amine 4.6 (10%). described below, in 1 min. The yield 
of 2.32 (to 10%) and 4.5 (to 10%) dropped as 4.6 (80%) formed over 1 d. 
None of the material recovered from the NMR tube was polymeric. 
5) N-Cinnamoyl-p-2-0H 2.32 (lmg, 4j..lmol) dissolved in d3-CD3CN 
(0.6mL). n-BuNH2 (0.45j..lL, 4j..lmol, 1equiv.) was added a preliminary IH NMR 
spectrum was run. KOH (2 OJ..lL , 0.44mmol solution KOH in D20. 2equiv.) was 
added. 1 H NMR spectroscopy indicated deacylation to produce the pyrrole 
4.5 (95%) and the pyrrole amine 4.6 (5%). described below, in 1 min. The 
yield of 4.5 dropped (to 0%) as 4.6 (100%) formed over 1 h. None of the 
material recovered from the NMR tube was polymeric. 
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2-Butylaminomethylpyrrole 4.6, an isolated but unstable oil; IH NMR 
(CD3CN) 00.87 (3H. t. J=7.3Hz. CH3); 1.26-1.42 (4H. m, NHCH2CH2CH2CH3); 
2.90 (2H, bt, J=7.4Hz, NHCH2); 3.62 (2H, s, pyr-CH2NH); 6.03 (lH, m, H-3); 
6.06 (IH, t, J=2.9Hz, H-4); 6.67 (IH. m, H-5); 13C NMR 0 13.6 (CH3): 20.5 
(CH2CH3); 35.8 (CH2CH2CH3): 50.5 (NHCH2): 59.1 (Pyr-CH2NH); 109.8 (C-4); 
119.2 (C-3); 121.8 (C-5); 125.9 (C-2); m/e (EI, 50eV) 152 (M. 12.5%); 80 (B, 
M-NHBu, 100%; HRMS (M) Found 152.1314 (Ca1cd. for C9H16N2 152.1313). 
6.8.3 Stability of Hydroxymethyl Pyrrole 2.32 in Solution in the Absence of 
HO-. described in Section 4.3.5 
1) N-Cinnamoyl-p-2-0H 2.32 (Img. 4llmol) was dissolved in d3-CD3CN 
(0.6mL) and D20 (51lL, 5J.l.ffiol. 1.25equiv.) was added. There was no change in 
the 1 H NMR spectral observed over 5 d. 
2) N-Cinnamoyl-p-2-0H 2.32 (Img, 4llmol) was dissolved in d3-CD3CN 
(0.6mL), D20 (51lL, 51lmol, 1.25equiv.) and n-BuNH2 (0.45IlL, 41lmol, lequiv.) 
were added. There was no change in the 1 H NMR spectral observed over 2 
months. 
6.8.4 Kinetic Analysis: Hydrolysis of 4.5 with KOH in da-Acetonitrile. 
described in Section 4.4 
N-Cinnamoyl-p-2-0H 2.32 (Img, 4llmol) was dissolved in d3-CD3CN 
(0.6mL) and n-BuNH2 (0.45IlL. 41lmol, lequiv.) was added. KOH (either IOIlL, 
lequiv., 0.44mmol solution KOH in D20, or 151lL. 1.5equiv., 0.44mmol, 
solution KOH in D20. or 20IlL. 2equiv., 0.44mmol. solution KOH in D20, or 
30IlL. 3equiv., 0.44mmol. solution KOH in D20) was added and vigourously 
shaken. A 1 H NMR spectrum was obtained after 30 s of KOH addition. The 
rate of change of the pyrrolic species 4.5 was monitored via the 1 H NMR 
spectra pyr-CH20COCH2CH2Ph (5.07ppm) signal. 
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Raw Data for Kinetic Analysis of Hydrolysis of 4.5 t 
Data from One Experiment at Each Concentration Shown 
Time 1 Equiv. 1.5 Equiv. 2 Equiv. 3 Equiv. 
t (min) HO- HO- HO- HO-
0 112.0 165.1 135.4 155.7 
1 98.6 154.8 116.4 106.7 
1.5 83.8 
2 89.6 156.0 100.5 74.2 
2.5 72.4 
3 77.3 147.0 91.9 60.9 
4 88.4 54.1 
5 76.4 147.7 83.5 45.0 
6 43.5 
7 146.4 79.3 27.4 
8 67.5 23.0 
10 75.2 145.6 64.5 21.1 
13 138.9 63.8 17.6 
15 73.9 136.3 59.7 4.5 
30 68.3 135.1 56.4 ()e 
45 64.9 132.9 
60 59.4 132.0 55.4 
90 56.0 129.8 54.1-
120 54.7 118.9-
1 (da~) 21.4-
Absoo 21 130 56 0 
t Data Collected at 23.1 °C; • End of Data Collection 
Table 6.1 
The absorbance at infinity (Absoo) was determined by observation of 
the data extrapolated to the value t=oo. 
The observed rate. k. was obtained is presented below. 
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Observed Rate of Hydrolysis of 4.5 with respect to 
HO- Concentration 
Concentration Equivalents Observed Rate 
HO- (M) HO- k 
0.66xlO-3 1 1.34xlO-3 
1 1.33xlO-3 
1 1.30xlO-3 
O.95xlO-3 1.5 1.98xlO-3 
1.29xlO-3 2 2.79xlO-3 
2 2.81xlO-3 
1.90xlO-3 3 3.96xlO-3 
Table 6.2 
The plot of kobs versus HO- concentration gave a straIght line, 
representing kOH[HO-] or the kobs with respect to decomposition of 4.5. 
The deacylation of 4.5 was found to be first order with respect to HO-
at zero to three equivalents of added HO- and has a rate constant of 
k=0.458Lmol-1s-1. 
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6.9 Work DescDoed in Section 4.6, Eludidation of Mechanism of 
Hydroxide Attack on 2.32 to give 4.5 
6.9.1 Formation of Optically Active Hydroxymethyl Pyrrole N-(N-Pth-L-Leu)-p-
2-CHDOH 4.14 
6.9.1.1 DMAP Promoted Acylation of 6-DI-P-2-c with N-Pth-L-Leu-Cl to give 
6-Dl-Labelled Formyl Pyrrole 4.14 
Dry hexane (10mL) was added to crude N-pth-L-Leu-CI 2.36 (prepared 
as in Section 6.1.2). After shaking, the hexane was removed and more hexane 
(10mL) was added, mixed and decanted. The combined hexane extracts were 
evaporated to dryness to give the purified acid chloride used in the following 
reaction. 
6-DI-Pyrrole-2-carboxaldehyde 4.15 (20mg, 0.21mmol), Hiinigs Base 
(41JlL, 0.21mmol) and DMAP (2.6mg, 0.021mmol) were dissolved in CH2Cl2 
(2mL) and the solution was added dropwise to a stirred, ice cooled solution of 
the purified N-Pth-L-Leu-CI 2.36 (0.31mmol, 87mg) in CH2Cl2 (5mL) under 
N2. The resultant yellow oil was found to be pure by 1 H NMR spectroscopy for 
the desired N-(N-Pth-Leu)-p-2-CDO 4.16. 
All of the data with the exception of the 1 H NMR spectrum were 
identical to the previously described non-labelled N-(N-Pth-Leu)-p-2-c 3.44, 
Section 6.4.1.2. 
1-(N-Phthalyl-L-leucyl)-2-formylpyrrole 4.16, IH NMR 00.98 (3H, d, 
J=6.5Hz, (Leu-CH3)Al; 1.04 (3H, d, J=6.5Hz, (Leu-CH3)B): 2.00 (2H, m, Leu-
CH2): 2.42 (lH, m, CH(CH312); 5.67 (IH, X part ABX, J=10.5 & 4.5Hz, Leu-
CH); 6.31 (IH, t, J=3.5Hz, H-4); 7.16 (IH, dd, J=3.5 & 1. 5Hz, H-3); 7.29 (IH, 
dd, J=3.4 & 1. 6Hz, H-5); 7.77 (2H, dd, J=5.5 & 3.0Hz, Pth-HI4); 7.85 (2H, 
dd, J=5.8 & 3.1Hz, Pth-HI5); 13C NMR 021.4 (CH3)B); 23.0 (CH3)Al: 24.9 
(CH(CH312); 37.5 (Leu-CH2); 51.5 (Leu-CH); 113.2 (C-4); 122.6 (C-3); 123.8 
(Pth-CI4); 125.5 (C-5); 131.5 (pth-CI3); 134.6 (Pth-CI5); 135.3 (C-2); 167.3 
(pth-CO); 168.7 (CO); 181.6 (CHO). 
6.9.1.~ Chiral Reduction of6-Dl-Labelled Formyl Pyrrole 4.16 to give 4.14 
Freshly prepared R-alpine borane16 (1.1equiv.) was added to a stirred 
solution of Dl-Iabelled formyl pyrrole 4.16 (lequiv.) in THF (10mL). The 
solution was stirred for 4 h then evaporated to dryness. Excess (+)-a-pinene 
was removed under high vacuum (oil pump) to yield the optically active 
hydroxymethyl pyrrole 4.14. 
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All the data, with the exception of the 1 H NMR, 13C NMR spectra and 
mass spectrum were identical to the previously described non-labelled non-
labelled N-(N-Pth-Leu)-p-2-0H 3.45, Section 6.4.2.2. 
[6-Dl]-I-(N-Phthaloyl-L-Ieucyl)-2-hydroxymethylpyrrole 4.14 IH NMR 
5 0.98 (3H, d, J::::6.5Hz, CH(CH31A.l; 1.05 (3H, d, J::::6.5Hz, CH(CH3)B); 2.00 
(2H, m, Leu-CH2); 2.46 (IH, m, CH{CH3)2); 4.63 OH. s. CHDOH); 5.54 (IH, X 
part ABX, J::::IO.5 & 4.5Hz, Leu-CH); 6.17 (lH, t, J::::3.5Hz, H-4); 6.22 (IH, m, 
H-3); 7.06 (IH. dd, J=3.4 & 1. 5Hz, H-5); 7.76 (2H, dd, J=5.5 & 3.4Hz, Pth-
aromH3); 7.86 (2H, dd, J=5.6 & 3.4Hz, Pth-aromH4); 13C NMR 5 21.4 
(CH(CH3)B); 23.0 (CH(CH3lA.l; 25.0 (CH(CH3h); 37.7 (Leu-CH2); 51.3 (Leu-
CH); 57.6 fCHDOH. t. Jc-n=22.IHzl; 113.0 (C-4); 114.9 (C-3); 120.1 (C-5); 
123.8 (Pth-aromC3); 131.3 (pth-aromC3a); 134.5 (Pth-aromC4); 136.1 (C-2); 
167.5 (Pth-CO); 169.4 (CO): HRMS (EI, 50eV) Found 341.14856 (Calcd. for 
C19H19DIN204 341.14857); Isotopic incorporation 93.6% D. 
6.9.2 Hydrolysis of Chiral. Labelled 4.14 with HO-
6.9.2.1 Trial Hydrolysis of Unlabelled N-(N-Pth-Leu)-p-2-0H 3.45 with HO-
N-(N-Pth-Leu)-p-2-0H 3.45 (5mg, O.Olmmol) was dissolved in d3-
CD3CN (0.6mL). Addition of KOH (10j.tL, 0.44mmol. KOH solution in D20, 
lequiv.) caused rapid hydrolysis of 3.45 to the unstable O-acyl pyrrole 
derivative 4.13. 
4.13, IH NMR 5 (d3-CD3CN) 0.99 (3H, t, J=6.4Hz, (Leu-CH3)Al; 1.04 
(3H, t, J=6.3Hz, (Leu-CH3)B); 1.99 (2H, m, Leu-CH2): 2.44 (IH, m, 
CH(CH3)2); 4.96 (IH, m, Leu-CH): 5.09 (IH, A part ABq, J= 12.6Hz, Pyr-CH2): 
5.13 (IH, B part ABq, J=12.6Hz, pyr-CH2); 6.06 (IH, m, H-4); 6.09 (IH, m, 
H-3); 6.78 (IH, t, J=3.lHz. H-5); 7.87-7.89 (4H. m, Pth-aromH). 
6.9.2.2 Hydrolysis of Labelled N-(N-Pth-Leu)-p-2-0H 4.14 with HO-
N-(N-Pth-Leu)-p-2-CHDOH 4.14 (5mg, O.OImmol) was dissolved in 
d3-CD3CN (0.6mL). Addition of KOH (lOj.tL. 0.44mmol, KOH solution in D20, 
lequiv.) caused rapId conversion to the Dl-Iabelled pyrrolic ester 4.19. 
4.19, IH NMR 5 (d3-CD3CN) 0.99 {3H, t, J=6.4Hz. (Leu-CH3)Al; 1.04 
(3H, t, J=6.3Hz, (Leu-CH3)B); 1.99 (2H, m. Leu-CH2); 2.44 (IH, m. 
CH(CH3h); 4.96 (IH, m, Leu-CH); 5.09 OH. s. pyr-CHD); 6.06 (IH, m, H-4); 
6.09 (IH, m. H-3); 6.78 (IH, t, J=3.IHz, H-5); 7.87-7.89 (4H, m, Pth-aromH). 
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The one up field signal was attributted to the'S' configuration and 
therefore retention of configuration. 
6.9.3 Formation of the 6-Dl-Labelled Hydroxymethyl Pyrroles N-Cinnamoyl-p-
2-CHDOH 4.10 and 4.24, described in Section 4.6.4 
6.9.3.1 Prepar,ation of N-Cinnamoyl-p-2-CDO 4.23 
Hydrocinnamoyl chloride (0.31rnrnol, 46JlL) was added to a solution of 
6-DI-pyrrole-2-carboxaldehyde 4.15 (20mg, 0.21mmol). Hunigs Base (41JlL, 
0.21rnrnol) and DMAP (2.6mg. 0.021mmol) dissolved in CH2Cl2 (2rnL) under 
N 2. The resultant brown oil was found to be 1 H NMR pure for the N-
c1nnarnoyl-p-2-CDO 4.23. 
All the data with the exception of the 1 H NMR spectrum and mass 
spectrum were identical to the non-labelled N-cinnamoyl-p-2-c 2.31. 
[6-Dl]-1-(3-Phenylpropanoyl)-2-formylpyrrole 4.23. IH NMR 0 3.16 
(2H, t. J=7.2Hz. COCH2); 3.27 (2H, t, J=7.2Hz. CH2Ph); 6.33 (1H, t, J=3.1Hz, 
H-4); 7.21 (1H. ddt J=3.1 & 1. 6Hz, H-3); 7.24 (2H, m, Ph-arornH2): 7.24 (1H, 
m, Ph-aromH4): 7.31 (2H, m, Ph-aromH3): 7.32 (lH, dd, J=3.1 & 1.6Hz, H-
5); FTIR (KBr) 3114.0, 1654.2. 1540.2cm- l ; HRMS (M) Found 228.10090 
(Ca1cd. for Cl4Hl2DINI02 228.10091); Isotopic incorporation 99.07% D. 
6.9.3.2 Reduction of 6-Dl-Formyl Pyrrole 4.23 to give 4.10 and 4.24, 
described in Section 4.6.4 
The Dl-Iabelled formyl pyrrole 4.23 was reduced under each of the 
following conditions. 
1) Achirally, under the Zn(BH412 conditions to give racemic 
hydroxylmethyl pyrrole 4.24, as described in Section 6.4.2.2. The Dl-Iabelled 
formyl pyrrole 4.23 (20mg. 0.21mmol) was dissolved in dry Et20 under N2. 
Zn(BH412 (0.25mmol, 2.3mL of O.llM solution in dry Et20, 1.2equiv.) was 
added and the resultant solution was stirred at rt for 30 min. The Et20 
solution was decanted from the organic insoluble zinc salts. Further Et20 
(2x5rnL) was added, decanted and combined with the previous washings. H20 
(2rnL) and acetic acid (2mL, 10% solution in water) were carefully added to 
the Et20 extracts. The separated aqueous phase was re-extracted with CH2Cl2 
(2x5mL) and the combined organic solvents were washed with H20 
(2x10mL). The organic phase was dried and evaporated. The resultant 
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racemic, labelled hydroxymethyl pyrrole 4.24 was pUrified by silica 
chromatography (EtOAc/Pet. Ether=1:2). All the data with the exception of 
the 1 H NMR spectra were identical to the unlabelled hydroxymethyl pyrrole 
2.32 described in Section 6.4.2.2.3. 
[6-Dl]-1-(3-Phenylpropanoyl)-2-hydroxymethylpyrrole 4.24, IH NMR 
() 3.08 (2H, dt, J=7.8 & 1. 5Hz, CH2Ph); 3.17 (2H, dt, J=7.8 & 1.5Hz, COCH2); 
3.71 (lH, bs, CH20H); 4.62 (IH. bs. CHDOH); 6.17 (lH, t, J=3.3Hz, H-4); 
6.21 (lH, m, H-3); 7.06 (lH, dd, J=3.3 & 1. 6Hz, H-5); 7.22 (lH, m, Ph-
aromH3); 7.28 (2H, m, Ph-aromH2); 7.30 (lH, m, Ph-aromH4). 
2) Chirally, under the R-alpine borane reduction conditions, Section 
6.9.3.1.1, to give the optically active hydroxymethyl pyrrole 4.10. Freshly 
prepared R-alpine borane12 (l.lequiv.) was added to a stirred solution of Dl-
labelled formyl pyrrole 4.23 (20mg. 1equiv.) in THF (lOmL). The solution was 
stirred for 4 h, then evaporated to dryness. Excess (+)-a-pinene was removed 
under high vacuum (oil pump) to yield the optically active Dl-Iabelled 
hydroxymethyl pyrrole 4.10. The cWrality of the -CDH- group was described 
as'S' by analogy with known chiral hydroxymethyl pyrroles, see Section 4.7. 
All the data, with the exception of the mass spectra, was identical to the 
racemic, labelled hydroxymethyl pyrrole 4.24 described 1) above. 
[6-Dl]-(6S)-1-(3-Phenylpropanoyl)-2-hydroxymethylpyrroIe 4.10, 
HRMS (M) Found 228.10090 (Calcd. for C14H12DINI02 228.10091); Isotopic 
incorporation 99.07% D. 
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6.9.4 Formation of the 6-Dl-Labelled N-Cinnamoyl-p-2-CHDO-camphanates 
4.25 and 4.26, described in Section 4.6.4 
6.9.4.1 N-Cinnamoyl-p-2-CHDO-eamphanate 4.25 
N-Cinnamoyl-p-2-CHDOH 4.24 was treated under the acid 
chlorlde/DMAP conditions. described in Section 6.7.3.1. 
N-Cinnamoyl-p-2-CHDOH 4.24 (20mg. 0.09mmol), DMAP (llmg. 
0.09mmol. 1equiv.) and Hiinigs base (19~L. O.llmmol. 1.2equiv.) were 
dissolved in CH2Cl2 (5mL) at rt. (-)-Camphanlc chloride (19mg. 0.09mmol. 
1equiv.) was added and the resultant solution was stirred for 24 h under N2. 
EtOAc (10mL) was added and the organic solvents were washed with citric 
acid (10mL. 10% solution in H20). water (2x10mL), dried and evaporated to 
dryness. The resultant pyrrolic ester was purified by silica chromatography 
(EtOAc/Pet. Ether= 1 :2) to yield the labelled camphanate 4.25. 
(1S)~( -)-I-(S-Phenylpropinoyl)pyrrol-2-ylmethyl Camphanate 4.25. 
gave 38mg (99%) as a brown solid; Rf 0.30; [0:]D 1S -860 (e1. MeOH): IH NMR 
() 0.89 (3H. s. camph-CH3); 0.95 (3H. s. camph-CH3); 1.03 (3H. s. camph-
CH3); 1.59 (2H. m. camph-CH2); 1.83 (lH. m. camph-CH2); 1.94 (lH. m. 
camph-CH2); 2.34 (2H. m. camph-CH2); 2.99 (2H. dt. J=6.8 & 2.0Hz. 
CH2Ph); 3.10 (2H. dt. J=7.0 & 1.8Hz. COCH2): 5.39 (lH. ABq. J= 1204Hz. 
CH20-camph); 5.43 (lH. ABq. J=12.4Hz. CH20-camph); 6.14 (lH. t. J=3.5Hz. 
H-4); 6.29 (lH. m. H-3); 7.07 (lH. dd. J=3.5 & 1.5Hz. H-5); 7.15 (2H. m. Ph-
aromH3); 7.19 (2H. m. Ph-aromH2); 7.24 (lH. m. Ph-aromH4); 13C NMR () 
9.7 (camph-CH3): 16.6 (camph-CH3); 16.6 (camph-CH3); 29.0 (camph-CH2): 
30.2 (CH2Ph): 30.7 (camph-CH2); 37.2 (COCH2); 54.2 (camph-C); 54.8 
(camph-C); 60.9 (CH20-camph); 91.2 (OCO-camph-C); 111.8 (C-4): 116.3 (C-
3); 121.4 (C-5); 126.5 (Ph-aromC4); 128.4 (Ph-aromC2); 128.6 (Ph-aromC3); 
129.1 (C-2); 140.0 (Ph-aromC1); 167.1 (CH20-CO); 170.5 (CO); 178.3 
(camph-CO); FTIR (neat) 2966.1. 1789.3. 1748.6. 1731.2. 1495.4cm-1; UV 
(CHC13) 286.4. 266.4nm; m/ e (EI. 70eV) 409 (M. 2.7%); 277 (B. M-C7HS+. 
100%); 80 (C5H6N+. 67.6%): HRMS (M) Found 409.18891 (Calcd. for 
C24H27NI0 5409.18891). 
6.9.4.2 N-Cinnamoyl-p-2-CHDO-eamphanate 4.26 
The Dl-Iabelled camphanate 4.26 was prepared under the same 
conditions as in Section 6.9.4.1 from the D I-labelled hydroxymethyl pyrrole 
4.10. 
N-Cinnamoyl-p-2-CHDOH 4.10 (20mg. 0.09mmol) was treated under 
the acid chloride/DMAP conditions. as described above. 
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The resultant pyrrolic ester was purified by silica chromatography 
(EtOAc/Pet. Ether= 1 :2). All the data with the exception of the I H NMR. 13C 
NMR spectra and the mass spectrum were identical to the racemic. labelled 
camphanate 4.25. 
[6-D I]-{6S, IS)-( -)-I-(3-Phenylpropinoyl)pyrrol-2-ylmethyl 
Camphanate 4.26. I H NMR 00.89 (3H. s, camph-CH3); 0.95 (3H. s. camph-
CH3); 1.03 (3H. s, camph-CH3); 1.59 (2H. m. camph-CH2); 1.83 (lH, m, 
camph-CH2); 1.94 (lH, m, camph-CH2); 2.34 (2H, m, camph-CH2); 2.99 (2H, 
dt, J=6.8 & 2.0Hz, CH2Ph); 3.10 (2H, dt, J=7.0 & 1. 8Hz, COCH2); 5.38 (IH. S, 
CHDO-camphl; 6.14 (lH, t, J=3.5Hz, H-4); 6.29 (lH, m, H-3); 7.07 (lH, dd, 
J=3.5 & 1. 5Hz, H-5); 7.15 (2H, m, Ph-aromH3); 7.19 (2H, m, Ph-aromH2); 
7.24 (lH. m. Ph-aromH4); 13C NMR 09.7 (camph-CH3); 16.6 (camph-CH3): 
16.6 (camph-CH3): 29.0 (camph-CH2); 30.2 (CH2Ph); 30.7 (camph-CH2); 37.2 
(COCH2); 54.2 (camph-C); 54.8 (camph-C); 60.9 (CHDO-camph. t. J~ 
n=23.6Hzl; 91.2 (OCO-camph-C); 111.8 (C-4); 116.3 (C-3); 121.4 (C-5); 126.5 
(Ph-aromC4); 128.4 (Ph-aromC2): 128.6 (Ph-aromC3); 129.1 (C-2); 140.0 
(Ph-aromC1); 167.1 (CH20-CO); 170.5 (CO); 178.3 (camph-CO); HRMS (M) 
Found: 410.19521 (Calcd. for C24H26DINI05 410.19519); Isotopic 
Incorporation 90.01% D. 
The Dl-Iabelled camphanate 4.26 was found to be the same 
confIguration at pyr-CHD-R as the starting material 4.10 on the basis of IH 
NMR spectral analysis of the known configuration of similar pyrrolic 
camphanates l7. The configuration was therefore assigned as ·S'. 
6.9.5 Hydrolysis of N-Cinnamoyl-p-2-0Ac 3.36 for Elucidation of Mechanism 
of Hydroxide Attack on 2.32, described in Section 4.6.5 
N-Cinnamoyl-p-2-0Ac 3.36 (lmg, 3llmol) was dissolved in d3-CD3CN 
(0.6mL) and n-BuNH2 (0.35IlL, 31lmol, lequiv.) was added. KOH (7.5IlL, 
0.44mmol, solution KOH in D20, 1equiv.) was added and the IH NMR spectra 
obtained at t=30 s. The rate of reaction was monitored via the pyr-CH2X I H 
NMR signals, X=OCOCH3 5. 35ppm, X=OCOCH2CH2Ph 5.07ppm, X=NHn-Bu 
3.62ppm the rate of deacylation is discussed in Section 4.6.2. 
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Raw Data for Hydrolysis of 3.36t 
Time 2 Equiv. 
t (min) HO-
0.0 164.3 
1.5 163.9 
2.5 162.8 
4.0 161.4 
5.5 159.9 
7.5 158.9 
10.0 159.0 
12.0 159.4 
14.0 155.2 
20.0 154.2 
25.0 152.2 
30.0 154.3 
40.0 153.7 
50.0 152.9 
70.0 151.2 
85.0 151.2· 
t Data Collected at 23.1 °C; • End of Data Collection 
Table 6.3 
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6.10 Azafulvene Chemistry: Experimental Evidence. described 
in Section 4.7 
6.10.1 Decompostion of 2-Hydroxymetbyl Pyrrole 4.1 
P-2-c (10mg. O.l1mmol) was dissolved in dry ether, followed by the 
addition of Zn(BH4)2 (0. 13mmol, 1.0mL of O.llM solution in dry Et20, 
1.2equiv.) was added and the resultant solution was stirred at rt for 30 min. 
The Et20 solution was decanted from the organic insoluble zinc salts. Further 
Et20 (2x5mL) was added, decanted and combined with the previous 
washings. H20 (2mL) and acetic acid (2mL. 10% solution in water) were 
carefully added to the Et20 extracts. The separated aqueous phase was re-
extracted with CH2 Cl2 (2x5mL) and the combined organic solvents were 
washed with H20 (2x10mL). The organic phase was dried and evaporated. 
The IH NMR spectra was consistent with authentic 2-hydroxymethyl pyrrole 
4.111. 
4.1 (5mg. 5J.lmol) was dissolved in d3-CD3CN (0.6mL) and the IH 
NMR spectra were recorded. After 2 h the 1 H NMR spectra of 4.1 had 
broadened into the baseline, suggesting polymer formation. The NMR tube 
had also become stained. 
6.10.2 Azafulvene Formation Suppressed by N-Acylatlon: Evidence Gained 
from Camphanates 4.25,4.26 and 4.28. discussed in Section 4.7.1 
The preparation of the camphanates 4.25 and 4.26 used in this 
Section is discussed in Section 6.9.4. 
The camphanate 4.28 was prepared via the Mitsunobu reaction on the 
chiral. labelled hydroxymethyl pyrrole 4.10. N-Cinnamoyl-p-2-CHDOH was 
treated under the Mitsunobu reaction conditions, described in Section 
6.7.3.2. 
N-Cinnamoyl-p-2-CHDOH 4.10 (30mg, 0.08mmol), triphenyl 
phosphine (45mg. 0.17mmol. 2.1equiv.) and (-)-camphanic acid (35mg. 
0.18mmol, 2.2equiv.) were dissolved in dry THF (10mL). Stirring for 5 min 
followed. then DEAD (27J.lL. 0.17mmol, 2.1equiv.) was added. The reaction 
was stirred for 3 h at rt under N2. The solvents were evaporated. and the 
residue then dissolved in CH2Cl2 (0.5mL). The solution was passed through a 
silica column (2cm, EtOAc/Pet. ether= 1:2 elutent). Chromatography 
(EtOAc/Pet. Ether=1:2) of the resultant oil then yielded 4.28. All the data, 
with the exception of the IH NMR spectra were identical to the Dl-Iabelled 
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camphanate 4.25. described in Section 6.9.4.2. 
(6S ,lS)-( -)-1-(3-Phenylpropinoyl)pyrrol-2-ylmethyl Camphanate 
4.28,lH NMR 00.89 (3H. s. camph-CH3); 0.95 (3H. s. camph-CH3); 1.03 (3H. 
s, camph-CH3); 1.59 (2H. m. camph-CH2); 1.83 (lH. m, camph-CH2); 1.94 
(lH, m. camph-CH2); 2.34 (2H. m, camph-CH2); 2.99 (2H. dt, J=6.8 & 2.0Hz, 
CH2Ph); 3.10 (2H, dt. J=7.0 & 1. 8Hz, COCH2); 5.39 (IH, S, CHDO-camp); 6.14 
UH, t, J::::3.5Hz, H-4); 6.29 (lH. m. H-3); 7.07 (lH, dd, J::::3.5 & 1.5Hz, H-5); 
7.15 (2H. m. Ph-aromH3): 7.19 (2H, m. Ph-aromH2); 7.24 (IH, m, Ph-
aromH4); 
The camphanate 4.28 was found to have a major component as the 
opposite configuration, ie: 'R' at pyr-CHD-R to that of the starting material 
4.26, ie: 'S', this is discussed in Section 4.7.1. 
Derivation of NMR Signal Configuration Configuration 
Camphanate 0 %'S' °Al'R' 
Achiral Reduction 4.25 5.38:5.39 49 51 
ACid Chloride/DMAP 4.26 5.38 99 1 
Mitsunobu 4.28 5.39t 39 61 
t Maj or Signal 
A discussion of the IH NMR spectral results is found in Section 4.7.1. 
6.10.3 Pyrrole Amines 4.6, 4.35 and 4.36: Evidence for Azafulvene Formation, 
described in Section 4.7.2 
The hydrolysis of non-labelled N-(N-Pth-Leu)-p-2-0H 3.45 and 6-Dl-
labelled N-(N-Pth-Leu)-p-2-CHDOH 4.14 were carried out in the presence of 
sec-BuNH2. 
6.10.3.1 Trial Hydrolysis of the Hydroxymethyl Pyrrole 3.45 
N-(N-Pth-Leu)-p-2-0H 3.45 (5mg, O.Olmmol) was dissolved in d3-
CD3CN (0.6mL) and racemic sec-BuNH2 (1.2).LL. O.Olmmol, 1equiv.) was 
added .. Addition of KOH (10).LL, 0.44mmol, KOH solution in D20, 1equiv.) 
caused rapid hydrolysis of to the pyrrolic ester 4.13, described in Section 
6.9.4.2, and the pyrrole amine 4.35. 
2-(1-Methylpropanoylamino)methylpyrrole 4.35, an unstable, isolated 
oil; IH NMR 0 0.92 (3H. t, J=7.2Hz. CH2CH3); 1.11 (3H, d, J=6.3Hz. 
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CH(CH3)); 1.43 (2H. m. CH2CH3); 2.89 (lH. m. CH); 3.54 bH. A part ABg. 
J= 14.2Hz. pyr-CH2); 3.56 flH. B part ABg. J= 14.1Hz. pyr-CH21; 5.98 (lH. m. 
H-3); 6.03 (lH. t. J=2.9Hz. H-4); 6.72 (lH. m. H-5); 13C NMR () 12.5 
(CH2CH3); 25.6 ((CH)CH3); 39.6 (CH2CH3); 45.8 (CH); 54.9 (Pyr-CH2); 106.7 
(C-4); 107.2 (C-3); 116.9 (C-5); 128.4 (C-2); m/e (EI. 70eV) 152 (M. 12.6%); 
123 (M-CH2CH3. 18.1%); 80 (B. M-NHBu. 100%); HRMS (M) Found 
152.13134 (Calcd. for CgH16N2 152.13134). 
6.10.3.2 Hydrolysis of the ChiraL Labelled Hydroxymethyl Pyrrole 4.14 
N-(N-Pth-Leu)-p-2-CHDOH 4.14 (5mg. O.Olmmol) was dissolved in 
d3-CD3CN (0.6mL) and chiral (S)-(+)-sec-BuNH2 (1.2~L. O.Olmmol. 1equiv.) 
was added. Addition of KOH (10~L. 0.44mmol. KOH solution in D20. 1equiv.) 
caused rapid conversion to the Dl-Iabelled pyrrolic ester 4.19. described in 
Section 6.9.4.3. and the Dl-Iabelled pyrrole amine 4.36. 
The data for 4.36 was identical to that described for the unlabelled 
amine 4.35. except for the IH NMR spectrum. 
[6-D 1]-(8S)-( + )-2-( I-Methylpropanoylamino)methylpyrrole 4.36. an 
unstable. isolated oil; IH NMR 0 0.92 (3H. t. J=7.2Hz. CH2CH3); 1.11 (3H. d. 
J=6.3Hz. CH(CH3)); 1.43 (2H. m. CH2CH3); 2.89 (lH. m. CH); 3.54 flH. s. 
pyr-CHD); 3.56 flH. s. pyr-CDH); 5.98 (lH. m. H-3); 6.03 (lH. t. J=2.9Hz. H-
4); 6.72 (lH. m. H-5). 
This is consistent with azafulvene chemistry to give the racemic 
product 4.36. 
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6.11 Work Descn'bed in Chapter Five 
6.11.1 a-Chymotrypsin Assay of 2.52, 2.55, 3.45, 3.53 and 3.55. described in 
Section 5.1 
6.11.1.1 GeneralAssay Conditions 
The assay was based on a colourimetric technique and carried out in 
microtitre plates (NUNC flat bottomed plates, GIBCO). The enzyme and test 
solution were preincubated to ensure maximum inhibition before addition of 
substrate. After the addition of substrate the optical density was measured 
over approximately 2 h. The lack of colour development. caused by enzymic 
release of 4-nitroanilide derivatives. indicated inhibition. Control samples 
were included in all cases. Each sample had a duplicate that was tested in 
conjunction with each other. MeOH was used to dissolve the proposed 
inhibitor and for sample dilution, as it is H20 soluble and directly compatible 
with the assay system. 
6.11.1.2 a-ChYTTlDtrypstnAssay18,19 
Solutions of the pyrroles 2.52, 2.55, 3.45, 3.53 and 3.55 were made to 
12.5jlg mL-1 and 1251lg mVl in dry MeOH. Tris-HCl (50IlL of 0.4M solution in 
H20. pH 7.6). test solution (IOOIlL) and a-chymotrypsin solution (50IlL, Sigma 
ex-Porcine pancreas. 9units mL-l in 50mM Tris-HCI buffer pH 7.6) were 
added to each well of the microtitre plate. Incubated at 37°C for 30 min was 
followed by the addition of N-succinyl-phenylalanine-4-nitroanilide (IOOIlL. 
ImgmL-l solution in 50mM Tris-HCI buffer, pH 7.6). The absorbance was read 
at 410nm at t=O, and after incubation at 37°C when significant colour change 
had taken place (apprOximately 0.4 absorbance units per h at 37°C). 
The inhibitor results are given in Section 5.1. 
6.11.2 HIV-1 Protease Assay20 of 2.32, 2.52, 3.39, 3.53 and 3.55, described in 
Section 5.2 
The method described by Dreyer was used for the HIV-I protease 
assay21. The samples were preincubated for 1 h with the enzyme in the 
MENDT buffer at pH 6.0. at 37°C. Addition of the substrate to the system 
started the peptidolytic reaction. After 20 min the amount of inhibition was 
determined. 
The inWbitlon results are detailed in Section 5.2. 
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6.11.3 Pyrrole Derivatives Stablllty Test, described in Section 5.2 
Hydroxymethyl pyrrole 2.52 (10mg, O.04mmol) was dissolved in 
DMSO (2mL) and placed in an acidic buffer (10mL, potassium 
phthalate/phthalic acid pH 5.9) at 37°e for one hour. After fifteen minutes a 
, 
precipitate had formed indicating decomposition. The precipitate was 
insoluble in water, and chloroform, and was attributed to pyrrolic polymer 
formation. 
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Appendices 
7.1 Abbreviations 
Ac 
AIDS 
Boc 
bs 
Bu 
Cbz 
COSY 
dd 
DCC 
DEAD 
DEPT 
DMAP 
DMF 
DMSO 
Et 
Fmoc 
HETCOR 
HIV 
H llnigs Base 
IR 
m 
MS 
m/e 
NMR 
NOE 
ORD 
p-2-c 
pth 
q 
s 
t 
1LC 
TEA 
THF 
Ts 
UV 
acetyl 
acquired immunodeficiency syndrome 
N- tert-butoxycarbonyl 
broad singlet (NMR) 
butyl 
benzyloxycarbonyl 
correlation spectroscopy 
doublet of doublets (NMR) 
1.3-dicyclohexylcarbodiimide 
diethyl azodicarboxylate 
distortionless enhancement by popuhition 
transfer 
4-dimethylaminopyridine 
N.N-dimethylformamide 
dimethylsulfoxide 
ethyl 
((9-fluorenylmethyl) oxy) carbonyl 
heteronuclear correlation 
human immunodeficiency virus 
N.N-diisopropylethylamine 
infrared 
multiplet (NMR) 
mass spectra 
mass to charge ratio (MS) 
nuclear magnetic resonance 
nuclear Overhauser enhancement 
optical rotary dispersion 
pyrrole-2-carboxaldehyde 
phthalyl 
quartet (NMR) 
singlet (NMR) 
triplet (NMR) 
thin layer chromatography 
triethylamine 
tetrahydrofuran 
tosyl (p-toluenesulfonyl) 
ultraviolet 
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7.2 Amino Acid Glossary 
VCOR 
I 
R' 
Pro 
proline 
R·HN ............. COR 
CH3 
Ala 
alanine 
o C<N-R 
o 
Pth 
Ts 
R'HN ............. COR R'H N ............. COR R'HN ............. COR 
~ 
Ph"""" HO"""" HOOC"""" 
Phe Ser Asp 
phenylalanine serine aspartic acid 
R·HN ............. COR R·HN ............. COR R·HN ............. COR 
-Y 
Gly Leu 
glycine leucine 
~NR Vo 
Cbz 
pnitrophenyl ester 
~ 
Val 
valine 
o 
Fmoc 
F 
I~ F*F 
RO 6-. F 
F 
penta-fluorophenyl 
ester 
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7.3 Pyrrole Glossary 
1.3 
azafulvene 
2.31R=CHO 
2.32R=CI\OH 
~OH 
N 
PthN0 
_ 0 
y 
U N CRO 
H 
p-2-c 
pyrrole-2-carboxaldehyde 
~ N R 
PthN0 
= 0 
Ph/ 
2.37R=CHO 
2.52R=CH20H 
~ N R 
H3CAo ' 
2.24R=CHO 
2.47R=CI\OH 
~OH 
N 
pthN~o 
Ph 
2.55 
3.45 3.39 
~OH 
H 
4.1 
~O Ph~~~ 
N ~ N 
H 0 H 
4.5 4.6 
~()MP: 
N 
H 
4.2 
n 0' CH 'N~ I( 3 
~o 0 
Ph 3.36 
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